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ABSTRACT

Hess, David A. Ph D., Purdue University, December 2013. Establishing the role of the
transcription factor MIST1 in XBP1-mediated maintenance of pancreatic acinar cell
homeostasis. Major Professor: Stephen F. Konieczny.
Pancreatic acinar cells (PACs) continuously produce more protein than any other cell
type in the human body. As a result, PACs and other specialized secretory cells have a
constant demand placed on their protein synthetic and packaging machinery. When
demand for secreted products exceeds the capacity of the cell’s basal protein production
facilities, dangerous accumulations of misfolded proteins can build up, resulting in a
condition known as ER stress. To ameliorate this stress, secretory cells activate a
coordinated, three-part compensatory network collectively known as the unfolded protein
response (UPR) to both expand the capacity of the ER and directly assist in refolding or
degradation of aberrant peptides. Interestingly, others have hypothesized that the UPR
branches largely overlap in their functions and targets, prompting us to investigate
whether loss of the IRE1/XBP1 branch via conditional ablation of XBP1 in mature mouse
PACs could be compensated for by the remaining UPR pathways. We show that survival
and homeostasis of PACs is wholly dependent on the IRE1/XBP1 axis of the UPR.
Specifically, ablation of Xbp1 in mouse PACs results in a gradual but cumulative onset of
irreversible ER stress. This results in abrogation of normal digestive enzyme synthesis,
onset of extensive signs of pancreatic distress, and eventual apoptosis via ER stressinduced death pathways. Remarkably, we also show that the pancreas initiates a robust
regenerative response via cell cycle reentry and proliferation of multiple adult cell types.
This regenerative mechanism rapidly restores a functioning exocrine compartment and
provides a novel means to study pancreatic damage and recovery from intrinsic stress
events. Finally, we investigated the role of the acinar cell-specific transcription factor
MIST1 as a downstream effector of XBP1. We verify that MIST1 is a direct target of
XBP1, and a number of MIST1 target genes directly participate in facilitating cell
recovery and survival during ER stress. Together, these data indicate that XBP1 and

xiv
MIST1 cooperate to sustain pancreatic acinar cells during times of high protein demand.
Future disease research exploiting stress induction via modulation of the XBP1/MIST1
transcriptional network may be used to generate novel therapeutics for treatment of
pancreatitis and pancreatic cancer.

1

CHAPTER 1. INTRODUCTION
1.1 Regulated secretion is a necessary component of metazoan survival
The generation and distribution of secreted cell products in higher eukaryotes occurs
through regulated cellular pathways that ensure proper homeostatic maintenance.
Internal- and externalization machinery is present in all multicellular organisms, and it
facilitates cellular environmental responses and survival via its role in trafficking of
signaling molecules to and from the cell surface, recycling and acquisition of necessary
cell components, and transport of synthesized products to extracellular spaces. For
many multicellular species including humans, specialized secretory cells are responsible
for synthesis, packaging, and secretion of proteins necessary for regulation of life
processes. In secretory cells, proteins destined for export are differentially processed
and packaged to allow for expulsion from the cell and subsequent action upon a target
tissue. At an organism level these secreted products often serve as vital components of
maintenance and regulatory mechanisms including essential processes such as
immunity and digestion. Due to the necessity of secreted products for survival, secretory
cells have evolved unique mechanisms to regulate the synthesis and release of proteins.
Secretory cells possess extensive protein production and secretion capabilities, thus
requiring a more developed regulatory system for ensuring proper protein production.
Examples of secretory cells include plasma B cells that secrete antibodies as a
component of the adaptive immune response, gastric chief cells that generate proteases
and hydrolases in the stomach, and pancreatic acinar cells that synthesize and secrete
inactive digestive enzyme precursors (zymogens) for eventual transport to the
duodenum. Each of these cell types share common phenotypic and molecular
characteristics including extensive ER and Golgi networks, a high degree of
responsiveness to extracellular signals required to coordinate the actions of many cells,
and expression of common transcription factors such as the basic helix-loop-helix
transcription factor Mist1 (discussed in section 1.5) (Acosta-Alvear et al., 2007; Pin et al.,
2000). Additionally, secretory cells often cooperate and form structures that allow
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multiple individual cells to secrete their contents into a shared lumen that relays the now
concentrated products into a ductal network. These structures, termed acini, can be
found in body tissues including lactating mammary glands and the pancreas. These
cellular characteristics are essential to the regulation of the complex secretory process.
All eukaryotic cells utilize separate but overlapping pathways for internalization
(endocytosis) of receptors and extracellular molecules and externalization (exocytosis)
of required cell surface molecules, extracellular matrix components, and secreted factors
(Figure 1.01). Vesicular endocytosis often initiates at clathrin- or caveolin-coated pits
that form upon assembly of protein complexes at the membrane and initiate the
internalizing process, although specialized pathways dependent on IL2Rβ, ARF6, flotillin
and other proteins have also been described (Doherty and McMahon, 2009).
Internalized vesicles are typically tagged and sorted into one of several categories
including, but not limited to, the recycling endosome for return to the cell surface, the late
endosome for sorting and transport along microtubules to various cell compartments, or
the endolysosome for degradation (Mellman, 1996). This sorting process assures that
the separate tasks of facilitating the relay of signals from the extracellular environment
and acquisition and recycling of membrane and ECM components can utilize similar
cellular machinery without interference.
Exocytosis, or more specifically protein secretion, is divided into two unique pathways; a
constitutive and a regulated system (Figure 1.02a). The constitutive pathway is utilized
for packing of proteins into vesicles that are constantly released from the membrane,
while regulated secretion is used to generate vesicles with highly concentrated protein
contents that are stored and only secreted upon receipt of an external secretory signal,
termed a secretagogue (Burgess and Kelly, 1987). Both pathways share early trafficking
steps as peptides destined for secretion or requiring extensive protein modification enter
the endoplasmic reticulum (ER) and proceed to the cis golgi network for processing
(Figure 1.1) (Kelly, 1985). Specifically, membrane-bound ribosomes synthesize a preprotein containing the complete amino acid sequence but lacking substantial secondary
structure (Mains et al., 1987). These peptides typically contain signal sequences on their
N-terminal tails that trigger translocation of the pre-proteins into the ER and subsequent
cleaving or modification of the signal sequences (Mains et al., 1987). Once inserted into
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Figure 1.1
Vesicular transport is utilized to convey signals and transport cell
products to and from the plasma membrane.
Exocytosis (red arrows) of secreted products involves vesicle-mediated transport from
the ER to the cis Golgi, through the Golgi cisternae, and packaging into one of several
types of secretory vesicle. Endocytosis (blue arrows) begins in coated pits that trigger
vesicle formation around the internalized component and eventual sorting either back to
the membrane or to other cell compartments. Retrograde movement of preexisting
vesicles is also shown (green arrows).
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Figure 1.2
Golgi

Proteins requiring extensive folding or processing traffic through the trans

(A) Constitutively secreted proteins (red circles) are packed loosely into vesicles and are
delivered directly to the membrane (left). Both lysosomal enzymes and proteins
undergoing regulated secretion are highly concentrated into budding vesicles (right).
Lysosomal enzymes (blue triangles) form separate vesicles based on the presence of a
mannose-6-phosphate tag. Proteins destined for regulated secretion (green diamonds)
are packaged into immature secretory granules (ISGs) where excess lipid and cytosolic
components are reclaimed. These vesicles then undergo fusion with other ISGs to
become mature secretory vesicles. (B) Pancreatic acinar cells form polarized, multicellular structures called acini (left, yellow dotted line) with basally-localized nuclei (N)
and ER and apically-localized zymogen granules (ZGs). These zymogen granules are
coordinately secreted into an adjoining ductal network (left, white dotted line). Electron
microscopy (right) reveals an extensive ER network and the apically localized zymogen
granules (white arrows).
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the ER lumen, glycoproteins destined for secretion or other cell fates are modified by the
addition of carbohydrate groups, while the cis Golgi network serves to modify these
attachments to allow for proper sorting and packaging into vesicles (Cooper, 2000).
Upon entering the trans Golgi network (TGN), proteins fated for either the constitutive or
regulated secretory pathways diverge and are packaged separately (Burgess and Kelly,
1987).
Sorting of processed proteins occurs in the TGN, where products can be diverted to
lysosomes, passed directly to the membrane via constitutive secretion, or stored in
secretory vesicles for regulated secretion. Lysosomal glycoproteins passing through the
Golgi are heavily modified and tagged for transport to the lysosome via attachment of
mannose 6-phosphate (M6P) to carbohydrate groups previously added in the ER
(Figure 1.02a, right). The M6P attachment is recognized by receptors in the TGN and
triggers packaging of the tagged enzymes into clathrin-coated vesicles for transport to
the lysosome (Glickman and Kornfeld, 1993). For secreted proteins, the constitutive
secretion pathway serves as a default, as proteins lacking any other recognition
sequences are directly trafficked to the plasma membrane (Burgess and Kelly, 1987).
The constitutive pathway is utilized for targeting of necessary cellular components
including plasma lipids and extracellular matrix components such as glycoproteins
(Burgess and Kelly, 1987). Constitutive secretion does not generate vesicles that are
stored within the cell for long periods of time; exocytosis takes place immediately after
vesicle formation rather than in response to external stimuli (Figure 1.02a, left) (Kelly,
1985). Indeed, constitutive secretory vesicles often traffic from the TGN to the plasma
membrane in as little as 10 minutes as compared to regulated secretory vesicles with a
cytoplasmic lifetime from hours to days (Grampp et al., 1992). As a result, proteins
secreted in this fashion do not achieve a high degree of protein concentration within
vesicles, a feature unique to the regulated secretory pathway (Burgess and Kelly, 1987).
Regulated secretion defines a specific exocytosis pathway common to secretory cells in
which synthesized products are diverted to specialized compartments within the TGN.
The sequestering of secretory proteins within the TGN allows for a substantial increase
in their concentration, often reaching densities ten to one hundred times higher than that
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of the early Golgi (Burgess and Kelly, 1987). After deposition of proteins into the isolated
compartment, the chamber is budded off from the TGN as an immature vesicle. This
vesicle fuses with other immature vesicles and continues to be modified as excess
membrane and cytosolic components are reclaimed and recycled, resulting in a mature
secretory vesicle with a much higher concentration of protein than the initial
compartment (Figure 1.02a, right) (Vitale and Denecke, 1999). These vesicles are
carried via attachment to the cytoskeleton to specific locations within the cell for storage
before eventual exocytosis in response to a hormonal or chemical signal (Burgess and
Kelly, 1987; Wacker et al., 1997). Cytoskeletal trafficking to distinct membrane locations
(required for apical/basal polarized cells) is accomplished via vesicle membraneembedded tags as well as the action of multiple members of the Ras superfamily of
small GTPases (Hsu et al., 2004). Standard light as well as electron microscopy of
exocrine secretory cells reveal that secretory vesicles appear as electron-dense
granules that are often localized to a specific location within the cell in order to allow for
rapid, directional release into an adjoining ductal network (Figure 1.02b). Due to the
prodigious quantities of protein required for the generation of secretory vesicles,
secretory cells utilize unique adaptive responses to control protein throughput.
All secreted proteins require ER processing, as correct peptide modifications and
arrangement of hydrophobic amino acids into the interior of the protein structure are
necessary for both membrane and extracellular fluid solubility. As such, secretory cells
have a uniquely specialized cellular anatomy, often utilizing transcriptional networks to
establish a physically expanded ER lumen in order to accommodate increased protein
biosynthesis (Federovitch et al., 2005). This expansion was first noted during B
lymphocyte differentiation into plasma B cells (Wiest et al., 1990), and has been
demonstrated in both B cells and fibroblasts to be dependent upon expression of the ER
stress-responsive transcription factor XBP1 (Shaffer et al., 2004; Sriburi et al., 2004).
XBP1 serves to upregulate a number of genes as a component of the compensatory
unfolded protein response (UPR), discussed at length in section 1.4. These gene targets
both expand the ER and increase the production of protein transporters necessary for
moving proteins in and out of the ER. Other transcriptional programs, discussed in
section 1.3, also serve to ameliorate the stress placed on secretory cells by high protein
synthesis demands. These responses serve as one component of an extensive quality
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control system designed to guarantee both efficient synthesis and correct folding and
packaging of proteins.
1.2 Quality control mechanisms ensure proper protein folding following synthesis
Eukaryotic cells utilize various quality control mechanisms throughout the cell to ensure
that only properly synthesized and folded proteins are produced. This quality monitoring
system begins during transcription, when the intrinsic 3’-5’ exonuclease activity of some
DNA polymerases allows them to excise incorrectly base paired nucleotides that are
inadvertently added during replication and replace them with the correct base using the
matching strand as a template (Khare and Eckert, 2002). Similarly, DNA integrity is
monitored prior to synthesis by a checkpoint mechanism regulated by the p53 and
Ataxia-Telangiectasia Mutated (ATM) proteins (Banin, 1998). Mutations in DNA damage
regulators are intimately linked to human disease, particularly in the case of p53 which is
known to be mutated in greater than 50% of human cancers (Olivier et al., 2010). The
importance of correct transcription and translation of proteins beyond the DNA damage
pathway is illustrated in RAS-driven cancers. The oncogenic form of the Kirsten rat
sarcoma (KRAS) protein possesses a single point mutation and amino acid substitution
(G12D) that serves as the activating mutation in multiple cancers, including greater
than 90% of tumors arising in pancreatic ductal adenocarcinoma (PDA) (discussed
extensively in Chapter 6) (Hidalgo, 2010). As such, mechanisms to maintain the integrity
of the DNA sequence serve as vital controls in prevention of disease. Maintenance of
proper protein folding, however, is equally important for cell survival and homeostasis.
The folding process is primarily regulated post-transcriptionally via production of
chaperone and sensor molecules that control cellular responses to accumulations of
misfolded proteins.
Protein denaturation can be triggered both physiologically and experimentally by
exposing cells to short durations of heat. Heat exposure above normal physiological
temperatures results in accumulation of misfolded or aggregated proteins in the cytosol
as the denatured regions assume non-native conformations (Richter et al., 2010). In
unstressed conditions, hydrophobic amino acids are internalized during protein folding or
membrane embedding, and the presence of exposed hydrophobic residues in the
cytoplasm can result in dangerous protein aggregates or anomalous activity, thus
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necessitating a means for cells to sequester the misfolded proteins and to assist their
refolding. Eukaryotic cells express a class of molecules known as molecular chaperones
that aid in the refolding of these proteins as well as serving roles in the normal synthesis
of certain peptides. These chaperones, typically referred to as heat shock proteins
(HSPs) due to a characteristic increase in their expression following heat treatment, are
present throughout the cell and bind to exposed hydrophobic surfaces in denatured or
unfolded proteins (Richter et al., 2010). The specific means by which HSPs assist
protein folding vary depending on the class of chaperone and subcellular location.
Some chaperones, including the predominantly mitochondrial-localized HSP60-like
proteins, attach to exposed hydrophobic surfaces in denatured proteins and assume a
conformation that forms a protective shell around the residues to isolate them from the
surrounding cytosol (Figure 1.03a) (McClellan et al., 2005). This generates a favorable
environment for refolding of the protein as well as preventing the interaction of the
hydrophobic residues with other exposed proteins that could lead to protein aggregation.
Additionally, this complex interacts with the pro-apoptotic proteins BAX and BAK, a
binding that allows HSP60 to serve as an anti-apoptotic regulator while proteins are
given time to assume their correct conformations (Itoh et al., 2002). Other classes of
chaperones utilize different mechanisms to assist refolding.
The HSP70-like family of chaperones assists protein folding as new peptides assume
their initial conformation following translation (Figure 1.03b) (Mayer and Bukau, 2005).
Prior to interaction with an unfolded protein, HSP70-like chaperones are ATP-bound and
have an open conformation with an exposed protein binding domain and exhibit only
weak intrinsic ATPase activity (Mayer and Bukau, 2005). Upon binding to (and
effectively sequestering) hydrophobic residues in a folding peptide, ATP hydrolysis takes
place and the chaperone changes conformation, now exhibiting an increased affinity for
the bound protein. During this time, mechanisms that have not been fully elucidated
allow HSP70-like proteins to change conformation and directly assist in solubilization
and folding of these substrates (Mayer and Bukau, 2005). Following dissociation of ADP
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Figure 1.3
Heat-shock proteins and the proteasome cooperate to repair or degrade
misfolded proteins
(A) HSP60 interacts with misfolded proteins via binding to exposed hydrophobic
domains. An ATP-dependent interaction allows a GroES “cap” to bind, resulting in a
protected, internal cavity that facilitates protein refolding. (B) HSP70 binds hydrophobic
regions of proteins emerging from the ribosome in an ATP-dependent reaction. HSP70
remains bound until hydrophobic residues are sequestered inside the folding protein,
then dissociates. (C) The proteasome is a multi-subunit complex that forms a hollow,
tube-like structure with internal proteolytic activity. (D) The E1a-c proteins form a
complex with E1 loading ubiquitin molecules onto E2, which subsequently adds the
ubiquitin to a substrate held in place by E3. Ubiquitinated proteins are then bound by a
recognition factor (RF) which promotes proteasome formation that subsequently
degrades the tagged protein.
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and Pi and reloading of the ATP, HSP70-like chaperones return to their open state and
release their bound substrate. These two chaperone families, as well as most chaperone
classes, all share common features that allow them to bind to unfolded protein regions in
an attempt to generate a soluble or sufficiently protected structure (McClellan et al.,
2005). When proteins are unable to assume their native conformations despite
chaperone action, cells utilize alternative strategies to identify, tag, and destroy
misfolded peptides.
The chaperone-mediated mechanism for assisted refolding operates alongside a
destructive pathway that utilizes proteolytic enzymes to degrade proteins with exposed
hydrophobic regions (Heinemeyer et al., 1991). This process is accomplished via an
ATP-dependent, multi-subunit complex termed the proteasome that, in the case of
misfolded proteins, uses embedded protease enzymes to unfold and cleave bound
substrates (Figure 1.03c) (Elsasser and Finley, 2005). Misfolded proteins are marked
for degradation via attachment of a polyubiquitin tag by a series of ubiquitin-activating
enzymes (UAEs) termed E1, E2, and E3 ligases (Pines and Lindon, 2005). UAEs
become targeted to misfolded proteins either via attachment of signal molecules by ERresident sensors that can be recognized by E3 (discussed in section 1.3) or via
recognition by E3 of certain hydrophobic motifs that are aberrantly exposed in denatured
proteins (Pines and Lindon, 2005). The UAEs each function in a coordinated manner,
with E1 enzymes loading ubiquitin molecules onto E2, while the E2 and E3 enzymes act
in concert to target (a process mediated by the E3 subunit) to polyubiquitinate (via the
E2 subunit) proteins that are to be destroyed (Pines and Lindon, 2005). The presence of
the polyubiquitin tail added by the E2 subunit following recognition stimulates attachment
of any of several targeting proteins that then trigger the formation and binding of the
proteasome complex and subsequent proteolytic degradation of the tagged protein
(Elsasser and Finley, 2005). While both the proteasome and the heat-shock proteins
allow recovery and destruction of misfolded proteins, neither of these systems can
regulate the process of translation that initially produces these peptides. This limits their
responsiveness to intrinsic protein folding stresses that may be triggered by the sudden,
rapid demand for protein synthesis often seen in secretory cells.
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Correct protein folding is particularly important for peptides destined for membrane
deposition or secretion from the cell. For proteins trafficked to the membrane, improper
arrangement of hydrophobic and hydrophilic regions can lead to insolubility in the lipid
bilayer, improper trafficking of receptors, or receptors that are unable to relay signals
from extracellular stimuli, all conditions observed as causative agents in human disease
(Kim and Rao, 2010). Improperly folded secreted proteins can also be detrimental due to
the possibility of aggregation in extracellular spaces or loss of function at the target site.
Indeed, secreted protein aggregates are believed to contribute to a number of human
diseases including the aggregation of amyloid-β in neuronal spaces in Alzheimer’s
disease and the aggregation of islet amyloid polypeptide in the pancreas during type II
diabetes (DeToma et al., 2012). In order to maintain efficient and effective protein
synthesis, homeostatic mechanisms have evolved in order to sense and respond to
accumulations of misfolded proteins while peptides are still progressing through the ER,
a condition known as ER stress (Oslowski and Urano, 2011). These mechanisms,
collectively termed the unfolded protein response (UPR), serve to regulate protein
processing, folding, and degradation via upregulation of chaperones, increased
expression of ER-associated degradation (ERAD) proteins, and direct modulation of
translation initiation (Walter and Ron, 2011). Additionally, specific components of the
UPR can trigger apoptosis if ER stress cannot be ameliorated. Recent work has
demonstrated that the UPR plays a vital role in maintaining secretory cell viability.
1.3 The unfolded protein response (UPR) is a multi-component compensatory
mechanism that maintains cellular homeostasis
In contrast to quality control mechanisms that respond to cytoplasmic protein
denaturation, the UPR is initiated by an accumulation of misfolded proteins within the
ER, a condition described as ER stress (Figure 1.04). ER stress can be caused
physiologically by a production demand that temporarily exceeds the physical capacity of
the ER, including the high levels of synthesis required following clearance of secretory
vesicles after signal-mediated release in secretory cells (Lee et al., 2005). ER stress can
also be triggered experimentally by treatment of cells with any number of drugs
including, but not limited to, thapsigargin (an inhibitor of sarco/endoplasmic reticulum
Ca2+ ATPases), tunicamycin (an inhibitor of N-linked glycosylation), or dithiothreitol (a

12

Figure 1.4
The unfolded protein response regulates gene targets associated with all
stages of protein synthesis
Translated proteins are inserted via membrane import complexes (blue). Proteins are
initially glycosylated via enzymatic modification (brown) before being acted upon by
enzymes (pink) that facilitate folding. Improperly folded proteins are bound by
chaperones (green) in an attempt to further facilitate folding. Successful folding results in
transport to the Golgi via COPII-coated vesicles, while improperly folded proteins are
exported from the cell (purple). Large accumulations of misfolded proteins generate
increasing hydrophobic interactions with BiP that result in activation of the unfolded
protein response.
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reducing agent, also known as DTT) (Samali et al., 2010). These drugs all impair protein
folding within the ER by disrupting either the transport of peptides/proteins into and out
of the ER (thapsigargin) or the proper addition of necessary modifications (glycosylation
for tunicamycin, disulfide bond formation for DTT) that are required for proteins to
properly fold (Samali et al., 2010). During ER stress proteins with exposed hydrophobic
resides begin to accumulate within the ER lumen. These residues interact with both ERresident chaperones and embedded sensor molecules that traverse the ER membrane
and initiate transcriptional cascades, altering protein synthesis and processing in an
attempt to allow clearance of the misfolded peptides.
In eukaryotes, the UPR is primarily initiated through the action of the ER-resident
chaperone Binding Immunoglobulin Protein (BIP), a member of the HSP70 class of
chaperones (Haas, 1994). BIP serves as an ER lumen-specific chaperone by binding to
exposed hydrophobic residues (similar to the previously discussed mechanism regarding
HSP70) in order to prevent aggregation within the ER as well as allow for proper folding
(Haas, 1994). BIP functions in concert with the ER-specific enzyme Protein Disulfide
Isomerase (PDI) to maintain newly synthesized proteins in a non-aggregated and
accessible conformation that allows PDI to modify disulfide bonds for structural
arrangement of the protein (Mayer et al., 2000). BIP also functions to regulate calcium
levels and prevent initiation of ER stress-induced apoptosis via an interaction with ERresident caspase-7 (Reddy et al., 2003). While each of these functions aid in
maintenance of normal protein production and cell homeostasis, BIP also serves as the
primary sensor for each of the three transmembrane proteins that serve as master
regulators of the UPR cascades.
In an unstressed state, steady-state levels of protein production require small amounts
of BIP in order to facilitate proper folding of proteins as they initially enter the ER. BIP
molecules normally remain docked to three separate transmembrane proteins; (PKR)like ER kinase (PERK), activating transcription factor 6 (ATF6), or inositol requiring
enzyme 1 (IRE1) (Walter and Ron, 2011). When unbound by misfolded peptides, BIP
stably binds to all three proteins individually and serves as an inhibitor of their functions
(Figure 1.05). Upon binding exposed hydrophobic residues in folding peptides, BIP

14
dissociates from the UPR initiator protein it was bound to, allowing the UPR master
regulators to initiate their downstream pathways (Ron and Walter, 2007). Once
sufficient dissociation has occurred, the UPR branches can initiate positive feedback
loops that sustain the response until the ER stress is resolved. Recent studies have
shown that IRE1 may also directly interact with misfolded proteins, although the bound
BIP chaperone is still thought to serve as a modulator of this activity (Mori, 2009; Walter
and Ron, 2011). The three branches coordinately trigger expression of both branchspecific and multi-branch gene targets in an attempt to ameliorate ER stress.
Each specific master regulator (PERK, ATF6, or IRE1) initiates a unique signaling
cascade that ultimately aids in one of three general functional stress responses:
adaptive response of the cell to ER stress, feedback control of the UPR process itself, or
cell fate determination in cases of unresolved ER stress (Figure 1.05) (Oslowski and
Urano, 2010). While ATF6 and IRE1 are uniquely activated in response to ER stress,
PERK has substantial crosstalk with other pathways, as its primary effector (eIF2α) is
also utilized by several other independent stress responses (Marchand et al., 2006).
During the adaptive response phase, protein throughput is attenuated while processing
of misfolded proteins is increased. Attenuation is primarily accomplished via the PERK
component of the UPR (Figure 1.05, right). Upon dimerization within the ER membrane
following BIP dissociation, PERK-dependent phosphorylation of eukaryotic translation
initiation factor 2A (eIF2α) leads to a reduction in global mRNA translation via inhibition
of the eIF2 complex (Chakrabarti et al., 2011). This slowdown preferentially allows for
production of certain proteins, including activating transcription factor 4 (ATF4), a
transcription factor that is involved in feedback regulation of the UPR (via expression of
the transcription factor XBP1) and cell fate determination (via expression of C/EBP
homologous protein, or CHOP) (Walter and Ron, 2011). Additionally, PERK
phosphorylates NF-ED-related factor 2 (NRF2) in order to drive antioxidant and
detoxification cascades along with proteasome components (Lee et al., 2012).
Independent of PERK activation, the ATF6 master regulator is released by BIP and
undergoes a conformational change allowing its cytoplasmic domain to dissociate and
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Figure 1.5

Diagram of the mammalian unfolded protein response (UPR)

The UPR consists of three separate pathways, each under the control of a different
transmembrane master regulator. The ATF6 branch (left, green) is activated via
proteolytic processing of the ATF6 receptor following activation and dissociation from the
ER membrane. The IRE1 branch (center, blue) is activated via mRNA splicing of the
Xbp1 mRNA into a new form encoding a potent transcription factor, XBP1s. The PERK
branch (right, orange) initiates a phosphorylation cascade resulting in global translation
slowdown as well as activation of the ATF4 and NRF2 transcription factors. All branches
are shown with examples of downstream cell responses/gene targets provided.
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translocate to the Golgi (Figure 1.05, left). The protein is then proteolytically processed
prior to further translocation to the nucleus (now termed nuclear ATF6 or nATF6) where
it upregulates expression of a number of chaperone proteins including BIP, XBP1, and
glucose-regulated protein 94 (GRP94) (Okada et al., 2002). The ATF6-dependent
expression of XBP1 is itself an example of the crosstalk and feedback control
mechanisms that exist between UPR branches, as XBP1 is the primary effecter of the
IRE1 branch via a unique activation mechanism (discussed extensively in section 1.4).
IRE1 functions primarily to promote expression of XBP1s (Figures 1.5, middle), an
active form of XBP1 that translocates to the nucleus and activates a number of genes
associated with adaptive response to ER stress including ERdj4 (associated with the
ER-resident degradation machinery) and EDEM1 (associated with translocation of
misfolded proteins from the ER back into the cytoplasm for degradation).
In higher eukaryotes, each of the UPR branches are utilized differently depending on cell
type, with different responses observed following attenuation of the individual branches
in various cells. Extensive characterization has been done on the IRE1 branch of the
UPR in yeast, as it is both the only UPR branch present in the species and because it is
the most conserved of the three branches among all metazoans. Increased UPR
complexity is a hallmark of higher eukaryotes, as multiple ATF6 variants exist that
function differently in the mammalian UPR. Similarly, IRE1 is expressed in two forms, α
and β, that may specify unique mechanisms for different UPR functions depending on
cell type (Walter and Ron, 2011). Interestingly, despite substantial overlap in function
and targets among the three UPR branches, individual embryonic deletion of the three
branches generates significant phenotypic differences varying from no substantial effect
to embryonic lethality in the case of the IRE1/XBP1 branch (Reimold et al., 2000; Urano
et al., 2000; Yamamoto et al., 2007; Zhang et al., 2002). This suggests a unique role for
the IRE1/XBP1 axis during development and possibly as a principle component of the
mammalian UPR.
1.4 XBP1 is the primary transcription factor utilized by the IRE1 branch of the UPR
IRE1 utilizes an unconventional mechanism to activate its portion of the mammalian
UPR (Figure 1.06b). Following oligomerization and autophosphorylation of multiple
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Figure 1.6
IRE1-dependent splicing of the Xbp1 mRNA is responsible for generation
of the XBP1s protein
(A) The Xbp1 mRNA contains a 26-nucleotide splice acceptor in Exon 4 (red). This
mRNA is localized to vicinity of the ER by unknown mechanism. (B) Upon activation,
IRE1 utilizes its endoribonuclease functions to excise the intron. A cytoplasmic ligase
then anneals to two ends of the mRNA, generating a novel transcript. (C) The unspliced
Xbp1 transcript is translated into XBP1u, a short-lived protein that remains largely in the
cytoplasm. The spliced transcript is translated into XBP1s. XBP1s has a unique Cterminus as the splice event causes a frameshift, resulting in a new transcriptionally
active protein with a nuclear localization signal and transcription activation domain.
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IRE1 proteins in the ER membrane, IRE1 activates an endoribonuclease domain located
on the cytosolic side of the molecule (Chakrabarti et al., 2011). This endoribonuclease
activity cleaves an ER-resident mRNA called Xbp1u (for Xbp1, unspliced variant). The
exact role of the translated XBP1u protein generated by the unspliced Xbp1u transcript
is unknown, although recent work has indicated a possible role as a regulator of
autophagy via interaction with FOX01 (Zhao et al., 2013). The IRE1-dependent splicing
event excises a 26-nucleotide long intron from the Xbp1u transcript (Lee et al., 2002).
This excision generates a frameshift coding for a novel protein, termed XBP1s (for Xbp1,
spliced variant) (Figure 1.06c). Despite sharing extensive N-terminal homology with
XBP1u including the basic leucine zipper motif, XBP1s has a distinct C-terminal domain.
This unique C-terminus contains a potent nuclear localization signal as well as a
transcription activation domain, while the XBP1u C-terminus has competing nuclear
localization and nuclear exclusion domains as well as an uncharacterized “degradation
domain” that prevents its accumulation in the cell (Yoshida et al., 2006).
A possible but not yet fully characterized mechanism for modulation of XBP1s utilizes
dimerization of the unstable XBP1u with XBP1s and subsequent retention in the
cytoplasm and proteasomal degradation (Yoshida et al., 2006). This mechanism is
believed to serve only as a small component of the overall feedback control of the UPR,
as XBP1s levels are drastically upregulated following splicing after ER stress onset,
producing far more protein than the low levels of XBP1u could regulate via dimerization
(Yoshida et al., 2006). Other research suggests a possible role for XBP1u as a
transcriptional partner of XBP1s, but only for a very small subset of genes outside the
canonical UPR targets (Guo et al., 2010), suggesting that XBP1s can regulate both UPR
and non-UPR transcriptional networks, an idea discussed more thoroughly in chapter 5.
XBP1s is a potent basic leucine zipper (bLZ) transcription factor that, upon translation
from the newly spliced mRNA, translocates to the nucleus and activates its target genes.
The IRE1-dependent splicing of Xbp1 is conserved in metazoans and has been heavily
studied in yeast where HAC1, an XBP1 homologue, is spliced by IRE1 and is
responsible for initiation of the entire UPR (Cox and Walter, 1996). Mammalian XBP1s
binds to a number of consensus sequences including ER Stress Elements (ERSE) I and
II and the Unfolded Protein Response Element (UPRE) (Acosta-Alvear et al., 2007).
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While binding to ERSE sequences and subsequent transcriptional activation is a
common feature of both XBP1 and nATF6, XBP1 preferentially binds the UPRE while
nATF6 shows very low affinity, indicating that XBP1 has a distinct role from ATF6 in the
UPR (Yamamoto et al., 2004) (Figure 1.07). Additionally, ATF4 (upregulated via the
PERK UPR branch), has a unique binding site independent of nATF6 and XBP1, likely
due to the fact that the phosphorylation of eIF2α carried out by PERK in the UPR is also
utilized by other enzymes as part of unrelated stress pathways including amino acid
deprivation and viral infection (Marchand et al., 2006). Recent work by the Yoshida
group has also illustrated that XBP1, BiP, and CHOP can cross-regulate each other, and
that CHOP can form a positive feedback loop via low-affinity binding to a number of
promoter regulatory sequences including ERSE (Takayanagi et al., 2013). This is
hypothesized to be a means of allowing a transition from a pro-survival, pro-recovery
UPR state to one promoting apoptosis driven by steadily increasing expression of
CHOP.
Embryonic knockout studies in mice have examined the roles of each of the three UPR
master regulators, as well as XBP1. Deletion of PERK or its primary effector, ATF4,
generates viable offspring, however PERK-/- mice have secretory cell defects in the
pancreas, an unsurprising result given the extensive secretory load placed upon
pancreatic cells (Tanaka et al., 1998; Zhang et al., 2002). Knockout of either ATF6α or
ATF6β has no effect on embryonic development, however compound knockout of the
two proteins results in embryonic lethality (Yamamoto et al., 2007). Interestingly, this
study also revealed extensive dimerization between ATF6α and XBP1, indicating
possible crosstalk between the two pathways independent of their co-activation of ERSE
sequences. IRE1 or XBP1 deletion in mice results in embryonic lethality. However,
targeting of a liver-specific XBP1 transgene (LivXbp1) in Xbp1-/- mice rescues this
phenotype, although mice die during post-natal development (Lee et al., 2005; Reimold
et al., 2000). Interestingly, Xbp1-/-;LivXbp1 post-natal pups have extensive abnormalities in
secretory tissues, with the presumed cause of death attributed to lack of pancreatic
enzyme production (Lee et al., 2005). The dependency of secretory tissues on an intact
UPR has prompted numerous researchers to utilize mouse models in order to
investigate the unique roles of XBP1 in various secretory cell types.
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Figure 1.7

XBP1 and nATF6 bind common and unique DNA consensus sequences

Three ER stress-specific consensus sequences (ERSE, ERSEII, and UPRE) have been
identified. ERSE can be bound by nATF6 only in concert with NF-γ, while XBP1s can
bind by itself. ERII can be bound by either nATF6 or XBP1s. UPRE preferentially binds
XBP1s and has only low affinity for ATF6. Underlined sequences represent core motifs
bound by XBP1.
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Multiple mouse models have been generated in order to interrogate the role of XBP1 in
secretory cells and tissues. A mouse strain with a heterozygous deletion of Xbp1
(Xbp1+/-) has been used recently to show that impaired XBP1 function, due to reduced
levels of its expression, results in exacerbated damage in an alcohol-induced model of
exocrine pancreatic disease (Lugea et al., 2011). Chimeric mice generated from the
previously described Xbp1-/- model are noticeably deficient in plasma cells and incapable
of secreting substantial amounts of immunoglobulin (Reimold et al., 2001). A Creinducible Xbp1 null mouse (Xbp1fl/fl) was recently generated that was utilized to
investigate the effects of adult ablation of Xbp1 in the chief cells of the stomach (Huh et
al., 2010). Interestingly, this work revealed little increase in ER stress but a marked
failure of cells to establish a fully differentiated gene expression pattern. Taken together,
these models have revealed variable roles for Xbp1 that are highly dependent on cellular
context. In addition to expression of Xbp1, the three cell types investigated (pancreatic
exocrine cells, plasma B cells, and gastric chief cells) also share expression of a number
of transcription factors linked to cell identity and secretion, among them the basic helixloop-helix protein MIST1. This prompted a close examination of the possible role of
MIST1 as a component of the XBP1 transcriptional network.
1.5 MIST1 is a transcription factor linked to proper functioning of secretory cells
The pancreas is responsible for endocrine-mediated regulation of blood glucose levels,
for the production of digestive enzyme precursors, termed zymogens, and for the
secretion of the zymogens via a ductal network that leads into the duodenum (Figure
1.08a). The digestive exocrine component of pancreatic function is accomplished by
coordinate action of multiple cell types including secretory acinar cells and duct cells
(Figure 1.08b). Spheres of acinar cells, termed acini (plural) or acinus (singular), are
connected to a branched ductal network, often described as analogous to grapes on a
vine. These duct networks merge, eventually becoming the main pancreatic duct that
joins the common bile duct before emptying into the duodenum. Pancreatic acinar cells
are responsible for production of the vast majority of digestive enzymes secreted into the
duodenum (Williams, 2010), and in humans they synthesize more protein than any other
cell type (Case, 1978). This function is facilitated via a characteristic cell organization in
which an extensive ER is maintained at the basal surface of the cells while packaged
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Figure 1.8
duodenum

Pancreatic acinar cells secrete digestive enzyme precursors into the

(A) The exocrine pancreas consists of large numbers of acinar clusters, arranged in a
“grapes on a vine” formation. These clusters are sites of zymogen synthesis and empty
into centralized lumens that eventually join to the pancreatic duct before joining the
common bile duct and emptying into the duodenum. (B) Acinar cells are arranged into a
spherical cluster termed an acinus (plural = acini). These acini are polarized with
zymogens clustered at the apical end. Additional cell types are present in the cluster
including duct cells that form a tubular network for zymogen transport and centroacinar
cells that connect the acini lumens to the ducts.
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zymogens are stored at the apical side, awaiting secretion into an adjoining ductal lumen
(Figure 1.08b). This organization is dependent on specific cytoskeletal arrangements as
well as surface attachment points for zymogen vesicles, all of which are controlled via
specific transcriptional programs. In the pancreas, the transcription factor MIST1 has
been extensively studied as a key factor in maintaining the organization and efficient
functioning of pancreatic acinar cells.
MIST1 is a basic helix-loop-helix transcription factor that is exclusively expressed in
secretory tissues including the serous secretory cells of the immunoglobulin secreting B
cells, zymogenic gastric chief cells, and pancreatic acinar cells (Capoccia et al., 2011;
Pin et al., 2000). Embryonic knockout or expression of a dominant negative Mist1
construct leads to pancreatic acinar cells that exhibit a number of defects including
disorganization of cell structures and loss of polarity, as well as impaired cellular
communication due to loss of intracellular gap junctions (Jia et al., 2008; Pin et al., 2000;
Rukstalis et al., 2003; Zhu et al., 2004). Additionally, deletion of Mist1 causes an
acceleration in Kras-induced development of pancreatic intraepithelial neoplasia, an
early event observed in mouse models of pancreatic cancer (Shi et al., 2009b). These
findings identify MIST1 as a critical regulator of pancreatic acinar cell organization and
function. Recent work has also established that MIST1 may serve to maintain proper
secretory function in acinar cells.
Intracellular communication via membrane channels is required for proper zymogen
biosynthesis as well as packaging and secretion in the pancreas (Meda, 1996).
Additionally, the polarized state of epithelial cells in multi-cell structures is highly
dependent on effective cell-to-cell communication via intracellular channels (Mellman
and Nelson, 2008). Recently, a system in which MIST1 expression is induced in a Mist1/-

animal (effectively a rescue of MIST1 expression, termed LSL-Mist1myc model) was

used to demonstrate that MIST1 is directly responsible for maintaining intracellular
communication and coordinated secretion between pancreatic acinar cells (Direnzo et
al., 2012). This facilitation is accomplished via transcriptional control of Connexin 32
(Cx32), a protein that forms a functional channel between acinar cells that aids in
coordination of secretory actions (Figure 1.09a) (Direnzo et al., 2012; Rukstalis et al.,
2003). Gap junction-mediated communication is a key feature of the coordinated
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Figure 1.9

MIST1 is essential for pancreatic acinar cell communication and secretion

(A) Quantification of connexin 32 aggregates following in Mist1-/- pancreata reveals near
complete loss of gap junction formation that is rescued upon ectopic expression of
MIST1. (B) Single cell injection of 6-carboxyfluorescein (6-FAM) into acinar clusters
indicates that Mist1-/- acinar cells do not communicate via gap junctions, as they are
unable to pass the dye from cell to cell. (C) Measurement of amylase secretion from
isolated acinar clusters following administration of cholescystokinin (CCK) demonstrates
that Mist1-/- acinar cells have significantly less secretion than wildtype or MIST1 rescue
cells. Figures A,B modified from Direnzo et al., 2012.
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secretion process necessary for normal digestive processes. The loss of MIST1 impairs
cell-to-cell communication as demonstrated by fluorescein dye injections of isolated
acinar clusters from mice (Figure 1.09b). This loss of communication was hypothesized
to be an underlying cause for the drastic drop in secretory capability seen in MIST1-/animals (Figure 1.09c). In addition to its role in facilitating cell communication and
coordination within the pancreatic acinus, MIST1 also directly enables successful
secretory vesicle formation and secretion.
Rescue of MIST1 expression via the previously described LSL-Mist1myc mouse model
restores the secretory capability of pancreatic acinar cells after being significantly
diminished when MIST1 expression is limited (Figure 1.09c). Ultrastructural analysis
reveals that acinar cells lacking MIST1 have decreased secretory vesicle size and
number, as well as a general lack of apical ER localization and expansion, a similar
defect as that seen in Xbp1-null pancreatic acini after birth (Direnzo et al., 2012; Lee et
al., 2005). Bioinformatic screens in mouse models examining MIST1-positive chief cells
and pancreatic acinar cells have also revealed that MIST1 regulates a subset of genes
in the RAB protein family, specifically Rab3D and Rab27a (DiRenzo, 2012; Huh et al.,
2010). The RAB3 family and RAB27a are typically associated with mature secretory
vesicles and may function as sensors for mature vesicles, thus serving as a bridge
between MIST1 and control of the final stages of exocytosis (Fukuda, 2008). These data
collectively indicate that MIST1 is transcriptionally linked to the synthesis, packaging,
trafficking, and coordinated secretion of zymogens in pancreatic acinar cells, making its
possible actions and mode of regulation during ER stress a prime area for investigation.
1.6 The unfolded protein response and MIST1 both play roles in maintenance and
recovery of acinar cell identity following damage in the exocrine pancreas
The mammalian pancreas is initially formed during development as two separate
outgrowths of the primordial gut tube that merge to form the complete organ (Slack,
1995). All mature pancreatic cells, including both the endocrine and exocrine linages,
derive from a common, multi-potent progenitor cell (Figure 1.10, left) (Jensen et al.,
2005). These progenitor cells have a unique expression pattern for a number of
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Figure 1.10 Exocrine development in the pancreas involves expression of key
transcription factors including MIST1
All pancreatic cells begin as a common progenitor expressing PDX1, SOX9, and HES1.
The endocrine lineage (lower path) loses expression of SOX9 and HES1 while gaining
expression of ISL1. These cells eventually initiate unique transcription programs for each
of the unique endocrine cell types. Exocrine cell differentiation (upper branches) is
marked by a loss of PDX1, followed by a split into the duct/centroacinar program
(marked by continued expression of SOX9 in both cases and HES1 in centroacinar cells)
and the acinar cell program specified by expression of the PTF1a/RBPJL complex and
MIST1.
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transcription factors (TFs), including coexpression of pancreatic and duodenal
homeobox 1 (PDX1), Sry/HMG box transcription factor 9 (SOX9), and active Notch
signaling components including hairy and enhancer of split-1 (Hes1) (Jensen et al.,
2005). Importantly, this unique progenitor signature is not fully recapitulated in any adult
cell type in the pancreas.
Developing cells in the pancreas achieve their differentiated state via repression or
expression of key transcription factors (Figure 1.10). The endocrine lineage includes five
distinct cell types (α, β, δ, ε, and PP) that upon maturation reside in the pancreatic islets
of Langerhans (Elayat et al., 1995). Each of these cell types has a unique transcriptional
program, although early endocrine specification involves continued expression of PDX1,
loss of SOX9, and expression of insulin gene enhancer protein 1 (ISL1) (Edlund, 2002).
Differentiated endocrine cells are identified via expression of their secreted products
including glucagon (α), insulin (β), somatostatin (δ), ghrelin (ε), and pancreatic
polypeptide (PP) (Elayat et al., 1995).
The mature exocrine lineage is marked by a lack of PDX1 expression and is divided into
three cell types; duct cells, centroacinar cells, and acinar cells. Duct and centroacinar
cells continue expression of the progenitor factor SOX9, while centroacinar cells also
continue to express HES1, leading to the hypothesis that centroacinar cells may be the
most “stem-like” cell within the pancreas (discussed in section 1.6). Acinar cells are
specified via coexpression of PTF1a/ RBPJL complex as well as MIST1 (Jensen et al.,
2005; Rooman and Real, 2011). The commitment of most pancreatic lineages to
specific, terminally differentiated cell identities has prompted extensive discussion as to
whether a persistent stem cell population exists within the adult pancreas. This question
is of key importance to the study of human diseases, including pancreatitis, in which
repair and replacement of damaged exocrine cells in required for proper organ function.
Attempts to identify and characterize repair mechanisms and specific cell compartments
that function to restore damaged acinar tissue have often yielded conflicting results.
Damage-responsive cell types exist both outside and within the exocrine compartment
(Figure 1.11a). Outside of the acinar/duct system, pancreatic stellate cells (PaSCs) are
tissue-resident, myofibroblast-like cells that reside in the periacinar space between acini
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Figure 1.11

Pancreatic cells outside the acinar compartment respond to damage

(A) Pancreatic stellate cells (star-shaped) reside in the peri-acinar space between acini
and are activated in response to damage. Centroacinar cells are found at the junction
between acinar and duct cells and are also known to proliferate in response to damage.
(B) Red dotted line marks a small, pre-cancerous metaplastic duct.
Immunohistochemical staining for Vimentin reveals both tissue resident (black arrows)
and damage-responsive (red arrows) pancreatic stellate cells. (C) Anti-HES1 stain
shows localization of centroacinar cells at the center of a cross-sectioned acinus.
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(Figure 1.11b) (Omary et al., 2007). PaSCs have been extensively studied, as they
serve as damage-responsive remodelers of the extracellular matrix. When activated via
tissue damage, PaSCs undergo a number of phenotypic and molecular changes
including altered size and shape, increased size and prominence of the ER, and
expression and secretion of ECM components including collagen I and II and fibronectin
(Bachem et al., 1998; Omary et al., 2007). Stellate cells are responsible for generating
new support structures when pancreatic damage results in substantial loss of acinar
tissue. Extensive development of fibrosis resulting from continued pancreatic damage is
a feature of many pancreatic tumors, often resulting in impaired treatment effectiveness
and complications in surgical resection (Garber, 2010). Extracellular remodeling,
however, is not capable of regenerating damaged tissue nor generating a primary tumor
mass, thus prompting investigations into which cells repopulate the pancreas following
injury.
A unique, non-secretory exocrine cell type, termed centroacinar cells (CACs), resides at
the junction of the acinar lumen and the adjoining ductal network (Figure 1.11c) (Slack,
1995). These cells have high expression of aldehyde dehydrogenase 1, a known marker
of stem cells in other organs, as well as a number of ductal genes, often making them
indistinguishable from normal ducts (Rovira et al., 2010). Interestingly, isolation of CACs
and subsequent growth in culture results in spontaneous reprogramming and
differentiation of centroacinar cells into both endocrine and exocrine cell lineages (Rovira
et al., 2010). Additional research has shown that following damage via pancreatic duct
ligation, cells within the ductal compartment (including CACs) can give rise to β-cells, an
endocrine cell type (Wang et al., 1995). This suggests that centroacinar cells may serve
as multi-potent, tissue-resident stem cells, but their regenerative activity may vary based
on the means in which damage is induced.
Most exocrine pancreas research focuses on two primary ailments: pancreatitis and
pancreatic cancer. Pancreatitis is often subdivided into two specific forms; chronic and
acute. Chronic pancreatitis is most commonly the result of alcoholism or familial
mutations (Omary et al., 2007; Pandol et al., 2010). Chronic pancreatitis has also been
linked to development of pancreatic cancer, although this correlation is largely limited to
patients with an underlying mutation in the cationic trypsinogen gene (PRSS1) (Gao et
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al., 2012; Hernández-Muñoz et al., 2008). Acute pancreatitis accounts for over 80% of
diagnosed pancreatitis cases and is most frequently caused by gallstone-triggered
blockage of the common bile duct or alcoholism (Dufour and Adamson, 2003; Pandol et
al., 2010). Both chronic and acute pancreatitis have been extensively studied in mouse
models, and they are both characterized by severe necrosis within the organ as well as
by extensive localized and systemic inflammatory responses (Su et al., 2006).
Pancreatic cancer (discussed extensively in Chapter 6) has been demonstrated in
mouse models to be the result of metaplastic conversion of acinar cells into
precancerous ductal lesions, termed PanINs (Schmid, 2002). This plasticity in acinar cell
identity (discussed in detail later) is also observed as part of the exocrine damage
response during recovery from pancreatitis, possibly linking chronic pancreatic injury and
cancer development. Additionally, chronic pancreatitis has been shown to exacerbate
PanIN development in KRAS-transformed acinar cells (Guerra et al., 2007). This
promotion may be linked to stromal and inflammatory interactions with acinar cells, as
stromal factors allow senescent PanINs to reenter a proliferative cycle and contribute to
cancer progression (Guerra et al., 2011). As demonstrated above, both pancreatitis and
pancreatic cancer are associated with acute or long-term acinar distress, conditions
replicated in the Xbp1fl/fl mouse model.
In order to study the effects of damage on the adult pancreas, multiple experimental
systems utilizing wild-type mice have been devised. Alcohol-induced pancreatitis can be
triggered by feeding mice alcohol-enriched diets, although this leads to only mild
pancreatic damage triggered by oversecretion of the endogenous acinar secretagogue
cholecystokinin (CCK) from duodenal cells (Su et al., 2006). Diet-induced models in
which mice are fed choline-deficient chow supplemented with ethionine lead to severe
necrotizing pancreatitis. This system, however, has a high mortality rate and does not
resemble the cause or appearance of human disease (Lombardi et al., 1975; Su et al.,
2006). One model that does mimic the changes in acinar structure seen in human
pancreatitis patients utilizes the CCK analog caerulein (Su et al., 2006).
Caerulein can be administered via a number of techniques, most frequently using an
intraperitoneal injection. Caerulein induces a supramaximal response in acinar cells,
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leading to aberrant secretion across the basolateral membrane and into the pancreatic
interstitial space rather than via the apical membrane into the ductal network
(Jungermann et al., 1995). This accumulation of zymogens in the periacinar space
triggers enzyme auto-activation and subsequent proteolytic digestion of the tissue
(Jungermann et al., 1995). Digestion leads to extensive pancreatic edema, local
inflammation and necrosis, and increases in serum levels of pancreatic enzymes as
activated zymogens escape into the bloodstream (Mayerle et al., 2013).
Advantageously, the damage induced in the caerulein model of pancreatitis is
completely recoverable despite severe exocrine necrosis, making it ideal for study of
pancreatic regeneration (Jensen et al., 2005).
Recovery following either disease-driven or experimentally-induced pancreatitis is
marked by activation of pancreatic stellate cells and subsequent deposition of new
extracellular matrix (Neubauer et al., 1995). This matrix fills voids left following acinar
necrosis and must be generated and then extensively remodeled in order to allow
regrowth of new cells, a task accomplished via coordinated secretion of ECM proteins,
adhesion molecules, and matrix proteases (Lugea et al., 2006). Drawn out periods of
injury can impair acinar cell repopulation and encourage continued deposition of
extracellular stromal and matrix proteins, eventually leading to development of fibrosis
that remains for the life of the organ (Hernández-Muñoz et al., 2008; Stetler-Stevenson,
1996). In addition to stimulation of organ repair and remodeling, pancreatic damage also
induces a rapid change in the transcriptional state of the acinar cells themselves.
Acinar cell damage (either extrinsic as is the case in caerulein-induced pancreatitis or
intrinsic in the case of activating oncogene expression) results in downregulation of
acinar differentiation regulators including MIST1 and loss of zymogen expression
(Figure 1.12a,b) (Rooman and Real, 2011). Acinar cells lacking high expression of
these differentiation factors have altered duct-like morphology, drastically reduced levels
of zymogen synthesis, and begin to express duct-restricted genes including the
transcription factor Sox9 (Figure 1.12b) (Kopp et al., 2012). This transdifferentiation
from a mature acinar to a more duct-like state is called acinar-ductal metaplasia (ADM)
and has been demonstrated in mouse models to be an key step in early development of
pancreatic cancer (discussed extensively in Chapter 6)
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Figure 1.12 Loss of acinar characteristics including expression of MIST1 occurs
following pancreatic damage
(A) H&E and IHC staining for MIST1 in mice with experimentally-induced pancreatitis.
Cells undergoing ADM in response to damage (left sides of images) lose expression of
MIST1, while healthy acinar cells (AC) retain expression. (B) H&E staining of a KRASinduced precancerous lesion shows an acinus in which half of the acinar cells have lost
acinar-like zymogen staining (labeled as “ductal”) while half of the cells retain an acinarlike appearance. (C) Proposed model for acinar cell plasticity in which damage or stress
causes a sharp decrease in acinar transcription factors including MIST1. This reduction
is accompanied by increased expression of ductal genes CK19 and SOX9. Upon
restoration of homeostasis, cells begin to express MIST1 and return to an acinar
phenotype. Figures A, B courtesy Dr. Daniel DiRenzo.
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(Shi et al., 2009b, 2012; Zhu et al., 2007). Cells undergoing ADM also activate
previously silenced developmental signaling pathways including Notch signaling,
frequently detected via expression of the HES1 protein (Figure 1.12c) (Rooman and
Real, 2011). These transcriptional changes are believed to make acinar cells more
capable of proliferation, a unique state as the adult pancreas is typically regarded as a
quiescent organ, with unstressed rodents having less than 1% observed acinar cell
turnover (Oates and Morgan, 1982).
Various techniques have been used to study pancreas regeneration, generating differing
hypotheses regarding which cell type serves as the source of new acinar cells. In
support of an acinar origin of regeneration, Jensen and colleagues utilized caeruleininduced pancreatitis and transcriptional profiling of recovering cells to establish that
surviving acinar cells repress their terminal differentiation program and activate
expression of PDX1 as well as activation of both the β-catenin and Notch signaling
pathways (Jensen et al., 2005). Similar results were seen using Cre-mediated lineage
tracing and multiple models of injury to investigate pancreatic plasticity, indicating that
acinar cells in the damaged pancreas dedifferentiate, form a unique duct-like transitional
state, and then give rise exclusively to new acinar cells (Houbracken et al., 2011; Means
et al., 2005). Notably, the use of caerulein in these experiments mimicked the acinar
structural changes seen in human disease but did not represent an endogenous stress,
as human acinar cells do not respond to caerulein (Ji et al., 2002).
In contrast, work by Esni and others recently utilized a model in which diphtheria toxin
receptors were expressed exclusively in acinar cells, allowing the selective ablation of
the entire acinar compartment but sparing the duct and centroacinar cells (Criscimanna
et al., 2011). In this system proliferative analysis revealed that the ductal/centroacinar
compartment (which share expression of the SOX9 marker and were thus
indistinguishable) was responsible for regenerating new acinar cells, also via activation
of embryonic signaling pathways (Criscimanna et al., 2011). These data indicate that at
least two distinct mechanisms for acinar repopulation may exist, although the lack of
inflammatory response in the Esni model may reduce the clinical relevancy of the data.
Mouse models utilizing endogenous stressors, including ER stress, and that also
generate tissue inflammation would be ideal for painting a clinically relevant picture of
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how acinar cells respond to damage. Notably, multiple experimental damage models
have now demonstrated a correlation between pancreatic injury and activation of the
unfolded protein response.
The UPR is activated in response to both alcohol- and L-arginine-induced experimental
pancreatitis (Alahari et al., 2011; Kubisch et al., 2006; Lugea et al., 2011). Pandol and
colleagues observed that impairment of XBP1 expression (and therefore only the IRE1
component of the UPR) results in reduced zymogen granule formation, increased
autophagy, and acinar cell apoptosis (Lugea et al., 2011). This suggests that the IRE1
branch of the UPR may be a key component of the acinar cell damage response
program. Interestingly, separate work by Pin and others utilizing Mist1-/- mice in an
alcohol-induced pancreatitis model demonstrated that the absence of MIST1 leads to
reduced UPR activity and an increase in pancreatic damage (Alahari et al., 2011). This
suggests that MIST1 may be regulating acinar cell damage responses, a hypothesis
recently confirmed in unpublished work by the Konieczny group showing that
misregulation of MIST1 expression in a caerulein-induced pancreatitis model can trigger
extensive acinar cell death. Indeed, given the extensive role that MIST1 plays in normal
secretory function as well as its emerging role in mitigating exocrine damage,
investigations as to whether MIST1 is a component of the pancreatic acinar cell UPR are
warranted.
In this study, an acinar cell-specific, Cre-inducible Xbp1 ablation model
(Mist1Cre/+;Xbp1fl/fl) was used to investigate the role of XBP1 in maintaining homeostasis
in pancreatic acinar cells. Specifically, targeted gene ablation was used to investigate
the effects of XBP1 on acinar cell viability. Additionally, cells still expressing XBP1 in the
pancreas were characterized following ER stress-induced organ damage as a means to
study pancreatic proliferative and regenerative mechanisms. Finally, in vitro cell culture
systems were used to investigate whether MIST1 is a direct target of XBP1 as well as its
possible role as a component of the mammalian unfolded protein response.
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CHAPTER 2. MATERIALS AND METHODS
2.1 Mouse strains
Xbp1fl, Mist1CreER, Rosa26LacZ, LSL-KrasG12D, and Mist1Kras mouse lines have all been
described previously (Habbe et al., 2008; Hetz et al., 2008; Jackson et al., 2001;
Soriano, 1999; Tuveson et al., 2006). All mice were maintained on a C57Bl/6
background. Mouse experiments were conducted with approval and in accordance with
PACUC regulations. Mouse euthanasia was conducted via CO2 asphyxiation followed by
cervical break.
2.2 Mouse genotyping
Mouse tail tips were harvested at post-natal day 21 in accordance with PACUC
regulations. Tail tips were digested in tail lysis buffer supplemented with 0.2 mg/mL
Proteinase K overnight at 56°C. Digested material was centrifuged for 10 minutes at
14,000 x g to remove tail debris. DNA isolation was accomplished via isopropanol
precipitation of supernatants followed by washing of DNA pellets in 70% ethanol and
subsequent resuspension in 100 μL of TE buffer at 65°C.
PCR genotyping using 1 μL of tail DNA was performed using standard protocols
provided with the Mango Taq PCR system (BIO-21083, Bioline, Taunton, MA). PCR
conditions included 35 cycles of 94°C for 30 seconds, 65°C for 90 seconds, and 72°C for
60 seconds. Tissue isolation and PCR conditions were identical for genotyping and for
monitoring DNA recombination events. Primers for both types of reactions are listed in
Table 2.01.
2.3 Tamoxifen administration for Cre-mediated induction
Tamoxifen (T5648, Sigma, St. Louis, MO) solution was prepared to a final concentration
of 20 mg/mL in corn oil (C8627, Sigma, St. Louis, MO), then placed in a scintillation vial
and heated with shaking at 37°C for five hours. CreERT2-inducible mouse lines were given
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Table 2.1

Primer list for mouse genotyping and detection of recombination

Genotyping Primers
Transgene

Forward

Reverse

Xbp1fl/+

5'-acttgcaccaacacttgccatttc-3'

5'-caaggtggttcactgcct-3'

Mist1CreER *

5'-ggttaaagcaaattgtcaagtacgg-3'

Rosa26LacZ *

5'-gcgaagagtttgtcctcaacc-3'

LSLKrasG12D

5'-tctgaattagctgtatcgtcaagg-3'

Mist1Kras *

5'-aggtgtccactaagcaccagt-3'

Band Size (bp)
WT=141
FL=183

5'- atagtaagtatgtgcgtcagcg-3'

WT=750

5'-gaagcattttccaggtatgctcag-3'

Cre=520

5'- ggagcgggagaaatggatatg-3'

WT=650

5'-aaagtcgctctgagttgttat-3'

LacZ=350

5'-gtcgagggacctaataacttcgta-3'

KR=500

5'ctggaaggcattgttgagttt-3'

WT=449

5'gctccaaccaccacaagttta-3'

KR=200

Recombination Primers
Allele

Forward

Reverse

Band Size (bp)

Xbp1WT

5'-ttgggactctctcgtgtg-3'

5'-caaggtggttcactgcct-3'

1682

Xbp1ΔEx2

5'-tggccacgtctacaaatgaa-3'

5'-caaggtggttcactgcct-3'

997

* Tripartite primers used to detect both WT and transgenic alleles
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tamoxifen via intraperitoneal injection into the left side to initiate nuclear Cre localization.
Total volume of injected tamoxifen was 200 μL, for a total tamoxifen delivery of 4 mg.
Mice were injected three times 24 hours apart, with the second injection set to time zero
for experimental timings.
2.4 Tissue section preparation, immunohistochemistry, and immunofluorescent
staining
For paraffin embedding, isolated tissues were placed in 10% neutral buffered formalin
for overnight fixation following necropsy. Tissues were then dehydrated in a graded
ethanol series proceeding from 70% to 100% ethanol before final dehydration in xylenes
and embedding in paraffin using an automated tissue processor (Citadel 1000, Thermo
Scientific, Waltham, MA). Tissues were subsequently embedded in paraffin blocks, and
a microtome was used to generate 5 μM thick sections that were placed on charged
microscope slides and heated to 40°C to ensure adherence to the glass.
For cryo-preserved tissues, isolated tissues were placed in a 4% paraformaldehyde/PBS
solution for 1 hour at 4°C followed by transfer and gradual dehydration in a 30% sucrose
solution for 4 hours at 4°C. Tissues were embedded in O.C.T. (4583, Sakura, Torrance,
CA) in plastic tissue molds before snap freezing via placement of the molds into 2methylbutane (78-78-4, Alfa Aesar, Ward Hill, MA) cooled in liquid nitrogen. Cryo blocks
were stored at -20°C before sectioning via cryostat, with 5 μM sections placed on
charged slides and stored at -80°C for subsequent staining.
Deparrafinization of tissue sections was accomplished by passing tissues from xylenes
through a decreasing percentage of ethanol baths (2X 100%, 2X 95%, 1X 70%, 1X 50%)
before final washing in distilled water. General histological analysis was accomplished
via standard hematoxylin (47199-010, Lerner Labs, Pittsburgh, PA) and eosin (41799028, Lerner Labs, Pittsburgh, PA) staining on deparaffinized tissue sections. Collagen
staining was performed by incubating deparaffinized sections with Sirius red stain
(365548, Sigma, St. Louis, MO) for 1 hour at room temperature followed by two washes
in acidified water (0.5% glacial acetic acid in distilled water). X-gal staining for βgalactosidase activity was performed on cryo sections that were thawed for 5 minutes at
room temperature before fixing with 10% neutral buffered formalin for 10 minutes and
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incubation in X-gal staining solution (1 mg/mL X-Gal, 5 mM potassium ferricyanide, 5
mM potassium ferrocyanide, 2 mM MgCl in PBS) at 37°C for six hours. Paraffin sections
were counterstained with hematoxylin while cryo sections were counterstained with
nuclear fast red (H-3403, Vector Labs, Burlingame, CA).
Immunohistochemistry (IHC) and immunofluorescence (IFC) staining was performed on
deparaffinized sections following antigen retrieval in antigen unmasking solution (H3300, Vector Labs, Burlingame, CA) that was heated in a 2100-Retriever (PickCell
Laboratories, Amsterdam, The Netherlands). Sections were then blocked using the
MOM blocking reagent (BMK-2202, Vector Labs, Burlingame, CA) for one hour. Primary
antibodies were diluted in MOM protein diluent and placed on sections for 1 hour at
room temperature or overnight at 4°C. Secondary biotin-conjugated antibodies were
then incubated with the sections for ten minutes. For IHC, Vectastain ABC reagent (PK7100, Vector Labs, Burlingame, CA) was incubated on the sections for 1 hour at room
temperature before development via Immpact DAB peroxidase substrate (SK-4105,
Vector Labs, Burlingame, CA). For IFC, tertiary, avidin- and fluorescent-group
conjugated antibodies were incubated with sections for 5 minutes along with DAPI.
Following final staining/developing, IHC slides were passaged through baths of 95%
ethanol, 100% ethanol, and xylenes and mounted using Vectamount (H-5000, Vector
Labs, Burlingame, CA) while IFC slides were directly mounted using Vectashield Hardmount Media (H-1400, Vector Labs, Burlingame, CA). Primary and secondary antibody
information is provided in Table 2.02.
Analysis of images was performed using ImageJ with the cell counter plugin. All
statistical analyses on cell and nuclear counts utilized a student’s T-test with a
significance threshold of 95%.
2.5 Electron microscopy
Harvested pancreata were fragmented and fixed in 3% paraformaldehyde/0.5%
glutaraldehyde in PBS. Samples were dehydrated via graded ethanol series and
embedded in Epon (Electron Microscopy Sciences, Hatfield, PA). Electron micrographs

39

Table 2.2

Antigen

Primary and secondary antibodies used

Dilution

Company

Cat #

Amylase

1:100

Calbiochem, San Diego, CA

171534

Amylase

1:1000

Santa Cruz Biotechnology, Santa Cruz, CA

sc-12821

β-gal

1:300

Novus Biologicals, Littleton, CO

NB100-65209

Chop

1:500

Cell Signaling, Boston, MA

2895S

CPA

1:1000

AbD Serotec, Raleigh, NC

1810-0006

E-Cadherin

1:1000

Abcam, Cambridge, MA

ab53033

Erk1/2

1:1000

Cell Signaling, Boston, MA

9102S

Glucagon

1:100

Dako, Carpinteria, CA

A0565

Hes1

1:1000

Gift of Tetsuo Sudo

-----

K19

1:100

Dev. Studies Hybridoma Bank, Iowa City, IA

Troma3

Ki67

1:500

Dako, Carpinteria, CA

M7249

LC3B

1:200

Cell Signaling, Boston, MA

3868S

Mist1

1:500

Pin et al, 2000

C175

nATF6a

1:1000

Santa Cruz Biotechnology, Santa Cruz, CA

sc-22799

p38

1:1000

Cell Signaling, Boston, MA

9212S

p-eIF2a

1:1000

Cell Signaling, Boston, MA

3597S

p-Erk1/2

1:1000

Cell Signaling, Boston, MA

9101S

pH3

1:100

Upstate (Millipore), Billerica, MA

06-570

S6

1:1000

Santa Cruz Biotechnology, Santa Cruz, CA

sc-74459

Sox9

1:500

Millipore, Billerica, MA

AB5535

1:200

Invitrogen

S-11227

1:200

Invitrogen

S-6368

1:200

Vector

BA-9200

Rabbit (2°)

1:200

Vector

BA-1000

Rat (2°)

1:200

Santa Cruz

sc-2987

Avidin (Alexa
594)
Avidin (Oregon
Green)
Mouse (2°)
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were taken of 100 nM ultra-thin sections on a Phillips CM-100 (Philips, Andover, MA)
electron microscope with the assistance of Dr. Barbara Damsz.
2.6 RT-qPCR
Pancreatic RNA was isolated following initial harvesting of a small tissue piece for
histology. PBS was then injected into the left ventricle of the heart to clear the tissues of
blood and plasma fluids. A 1 mm3 fragment of pancreatic tissue was then excised and
harvested following homogenization with a Tissue Tearor (985-370, Biospec Products,
Bartlesville, OK) using the Total RNA Kit 1 (R6664-02, Omega Biotek, Norcross, GA).
Isolated RNA was converted to cDNA using the iScript cDNA synthesis kit (170-8891,
Bio-Rad, Hercules, CA). Real-time PCR was performed using FastStart Universal SYBR
Green (04913914001, Roche, Indianapolis, IN) in an ABI 7300 Real-Time PCR System
(Applied Biosystems, Foster City, CA). PCR conditions involved 40 cycles of 95°C for 30
seconds, 59°C for 60 seconds, and 72°C for 30 seconds. Relevant Ct data were
generated using the ABI 7300 software package followed by analysis using the 2-ΔΔCT (or
ΔΔCT) method in which all values were normalized first to 18s expression levels as an
internal control and then renormalized to a control biological sample for fold analysis.
2.7 Cell Culture
Cell culture experiments were conducted using mouse 266-6 pancreatic acinar cells
(CRL-2151, ATCC, Manassas, VA) and primary mouse embryonic fibroblasts (MEFs).
Wild-type MEFs were obtained from the Purdue University Transgenic Mouse Core
Facility following isolation from harvested embryos and a single passage in 2D culture.
Xbp1KO MEFs were a generous gift from Dr. Ann-Hwee Lee at Harvard University.
266-6 cells were cultured in high-glucose Dulbecco’s Modified Eagle Medium (hgDMEM)
supplemented with 10% fetal bovine serum (FBS) and 1% Pen/Strep antibiotic solution
(15140-122, Invitrogen, Grand Island, NY). MEFs were grown in hgDMEM
supplemented with 10%FBS, 0.5% Pen/Strep, 1% L-Glutamine, 1% non-essential amino
acids, and 1:10000 β-mercaptoethanol.
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Table 2.3

Primers used for RT-qPCR. All sequences are for mouse transcripts

18S
Amylase
Arcn1
Arfgap3
Atp2a2
Bip
Chop
Dnajb9/ERdj4
Dnajc1
Dnajc3
Edem3
Elastase
Gli1
H47
Hes1
Htra2
Mist1
Nestin
Os9
Pdi1
Piga
Ppib
Ppp1r15b
Reg1
Rrbp1
Sec11c
Sec61a
Sec61b
Serp1
Sox9
Spcs2
Spcs3
Ssr3
Uso1
Xbp1ΔEx2
Xbp1s
Xbp1u

Forward Primer
5'-tgtctcaaagattaagccatgc-3'
5'-cagagacatggtgacaaggtg-3'
5'-agcagctttcccaaaactca-3'
5'-tttgactgtggtgccaaaaa-3'
5'-aaaccttgctggaacttgtga-3'
5'-gtgtcctctctggtgatcagg-3'
5'-cctgaggagagagtgttccag-3'
5'-ccccagtgtcaaactgtaccag-3'
5'-gacctggagttgttcgacttg-3'
5'-ccgacgccttatcacagttt-3'
5'-agcgtcatggagcctggt-3'
5'-actatgtccagctgggtgttc-3'
5'-tttcttgaggttgggatgaag-3'
5'-gcagagcagagaggagcag-3'
5'-agagaaggcagacattctgga-3'
5'-cattggagtgatgatgctgac-3'
5'-tggtggctaaagctacgtgt-3'
5'-gagagtcgcttagaggtgcag-3'
5'-ggtccaaatgtgatctcaacg-3'
5'-caagatcaagccccacctgat-3'
5'-gacccatttaggaggcatga-3'
5'-gcgcaatatgaaggtgctct-3'
5'-tcttgtaaggcccagctgtt-3'
5'-atggctaggaacgcctacttc-3'
5'-gctgccaatcagggtaaaaa-3'
5'-aaggcctgattgttctcacg-3'
5'-ctatttccagggctccgagt-3'
5'-atccactgttcggcagag-3'
5'-agaaaaggcgtcggtaggac-3'
5'-cttctgtgggagcgacaactt-3'
5'-ggatgactctgccaaaaagg-3'
5'-aactccctgttcgccttctc-3'
5'-cctgctccttcaggatttca-3'
5'-cgcttagaagtgggaatcca-3'
5'-agaaagcgctgcggagaac-3'
5'-tgagtccgcagcaggt-3'
5'-tcagactatgtgcacctctgc-3'

Reverse Primer
5'-gcgaccaaaggaaccataac-3'
5'-atcgttaaagtcccaagcaga-3'
5'-tcctctaaggctcggcaata-3'
5'-ttgagttccctccaacttgc-3'
5'-ccacgattgcattggctac-3'
5'-tgtcttttgttaggggtcgtt-3'
5'-cagatcctcataccaggcttc-3'
5'-agcgtttccaattttccataaatt-3'
5'-tgagtttgtgcattttcatcttt-3'
5'-aagtccatcttcagcgcaat-3'
5'-gttgccataagcatgatcaaa-3'
5'-cagtaagaggagctggagcag-3'
5'-ggtggagtcattggattgaac-3'
5'-agctgtctctgcctcaaagc-3'
5'-gtcacctcgttcatgcactc-3'
5'-aatggccaagatcacatcac-3'
5'-catagctccaggctggtttt-3'
5'-gatctgagcgatctgactctgt-3'
5'-ggtcagtacgtaggagcagga-3'
5'-agttcgccccaaccagtactt-3'
5'-tggtccctctcctccaatta-3'
5'-ttccaaagagtccaaagacga-3'
5'-gccaatggcaacttctgttt-3'
5'-cccaagttaaacggtcttcagt-3'
5'-gcttccaaccgtagagacca-3'
5'-tcggaatgtctcttccttcaa-3'
5'-aggtgtgtactggcctcggt-3'
5'-cagcagcgatgaacagaaga-3'
5'-cacatgcccatcctgatactt-3'
5'-agggagggaaaacagagaacg-3'
5'-ctggcttggactcaggaaag-3'
5'-tgtgatgaatcccaggtcac-3'
5'-cattcttgtacgcgaaggcta-3'
5'-gagtgacattttctggctgct-3'
5'-cctccacctctggaacctc-3'
5'-agagaaagggaggctggtaag-3'
5'-agagaaagggaggctggtaag-3'
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ER stress induction was achieved via treatment with either 500 nM thapsigargin (T9033,
Sigma, St. Louis, MO), 2.5μM tunicamycin (654380, EMDMillipore, Billerica, MA), or
5mM dithiothreitol dissolved in DMSO. DMSO alone was used as a control vehicle.
2.8 Generation of shCtrl, shXbp1, and shMist1 viruses and cell lines
Lentiviral plasmids (pLKO.1 backbone) were obtained from Sigma-Aldrich (St. Louis,
MO) containing validated sequences for silencing of XBP1 or MIST1 as well as a control,
non-targeting shRNA (sequences in Table 2.04). The plasmids were grown up in DH5α
cells, mini-prepped, and transfected along with viral packaging plasmids in 293T cells.
Table 2.4

Name
shXbp1
shMist1
shCtrl

Sequences of shRNA plasmid constructs against mouse transcripts

Sequence

Target

5'CCGGCCATTAATGAACTCATTCGTTCTCGAGAACGAATGAGTTCA
TTAATGGTTTTT-3'
5'CCGGCGGATGCATAAACTCAACAATCTCGAGATTGTTGAGTTTAT
GCATCCGTTTTT-3'
5'CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTGT
TGTTTTT-3'

3' UTR
CDS
N/A

The transfected cells were allowed to synthesize virus for 24 hours before having
supernatants collected at 12 hour intervals for 3 days (24 through 72 hours posttransfection). Supernatants were then spun at 25,000 x g for two hours and pellets were
resuspended in 1 mL of TNE buffer (50 mM Tris-HCl – pH 7.4, 100 mM NaCl, 0.1 mM
EDTA) and stored in 200 μL aliquots at -20°C.
To infect new cells, a 70% confluent 10cm plate of 266-6 cells was treated with a
solution consisting of 2 mLs complete hgDMEM, 10 μg/mL polybrene, 10 mM HEPES,
and 200 uL of thawed viral aliquot. Cells were given 24 hours to become infected before
media was replaced with selection media consisting of complete hgDMEM with 1.0
μg/mL puromycin added. Complete control (uninfected) cell death was achieved in
puromycin selection within three days, with virally infected cells being passaged twice to
remove all traces of virus and then expanded and frozen down for future use.
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2.9 Luciferase assays
Mist1-promoter luciferase vectors were generated by Dr. Jeff Ishibashi using the pBRITPURO viral backbone. 266-6 cells were transfected using standard protocols for PEI
(polyethyleimine) (23966-2, Polysciences Inc., Warrington, PA) transfections. Briefly, this
involved seeding 6 cm plates with 266-6 cells to 70% confluence. Transfection mixes
contained 400μL serum-free, antibiotic-free hgDMEM at room temperature, 1.5 μg each
of Mist1pr-luc vector and pBRIT-Xbp1s or pBRIT PURO control, 2 ng Renilla luciferase
expressing vector (for internal control purposes), and 9 μL PEI (1 μg/μL stock). Mixes
were created and allowed to incubate at room temperature for 15 minutes, then added
dropwise to a culture dish in which the cells had been washed three times in media to
remove any secreted growth factors. Cells were incubated for 48 hours before being
harvested in passive lysis buffer (E194A, Promega, Madison, WI) and analyzed using
the Luciferase Assay System (E1501, Promega, Madison, WI) and Renilla Luciferase
Assay System (E2820, Promega, Madison, WI). 10 μL of each supernatant was added
to both luciferin-containing and coelenterazine-containing glass vials (with each in its
respective buffer from the Promega kits). Luminescence readings were obtained using a
Lumat luminometer (LB9501, Berthold, Oak Ridge, TN). Luciferin luminescence values
were normalized to coelenterazine luminescence values via simple division as an
internal control, as all samples had the same amount of Renilla plasmid added at time of
transfection.
2.10 Bioinformatic analysis of candidate MIST1 effectors
Generation of the initial list of candidate MIST1 effectors was accomplished via analysis
of pooled data from multiple sources including: ChIP-Seq data generated from Mist1WT
mice in collaboration with Dr. Raymond MacDonald at UT Southwestern (unpublished),
microarray data from a Mist1 rescue mouse panel (Direnzo et al., 2012), a mouse UPRspecific PCR array (PAMM-089, SA Biosciences, Valencia, CA), published gene lists
reporting secretory genes associated with XBP1- and nATF6-transfected NIH3T3
fibroblasts (Bommiasamy et al., 2009; Sriburi et al., 2007), and microarray data from
tunicamycin-treated Ire1KO liver samples (So et al., 2012).
Selection criteria for candidate genes initially involved selection of all general UPR and
secretion-specific UPR genes available from the previously listed sources, generating a
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184 candidates. These candidates were analyzed for ChIP enrichment (see Appendix A)
using the MochiView software suite (Homann and Johnson, 2010). This eliminated 65
candidates that had no MIST1 enrichment within the target gene’s promoter or first two
exons/introns. We then used sequence analysis on the 500 base pair regions
surrounding ChIP enrichment sites in the remaining genes and scanned for the presence
of GC or TA E-boxes, known DNA binding sites for MIST1. We eliminated genes with no
detectable E-boxes. We then analyzed the resulting genes via utilization of microarray
data previously generated by Dr. Daniel DiRenzo that detected the relative gene
expression differences between Mist1WT, Mist1KO, and Mist1KO;LSL-Mist1myc transgenic
mice. These animals expressed a Mist1 transgene in a Mist1KO background for 36 hours
prior to RNA harvesting, thus allowing us to determine whether expression of any of the
candidate effectors was significantly altered in Mist1KO acinar cells and fully or partially
rescued upon Mist1myc expression (see Appendix B). By restricting our search to genes
that displayed expression changes upon MIST1 expression, we reduced our list of
possible targets to 54 candidates. As a final refining step, we checked our candidates
against published microarray data (available in the NCBI Geo repository) analyzing WT
and Ire1KO liver samples treated with tunicamycin. We then grouped the remaining list of
candidate effectors based on ChIP-Seq enrichment, expression levels after MIST1myc
expression, and demonstrated significance in ER stressed, IRE1KO liver samples. This
final list of candidate effectors contained 15 high-scoring genes, and we chose 6
additional effectors missing a single criteria but with highly significant ChIP enrichment
or expression changes upon rescue. These genes are listed in Table 5.02, with a
summary diagram of the selection criteria in Figure 5.08. All genes are shown in
Appendices A-D with relative ChIP enrichment scores (Appendix A,B) and Mist1 rescue
array scores (Appendix C,D).
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CHAPTER 3. XBP1 IS A NECESSARY COMPONENT OF THE PANCREATIC
ACINAR CELL UNFOLDED PROTEIN RESPONSE
3.1 Introduction
Studying the unfolded protein response (UPR) requires consideration of a number of
factors regarding cell type and function. As previously described, all cells utilize
secretory pathways in some fashion, typically via constitutive secretion of membrane
and extracellular matrix (ECM) components (Burgess and Kelly, 1987). Constitutively
secreted proteins typically mature extensively in the Golgi, often requiring substantial
modification including glycosylation of N-terminal protein signals, phosphorylation,
sulfation or hydroxylation of specific residues, and early proteolytic processing steps
(Mains et al., 1987). Constitutive secretion, however, generates vesicles with low protein
titers, placing little stress on the ER/Golgi machinery and leading to low UPR activation
(Grampp et al., 1992). As such, non-secretory cells typically have a reduced UPR
activity and are not ideal models for studying UPR regulation.
One exception to reduced protein throughput being a characteristic of non-secretory
cells is during development, when secreted protein families, including the bone
morphogenetic proteins (BMPs), are essential to proper body planning (Hogan, 1996).
Additionally, gene-trap experiments targeted specifically to secreted and transmembrane
proteins have demonstrated the importance of secreted proteins and an intact secretory
pathway during development (Mitchell et al., 2001). However, embryonic knockout
studies utilizing a compound knockout of Atf6α/β or deletion of Ire1/Xbp1 result in
embryonic lethality, making developmental systems difficult to utilize in the investigation
of the UPR (Lee et al., 2005; Reimold et al., 2000; Yamamoto et al., 2007). Therefore,
an ideal experimental system for UPR research should utilize an inducible mechanism
for ablation or activation of necessary UPR components. Such a system must also utilize
a cell type that relies upon the UPR in order to observe any changes in cell phenotype
following its disruption.
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Non-secretory cell types, including the NIH3T3 fibroblast cell line, have been used to
bioinformatically analyze the effects of Xbp1s via transfection studies. As summarized in
Table 3.01, XBP1s transfection results in expression of target genes associated with
nearly every step in the secretory pathway (see Figure 1.04 for matching classifications
of XBP1 target genes) (Sriburi et al., 2007). This data illustrates the importance of XBP1
in driving cellular responses to ER stress. The exact means by which XBP1 controls
homeostasis in secretory cells has been difficult to study, owing to a lack of normal
secretory cell systems and the previously described lethality of Xbp1-knockout mice.
Dedicated secretory cells are typically polarized, thus requiring extensive interaction of
the endo- and exocytic pathways, cytoskeletal regulatory mechanisms, and the secretory
machinery (Deitcher, 2002). Exocrine cells therefore make extensive use of the UPR
both during secretion and in the basal state. In situ hybridization analysis of developing
mouse embryos revealed extensive Xbp1 mRNA expression in osteoblasts and exocrine
glands (Clauss et al., 1993). This data also indicated that Xbp1 expression peaks at
E14.5, suggesting a developmental role for XBP1 outside of its role in the UPR (Clauss
et al., 1993). However, follow up studies utilizing XBP1s reporter mice established that
XBP1 is constitutively expressed and spliced in the adult pancreas, indicating that a
basal level of UPR activity is maintained there, making it ideal for studying the
IRE1/XBP1 branch (Iwawaki et al., 2004).
XBP1 is of key interest in the study of pancreatic disease and cancer. Impaired
expression via hemizygous gene deletion in mice demonstrated that XBP1
specifically protects the exocrine pancreas from alcohol-induced damage (Lugea et al.,
2011). This is particularly interesting as alcoholism is a known risk factor.
Pharmacological inhibitors of Xbp1 splicing with standard chemotherapeutics has shown
synergistic effects in halting the growth of multiple myeloma cells (Mimura et al., 2012).
for development of chronic pancreatitis, possibly linking XBP1 and pancreatic disease
(Dufour and Adamson, 2003). XBP1 may also play a role in tumorigenesis, as transgenic
models have revealed a positive correlation between rates of XBP1 splicing and tumor
cell growth, indicating a possible avenue for new therapeutics (Spiotto et al., 2010). This
development would be particularly important, as pancreatic ductal adenocarcinoma
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1. Targeting and translocation
Signal recognition particle
Srp9, Srp19, Srp54a, Srp68, Srpr, Srprb
Signal sequence receptor
Ssr1, Ssr2, Ssr3, Ssr4
Translocon
Sec61a1, Sec61b, Sec61g, Sec63, Tram1
Signal peptidase
Spcs2, Spcs3, Sec11a, Sec11c
2. N-linked glycosylation
Core oligosaccharide synthesis Alg2, Alg12, Mgat2
Oligosaccharyltransferase
Ddost, Dad1, Rpn1, Rpn2
Oligosaccharide processing
Mogs
3. Facilitation of protein folding
Dnajb2, Dnajb9, Dnajb11, Dnajc1, Dnajc10
Chaperones
Fkbp1b, Fkbp2, Fkbp7, Fkbp10, Fkbp11, Fkbp14
Hspa5, Hspa13, Hsp90b1, Hyou1, Ppib
Ero1lb, Erp29, Erp44, Pdia3, Pdia4, Pdia6, Selm,
Disulfide bond formation
Txndc5, Txndc11
ER-associated degradation
Derl1, Edem1, Herpud1, Syvn1
4. Vesicular trafficking and transport
Anterograde transport
(ER→Golgi)
COPII vesicles
Sec23a, Sec23b, Sec24d, Sec31a, Yipf5, Yif1a
Cargo receptors
Lman1, Mcfd2
SNAREs
Bet1, Betl1, Sec22b
Retrograde transport (ER←Golgi)
Arcn1, Arfgap3, Copb1, Copb2, Cope, Copg,
COPI vesicles
Copz1
Cargo receptors
Kdelr2, Kdelr3, Lman2
Transport/recycling in the Golgi Blzf1, Cog3, Cog6, Gosr2, Rab33b, Uso1
Exocytosis
SNAREs
Stx5a, Stx18, Vamp2, Vamp4, Vamp7
Small GTPases
Rab3a
5. Others
Atf6, Atp2a2, Bfar, Creb3, Creb3l1, Crebl1,
ER proteins
Dolpp1, Eif2ak3, Ggcx, H13, Hmox1, Lepre1,
Ormdl3, Rrbp1, Rcn3, Piga, Sdf2l1, Surf4, Wfs1
Golga3, Golga4, Golgb1, Gcc1, Golph3, Golph3l,
Golgi proteins
Gopc, Gorasp2, Rabac1
Table 3.1.
XBP1 target genes are involved in multiple steps of normal protein
synthesis and degradation in the ER
Transfection of XBP1s in NIH3T3 fibroblasts results in expression of genes associated
with facilitation of secretory protein synthesis (diagrammed in Figure 1.04).

48
(PDA) has a dismal 6% 5-year survival rate due in large part to ineffective
chemotherapeutics (Siegel et al., 2013). In fact, recent pre-clinical work combining
Initial studies utilizing Xbp1-/- mice demonstrated that complete knockout of the gene is
embryonic lethal, although liver-specific expression of an Xbp1 transgene (Xbp1-/;LivXbp1) allows mice to survive into neonatal development (Lee et al., 2005). As shown in
Figure 3.01, Xbp1-/-;LivXbp1 mice die due to pancreatic insufficiency, an expected finding
given previous data showing that XBP1 is required for initial development of the exocrine
secretory machinery and that pancreatic acinar cells have the highest protein production
level of any human secretory cell (Case, 1978; Lee et al., 2005). Interestingly, recent
work utilizing an inducible XBP1-knockout model in gastric chief cells demonstrated that
XBP1 was required for expression of the key differentiation marker MIST1, a basic helixloop-helix transcription factor also expressed in differentiated pancreatic acinar cells
(Huh et al., 2010). However, our analysis of Xbp1-/- post-natal pup pancreata revealed
sparse acini with that surprisingly still expressed MIST1 despite lacking Xbp1 (Figure
3.01c, right panel). This indicates that the regulation of XBP1 target genes, and
possibly the determinination as to whether a gene is actually a target, is likely cell-type
dependent. These data prompted us to study whether XBP1 is essential for acinar cell
UPR activation and homeostasis in the adult pancreas.
In this study, we addressed the issue of Xbp1 knockout lethality via generation of an
acinar cell-specific, Cre-inducible mouse line. Our work has demonstrated that acinarspecific Xbp1 ablation results in a gradual onset of ER stress and activation of the PERK
and ATF6 components of the UPR. Furthermore, the activities of the PERK and ATF6
branches are unable to restore normal protein throughput levels in acinar cells, resulting
in visible distress including loss of ER staining and integrity, accumulation of autophagic
vesicles, and decreased acinar cell zymogen synthesis. The loss of Xbp1 eventually
leads to apoptotic cell death approximately four weeks after ablation. These findings
demonstrate that XBP1 is an essential component of the pancreatic acinar cell UPR, and
its expression is required for maintenance of acinar cell homeostasis.
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Figure 3.1
Xbp1-/-;LivXbp1 mice have malformed pancreata with sparse acini and
patchy expression of MIST1
(A) Xbp1-/-;LivXbp1 mice (bottom) die during post-natal development and are substantially
smaller than wild-type counterparts (top). (B) Wild-type pancreata at 10 days post-natal
development have substantial zymogen accumulation (left image, pink staining) with
strong expression of MIST1 (right image). (C) Xbp1-/-;LivXbp1 pancreata have reduced
zymogenic staining with reduced numbers and size of acinar cells (left image and inset)
but maintain MIST1 expression. Panel A courtesy of Dr. Laurie Glimcher.
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3.2 Generation and testing of Mist1CreER/+; Xbp1fl/fl mice
The goal of this work was to generate a mouse line that would facilitate acinar-specific
ablation of Xbp1 in the adult pancreas. This system allows the study of XBP1 as a
component of the UPR in fully developed, wild-type acinar cells. Two established lines
were crossed to generate a CreERT2-mediated system allowing ablation of Xbp1 via simple
intraperitoneal (i.p.) injection of tamoxifen.
An established mouse line, termed Xbp1fl/fl, was obtained from Dr. Laurie H. Glimcher at
Harvard University in order to effectively study inducible Xbp1 ablation. The Xbp1fl/fl
mouse line was originally generated in the Glimcher lab by Dr. Ann-Hwee Lee and is
diagrammed in Figure 3.02a/b (Hetz et al., 2008). The wild-type Xbp1 gene (responsible
for producing the Xbp1u transcript that can be spliced to Xbp1s) has five exons, with the
DNA-binding and leucine zipper spanning exons 2 and 3 and the 26nt splice site located
in exon 4 (Figure 3.02a/b). Two loxP sites flanking exon 2 were engineered via standard
techniques to generate the Xbp1fl/fl line. Upon Cre-mediated recombination, exon 2 is
excised, resulting in transcription of a modified mRNA transcript that no longer encodes
active XBP1s (Hetz et al., 2008). Importantly, despite being unable to be translated into
a functional protein, the Xbp1fl transcript still contains the intact 26nt splice site, allowing
the monitoring of IRE1-dependent splicing, and thus UPR activity, via RT-qPCR with
splice-specific primers (Hetz et al., 2008). This construct was then paired with an acinar
cell-specific Cre recombinase line generated in the Konieczny lab.
The Mist1CreERER line was designed by Dr. Guanglu Shi in collaboration with the Purdue
Transgenic Mouse Core Facility (Figure 3.02c) (Shi et al., 2009b). Briefly, homologous
recombination and embryo injection of ES cells were used to generate a knock-in mouse
line in which the coding sequence of the Mist1 gene was replaced with a new sequence
encoding the Cre-ERT2 fusion protein at the endogenous Mist1 locus. This fusion protein
is a standard Cre-recombinase fused to a tamoxifen-sensitive mutant human estrogen
receptor that forces cytoplasmic localization of the recombinase (Feil et al., 1997). The
modified estrogen receptor is bound to the recombinase and prevents its nuclear
localization until tamoxifen (typically administered to the animal via i.p. injection or oral
gavage) crosses the cell membrane and binds the receptor, causing its dissociation from
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Figure 3.2
Schematic of transgenes used in creation of the Mist1CreER/+; Xbp1fl/fl;
LacZ
R26
mouse line
(A) Schematic of the normal Xbp1 locus, with boxes representing translated exons. The
DNA-binding, basic leucine zipper (bLZ, yellow) domain spans exons 2 and 3, while the
IRE1-dependent splice site (red) is in exon 4. (B) Schematic of the Xbp1flox (Xbp1fl) locus
with loxP sites flanking exon 2 at the endogenous Xbp1 locus. (C) Schematic of the
Mist1CreERER (Mist1CreER) transgene that was knocked into the endogenous Mist1 locus.
(D) Schematic of the ROSA26LacZ (R26LacZ) locus, showing Cre-dependent, conditional
expression of β-galactosidase. (E) Diagram of desired mouse lineage with its effects.
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Cre and allowing nuclear translocation of the recombinase (Feil et al., 1997).
Importantly, the cytoplasmic restriction of the protein prevents Cre-mediated ablation of
Xbp1, thus creating a system in which intact XBP1 expression can be inducibly switched
off. The knock-in model restricts expression of Cre-ERT2 to cells that natively express
MIST1, including pancreatic acinar cells.
Mist1CreERER/CreER; Xbp1+/+ mice were mated to Mist1+/+; Xbp1fl/fl over multiple generations,
yielding mice with a Mist1CreER/+;Xbp1fl/fl genotype as well as relevant variations used as
experimental controls. Additionally, a transgene that conditionally encodes the βgalactosidase (LacZ) gene from the ROSA26 locus was crossed into the line (Figure
3.02d). The ROSA26 locus, originally identified via gene-trap experiments in mouse ES
cells, is constitutively active in all cells and is frequently utilized for transgenic expression
of reporter genes (Casola, 2010; Friedrich and Soriano, 1991). In ROSA26LacZ (R26LacZ)
mice, a lox-stop-lox (LSL) cassette containing multiple in-frame stop codons preceding
the LacZ gene was knocked in to the ROSA26 locus. This results in a non-coding locus
that becomes active upon Cre-mediated excision of the LSL cassette and begins lowlevel transcription of β-galactosidase. This results in permanent labeling of all cells in
which Cre has been active or was active in a progenitor cell. Importantly, because this is
a permanent recombination event, all progeny of β-gal-positive cells will remain β-galpositive.
By combining all three transgenes through standard crosses, we generated a mouse line
with inducible, cell-specific ablation of XBP1 along with coexpression of β-galactosidase
for lineage tracing (Figure 3.02e). As diagrammed in Figure 3.03a, ablation of Xbp1
exon 2 generates a frameshift that encodes an early stop codon six amino acids into
XBP1 exon 3, resulting in a transcript that codes for a truncated protein lacking DNAbinding, transcriptional activation, and nuclear localization domains (Figure 3.03b). This
truncated protein (Xbp1ΔEx2) has no transcriptional activity and is rapidly degraded,
completely eliminating XBP1s in all progeny cells.
Initial testing for CreER efficacy using DNA extracts from tamoxifen-treated mice revealed
expression of the recombined Xbp1fl construct (termed Xbp1ΔEx2) restricted to tamoxifen-
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Figure 3.3

Effects of Cre-mediated recombination at the Xbp1flox locus

(A) Cre-mediated recombination results in a modified gene that no longer encodes for a
portion of the basic leucine zipper (bLZ). Additionally, a frameshift resulting from the loss
of exon 2 encodes a STOP codon located six amino acids into exon 3 in the translated
protein. (B) XBP1u is a direct translation of the unspliced Xbp1 transcript and has few
well-studied functions in cells. XBP1s has a unique C-terminus that contains a potent
transcriptional activation domain and nuclear localization signal, resulting in its
translocation to the nucleus and activation of its target genes. XBP1ΔEx2 consists of exon
1 and six amino acids of exon 3 of the XBP1 proteins and is unstable.
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administered pancreata and not in tail, kidney, or untreated tissues (Figure 3.04a).
These were selected as representatives of MIST1-expressing (pancreas) and nonexpressing (kidney, tail) cell types. The restriction of Cre activity was mimicked using
standard qPCR (Figure 3.04b), confirming restriction of Cre-mediated recombination to
MIST1-expressing tissues. Further analysis was conducted to determine the subset of
pancreatic cells in which Xbp1 had been ablated.
As a first step to monitor acinar-specific recombination, pancreatic sections were
generated from Mist1CreER/+; Xbp1fl/fl; R26LacZ mice treated with corn oil (vehicle) or
tamoxifen (TM). As shown in Figure 3.05a,b, X-gal staining, a marker for βgalactosidase (β-gal) activity, revealed substantial staining of pancreatic acinar cells with
no staining in the untargeted pancreatic islets or ducts. Histological analysis of harvested
pancreata from these animals also showed normal appearance and protein expression
in both the β-gal negative islets and duct cells (Figure 3.05c,d). Quantification of β-gal
activity via X-gal staining (Figure 3.05e) indicated virtually no recombination in untreated
or MIST1-negative tissues. In contrast, approximately 90% of Mist1CreER/+; Xbp1fl/fl;
R26LacZ acinar cells were positive for β-gal. These data demonstrated that Cre
recombinase activity in Mist1CreER/+; Xbp1fl/fl; R26LacZ mice was restricted to Mist1expressing organs, and recombination is restricted within the pancreas specifically to
acinar cells. Further testing was conducted to determine whether the tissue-specific
expression of the Xbp1ΔEx2 transcript resulted in loss of Xbp1 activity.
As previously shown in Figure 1.05, each UPR branch activates both branch-specific
gene targets as well as shared effectors that are coactivated by one of the other master
regulator cascades. IRE1/XBP1 is responsible for activation of a number of branchspecific UPR targets, among them protein disulfide isomerase (PDI, a regulator of
disulfide bond formation in the ER), the related protein disulfide isomerase associated 2
(PDIA2/PDIp), and Sec61α (a component of the ER translocation apparatus used for
moving proteins into and out of the ER) (Todd et al., 2008, 2009). Constitutive, low-level
XBP1s activity has been previously observed in the pancreas (Figure 3.07a) (Iwawaki et
al., 2004), prompting us to investigate the expression of known XBP1-specific target
genes for confirmation of Xbp1 loss of function.
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Figure 3.4
Mist1CreER/+; Xbp1fl/fl mice express the Xbp1dEx2 transcript in a pancreasrestricted fashion
(A) Standard PCR utilizing primers specific for the Xbp1ΔEx2 transcript were used on
homogenates from pancreas (P), kidney (K), and tail (T) tissues in tamoxifen-treated and
untreated Mist1CreER/+; Xbp1fl/fl mice. Expression of the recombined transcript is only
detected in the pancreas of tamoxifen-treated mice. (B) qPCR for the Xbp1ΔEx2 transcript
also reveals expression effectively restricted to tamoxifen (TM)-treated pancreata. (* = pvalue < 0.001 relative to tamoxifen-treated kidney sample). RT-qPCR analysis
completed in collaboration with Dr. Sean Humphrey.
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Figure 3.5
Ablation of Xbp1 in tamoxifen-treated Mist1CreER/+; Xbp1fl/fl; R26LacZ mice is
restricted to the acinar cells in the pancreas
(A) X-gal staining of pancreata from Mist1CreER/+; Xbp1fl/fl; R26LacZ mice without tamoxifen
shows no staining, indicating a lack of Cre activity. (B) X-gal staining of tamoxifentreated Mist1CreER/+; Xbp1fl/fl; R26LacZ mouse pancreata shows extensive β-galactosidase
activity in acinar cells, but not islets (black arrow). Additionally, the red outline marks a βgal negative centroacinar cell. (C) Staining for insulin and glucagon in Mist1CreER/+;
Xbp1fl/fl; R26LacZ mouse pancreata show normal arrangement of cells and protein
expression. (D) Staining for cytokeratin 19 (K19) in Mist1CreER/+; Xbp1fl/fl; R26LacZ
pancreata reveals normal appearance and K19 expression in ducts (black arrows). (E)
Quantification of acinar β-gal activity demonstrating Cre-activity in approximately 90% of
pancreatic acinar cells in TM-treated samples.
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As shown in Figure 3.06a, expression of PDI, PDIp, and Sec61α is immediately and
significantly reduced in Mist1CreER/+; Xbp1fl/fl samples within 48 hours of TM treatment.
This is contrasted by expression of CHOP (Figure 3.06a, right), an ER stress response
gene regulated by multiple UPR branches that shows no significant change. These
results suggest than Xbp1 ablation effectively silenced the IRE1 component of the UPR
without effect on the other branches.
We next sought to verify that ablation of Xbp1 had not altered upstream UPR activators.
To confirm that IRE1 was still actively splicing Xbp1 transcripts, IRE1 activity was
assayed via RT-qPCR using splice-specific primers that detected IRE1-dependent
excision of the 26 nucleotide intron still present in the Xbp1ΔEx2 transcript (diagrammed in
Figure 3.03a). As shown in Figure 3.06b, splicing of the Xbp1ΔEx2 transcript confirmed
robust IRE1 activity within the pancreas following tamoxifen-mediated Xbp1 ablation.
This activity was sustained over several weeks, showing significant increases following
ablation (discussed in section 3.3). Despite the high level of IRE1 activity, the XBP1
targets Sec61α and PDI were not significantly upregulated (Figure 3.06c), indicating that
tamoxifen-mediated Cre-dependent splicing abrogates XBP1 function in the pancreas.
These mice will henceforth be referred to as Mist1CreER/+; Xbp1ΔEx2 mice.

3.3 Xbp1 ablation causes ER stress and activation of an incomplete UPR in
Mist1CreER/+; Xbp1ΔEx2 acinar cells
Previous work performed by the Miura research group utilized transgenic mice to
express an XBP1s-GFP fusion protein to be used as a reporter of ER stress (Iwawaki et
al., 2004). These mice have substantial expression of the tagged fusion protein
specifically in the pancreas, indicating that ER stress with
corresponding UPR activation is constitutive in the normal adult pancreas (Iwawaki et
al., 2004) (Figure 3.07a). The constant secretory load and corresponding UPR makes
the pancreas an ideal target for investigating the degree of crosstalk between the three
master regulator molecules and their downstream signaling components. The extensive
overlap in UPR targets and functions prompted us to ask whether XBP1 is an essential
component for UPR-mediated resolution of ER stress in pancreatic acinar cells. Previous
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Figure 3.6
Tamoxifen administration in Mist1CreER/+; Xbp1fl/fl mice disables the XBP1dependent expression of target genes
(A) RT-qPCR analysis of pancreata from tamoxifen-treated Mist1CreER/+; Xbp1fl/fl mice
indicates that expression of PDI, PDIp, and Sec61α is significantly reduced compared to
CHOP. (B) RT-qPCR using primers specific for IRE1-mediated Xbp1 RNA splicing
indicates significant and sustained activity of IRE1. (C) RT-qPCR for XBP1-specific
targets PDI and Sec61α show no significant increase in expression over control despite
active splicing of the Xbp1 transcript. (* = p-value < 0.05 relative to control samples,
normalized to 18s expression) RT-qPCR analysis (Figure C) conducted in collaboration
with Dr. Sean Humphrey.
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Figure 3.7
Ablation of Xbp1 results in sustained and progressive activation of the
unfolded protein response (UPR)
(A) Gut isolates of ER stress-activated indicator (ERAI) mice expressing an Xbp1-Venus
fusion protein that fluoresces upon splicing of the Xbp1 transcript (Iwawaki et al., 2004).
Transgenic mice reveal constitutive expression of XBP1s specifically in the mouse
pancreas (P) but not the intestine (I) or stomach (S). (B) Protein isolates from
Mist1CreER/+; Xbp1ΔEx2 pancreata reveal increasing activation of the PERK (assayed via
phosphorylation of eIF2α) and nATF6 (primary effector of ATF6) pathways. (C) RTqPCR analysis of ER stress indicators in pancreatic RNA isolates reveal progressively
increasing expression of both Chop and Bip. (D) Chop and Bip are upregulated in RNA
isolates from Mist1CreER/+; Xbp1ΔEx2 pancreata at three weeks post-ablation but not in
Mist1CreER/+; Xbp1ΔEx2/+ or untreated Mist1CreER/+; Xbp1fl/fl controls. (* = p-value < 0.05
relative to control samples, normalized to 18s expression). RT-qPCR analysis conducted
in collaboration with Dr. Sean Humphrey.
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investigations of other master regulators indicated that ablation of PERK or ATF6α failed
to generate increases in ER stress indicators (Iida et al., 2007; Wu et al., 2007). Both of
these studies concluded that the UPR could function in the absence of one of the three
branches.
In order to monitor the effects of Xbp1 ablation, mice were administered tamoxifen and
sacrificed at one week intervals. Pancreata were harvested for histology, protein, and
RNA isolation to allow for complete analysis of each organ. As seen in Figure 3.07b,
loss of Xbp1 was followed by steadily increasing detection of phosphorylated eIF2α
(eIF2α) and nuclear ATF6 (nATF6), indicative of activation of the PERK and ATF6
master regulators, respectively. (see Figure 1.05 for diagram). This increase in UPR
pathway activation correlated with increasing transcript levels of both Bip and Chop
(Figure 3.07c), previously described as key UPR targets activated by multiple UPR
master regulator branches. These data suggest that loss of XBP1 function leads to
progressively increasing levels of ER stress.
Previous investigations by other groups have indicated that loss of one Xbp1 allele can
substantially impair UPR function in mice with experimentally-induced acute pancreatitis
(Lugea et al., 2011). We investigated whether the UPR activation we observed
accompanying basal pancreatic functioning could be similarly triggered via heterozygous
deletion of one copy of Xbp1. As shown in Figure 3.07d, Xbp1ΔEx2/+ mice failed to show
increased expression of Bip or Chop at three weeks post tamoxifen treatment, indicating
a lack of significant ER stress due to loss of one Xbp1 allele. This illustrates that the
apparent increase in ER stress indicators Bip and Chop is specifically due to the
complete loss of XBP1 function and that a single Xbp1 allele is capable of sustaining the
unfolded protein response during normal pancreatic functioning.
3.4 Loss of Xbp1 triggers progressive cell damage in acinar cells
Pancreatic acinar cells make extensive use of their protein production machinery in
order to synthesize and secrete digestive zymogens. As such, zymogen production and
activation are effective ways of measuring cell stress levels and protein throughput.
Specifically, zymogen forms of amylase, elastase, and carboxypeptidase A (CPA) are all
expressed at high levels in acinar cells. Additionally, accumulation of aberrantly auto-
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activated CPA is a hallmark of improper acinar secretion that is triggered by pancreatic
damage, leading to inflammation seen in pancreatitis patients (Jaffray et al., 2000).
Certain acinar transcription factors, including MIST1, are also affected during stress, with
a marked decrease in expression associated with pancreatic damage due to pancreatitis
or oncogenic transformation (Shi et al., 2009b). We thus sought to investigate the overall
health of Mist1CreER/+; Xbp1ΔEx2 acinar cells via analysis of MIST1 levels and the
presence of intact and damage-associated zymogen forms.
In contrast to the increased ER stress markers seen previously, expression of amylase
and elastase transcripts progressively declined following
ablation of Xbp1, suggesting that there may be a reduction in overall protein throughput
(Figure 3.08a). This finding is also seen at the protein level, along with an inversely
correlated accumulation of activated CPA, indicative of acinar cell distress (Figure
3.08b). These data prompted an investigation of whether visible signs of distress could
be observed via histological analysis.
Due to the limited efficacy of Cre-mediated recombination, a small subset of acinar cells
(<10%) were expected to continue expressing normal XBP1s derived from the
unrecombined Xbp1flox allele. This fortuitously allowed a comparison of Xbp1ΔEx2 acinar
cells to unablated cells within the same tissue. LacZ staining of four week post-tamoxifen
tissue samples revealed isolated acini which had not responded to tamoxifen induction
and thus failed to activate β-gal expression or ablate Xbp1 (Figure 3.08c, red outlines).
The previously described loss of zymogen and Mist1 expression known to be a
consequence of acinar cell damage was restricted to the β-gal positive cells, confirming
that “normal” acini were unaffected by neighboring cell loss of Xbp1 (Figure 3.08d).
These two distinct populations were thus dubbed the zymogenic (XBP1-expressing) and
non-zymogenic (Xbp1ΔEx2) populations. The presence of two distinct populations
provided an opportunity to comparatively analyze the cell architecture within the
Xbp1ΔEx2 acinar cells.
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Figure 3.8
Ablation of Xbp1 results in reduction of protein expression that is
accompanied by increased damage indicators
(A) RT-qPCR for amylase and elastase transcripts show a progressive drop in steadystate levels following loss of XBP1. (B) Protein blot for amylase (AMY) and activated
CPA (CPAActive) levels show a decrease in amylase protein while activated CPA, a
marker for pancreatic damage, accumulates over the same period. (C) LacZ staining
reveals isolated acini that failed to ablate Xbp1 (β-gal negative) and retain expression of
acinar hallmark proteins. (D) Immunofluorescence staining for amylase and MIST1
reveals a loss of both proteins in the Mist1CreER/+; Xbp1ΔEx2 population with continued
expression in the cells that failed to ablate Xbp1. (* = p-value < 0.05 relative to control
samples, normalized to 18s expression) RT-qPCR analysis done in collaboration with
Dr. Sean Humphrey.
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As previously described, expression of XBP1s is linked to expansion of the ER in cells
undergoing ER stress, implying that ablation of Xbp1 could result in altered cellular ER
morphology (Federovitch et al., 2005; Shaffer et al., 2004; Sriburi et al., 2004).
Consistent with this idea, hematoxylin and eosin (H&E) staining of isolated pancreata
(Figure 3.09a-c) showed a progressive loss of basophilic (dark purple) ER staining,
along with a decrease in eosinic (pink) zymogen staining. Notably, this loss in zymogen
staining is absent in the zymogenic population (Figure 3.09c, white outlines).
Comparative electron microscopy between zymogenic and non-zymogenic cells at 4
weeks post-ablation (Figure 3.09d,e) showed a marked change in endoplasmic
reticulum appearance, with overall disorganization of the ER, disruption of the nuclear
envelope, and a near absence of secretory/zymogen vesicles. The ER itself was swollen
and lacked the orderly stacking seen in normal cells. Additionally, loss of Xbp1 triggered
an increase in protein degrading autophagy as determined by increased expression of
the autophagy-related protein LC3B and direct observation of autophagosomes by TEM
in Xbp1ΔEx2 acinar cells (Figure 3.09f).
3.5 Acinar cells lacking Xbp1 die approximately four weeks after ablation
Unchecked ER stress and continued activation of the UPR results in initiation of an
apoptotic cascade via coordinated action of all three master regulators of the UPR
(Szegezdi et al., 2006). A key regulator of this process is the C/EBP homologous protein
(CHOP) transcription factor that is activated by all three pathways but only dependent on
activation of the PERK branch (Harding et al., 2000). CHOP leads to numerous proapoptotic expression changes including a decrease in expression of pro-apoptotic BCL2
and an increase in expression of pro apoptotic proteins such as GADD34, ERO1α, and
TRB3 (Szegezdi et al., 2006). Notably, the IRE1 component of the apoptotic arm is not
XBP1-dependent but rather relies on a direct interaction of IRE1 and TRAF2, a known
upstream regulator of the BCL2 family of proteins that prevent apoptotic initiation
(Szegezdi et al., 2006). Though the exact mechanism of ER stress-induced cell death is
still being elucidated, it is apparent that persistent activation of the UPR results in
activation of an apoptotic cascade that initiates and develops through non-XBP1
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Figure 3.9
Loss of Xbp1 triggers altered acinar morphology, ER disorganization, and
increased autophagy
(A) Hematoxylin and eosin (H&E) staining of Mist1CreER/+; Xbp1ΔEx2 pancreata 24 hours
post-TM with normal morphology. (B) Mist1CreER/+; Xbp1ΔEx2 pancreata two weeks after
Xbp1 ablation. (C) Mist1CreER/+; Xbp1ΔEx2 pancreata four weeks after Xbp1 ablation. White
outline denotes a zymogenic region. (D) Transmission electron micrograph (TEM) of a
zymogenic acinar cell four weeks post-ablation. Yellow arrows denote normal stacked
ER (also shown in high magnification inset). White arrows denote zymogens with a
normal, electron-dense appearance. (E) TEM of a Mist1CreER/+; Xbp1ΔEx2 non-zymogenic
acinar cell. White arrows and inset show disorganized ER with free ribosomes (inset).
Yellow arrows denote aberrant zymogen granules and a black arrow denoting an
autophagosome, indicative of autophagy. (F) Immunofluorescence staining for LC3B
reveals increased autophagy in the non-zymogenic population at four weeks post-Xbp1
ablation (red outlines denote zymogenic clusters).
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dependent pathways. This prompted us to investigate the fate of the Xbp1ΔEx2 acinar
cells.
As noted in section 3.2, Xbp1ΔEx2 acinar cells exhibit a progressive activation of the UPR
following Xbp1 ablation (Figure 3.08). The noted increase in CHOP transcripts
discussed earlier is correlated with increased expression of CHOP protein that is
restricted to the Xbp1ΔEx2 acinar cells (Figure 3.10a). This marked
increase in CHOP expression is not observed until four weeks post-ablation.
Additionally, at the four week time point electron microscopy allowed for direct
observation of large numbers of autophagosomes, again indicating an increase in
autophagy likely related to extensive protein misfolding (Figure 3.10b). This time point
coincides with the onset of cell death as determined by labeling of tissue sections via
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), again restricted
to the non-zymogenic population (Figure 3.10c). Isolated protein homogenates from this
time point also reveal increases in stress pathway markers pERK1/2 (MAPK pathway)
and p38 (Figure 3.10d). All of these data indicate that the non-zymogenic, Xbp1ΔEx2
acinar cells die via apoptosis following a period of progressive increasing ER stress.
3.6 Discussion
The unfolded protein response (UPR) plays an essential role in maintenance of
homeostasis within secretory cells. While the mechanics of activation and execution of
each master regulatory branch have been well studied, the complex interplay between
branches and their reliance on each other for full effectiveness is still being investigated.
Indeed, various studies have indicated that the substantial overlap between the three
UPR networks can largely compensate for each other, as elimination of individual
branches typically results in no increase in ER stress (Huh et al., 2010; Iida et al., 2007;
Wu et al., 2007). Understanding this interplay between branches is essential as
knowledge of the UPR is increasingly being utilized to design novel therapeutics against
various malignancies (Wang et al., 2010). This emphasis is due to increasing numbers
of studies

66

Figure 3.10 Xbp1 ablation leads to activation of apoptotic UPR pathways and
eventual cell death
(A) Immunofluorescent analysis of 4-week post-ablation pancreata shows strong
expression of CHOP localized to the non-zymogenic population. Zymogenic cells remain
CHOP-negative. (B) Transmission electron micrograph of a non-zymogenic acinar cell
reveals an autolysosome, indicative of end stage autophagy. (C) TUNEL staining of 4week post-ablation pancreata reveals positive staining in the non-zymogenic acinar
population. (D) Protein blots on isolated pancreatic extracts reveal extensive,
progressive activation of the MAPK and p38 stress pathways. Panel D courtesy Dr.
Sean Humphrey.

67
indicating that ER stress is a common hallmark in cancerous cells (Cyr and Hebert,
2009; Kaufman, 2002; Koong et al., 2006; Walter and Ron, 2011; Wang et al., 2010) as
well as a viable means of inducing cell death in combination with standard
chemotherapeutics (Martins et al., 2011; Nawrocki et al., 2005a, 2005b). The need for
such novel approaches is particularly important in pancreatic ductal adenocarcinoma
(PDA), a nearly untreatable malignancy with a five-year survival rate of only 6% (Siegel
et al., 2013). In this study a cell-specific, inducible Xbp1-knockout mouse model was
utilized to determine if nullification of the IRE1 branch of the UPR could be compensated
for by the PERK and ATF6 networks in pancreatic acinar cells.
The pancreas has been shown previously to have a basal activation of the unfolded
protein response (Figure 3.07a). This is presumed to be due to the high secretory
demands placed on pancreatic acinar cells. Based on this information, we hypothesized
that impairment of proper UPR function via ablation of Xbp1 would result in a sustained
ER stress response. Indeed, we observed a progressively increasing activation of the
PERK and ATF6 branches of the UPR (Figure 3.07), consistent with an inability to
properly resolve basal ER stress in acinar cells. UPR activation reached a maximum at
four weeks post-ablation, which also correlated with the highest degree of cell death.
These results suggest that XBP1, while essential to provide a full unfolded protein
response, is not required for the action of the other two branches. Indeed, the PERK and
ATF6 branches appear fully functional and active via analysis of their immediate
effectors. Thus, the incomplete UPR initiated in the absence of XBP1 might be sufficient
to counter short, minor periods of stress in cells with lower protein loads, but the PERK
and ATF6 branches are not sufficient to mitigate chronic ER stress.
As shown in Figure 3.09, two distinct acinar cell populations are present in Mist1CreER/+;
Xbp1ΔEx2 pancreata, likely due to limitations in Cre efficacy. Fortuitously, the 90%
recombination frequency permits observations of the 10% XBP1-expressing,
“zymogenic” acinar cells in contrast to their Xbp1ΔEx2 counterparts. This served as an
excellent system for analyzing the effects of XBP1-null cells vs. normal cells under
identical conditions. Electron micrographs revealed substantially altered morphology in
Xbp1ΔEx2 acinar cells including degradation of the ER (Figure 3.09d,e). These findings
are consistent with previous data showing that XBP1 is responsible for the physical
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remodeling of the ER during periods of ER stress (Shaffer et al., 2004; Sriburi et al.,
2004). Indeed, loss of XBP1 and the associated disruption of ER architecture results in a
swelling of the ER, possibly due to insufficient protein transport out of the ER, a process
known to be regulated by the XBP1-target EDEM1 (Table 3.01). It is thus likely that
XBP1 functions primarily as a mediator of the adaptive phase of the UPR, remodeling
the ER to expand capacity and increasing export of misfolded proteins.
Ablation of Xbp1 also has apparent cell-wide consequences. As shown via
immunofluorescent staining for the autophagy marker microtubule-associated protein
light chain 3b (LC3B) (Figure 3.09f), cells lacking XBP1 have increased autophagy, a
likely consequence of accumulating large amounts of improperly folded proteins that are
no longer being modulated by the remaining UPR branches. This finding is of particular
importance, because induction of autophagy in transformed cells is emerging as a
possible druggable mechanism for tumor suppression (Suh et al., 2012), supporting the
idea that modulators of XBP1 could serve as a novel therapeutic intervention in human
disease.
Long-term loss of XBP1 function is deleterious to acinar cells, as non-zymogenic cells
express high levels of CHOP four weeks after ablation (Figure 3.10). This again
demonstrates that the PERK and ATF6 of the UPR are unaffected by loss of XBP1.
CHOP expression is primarily under the control of the PERK UPR master regulator,
although recent work has implicated XBP1 as a coregulator (Takayanagi et al., 2013).
Indeed, the gradual accumulation of CHOP over the four weeks following Xbp1 ablation
supports recent work by the Yoshida group showing that CHOP expression may be
auto-regulatory in nature (Takayanagi et al., 2013).Thus, our studies lead to a model in
which ablation of XBP1 causes mounting ER stress, resulting in continuous expression
of CHOP that eventually triggers a switch to an apoptotic cell fate (Figure 3.11). Indeed,
the extended window of ER stress seen in the Mist1CreER/+; Xbp1ΔEx2 model may serve as
a novel tool for investigating regulation of the unfolded response.
Complete loss of XBP1 activity is ultimately fatal in pancreatic acinar cells (figure 3.10).
The observed co-localization of CHOP and TUNEL staining to the non-zymogenic,
Xbp1ΔEx2 acinar cell population indicates that the cells likely died via activation of the

69

Figure 3.11 Proposed model regarding the effects of Xbp1 ablation on ER stress in
pancreatic acinar cells
(A) Standard model of XBP1s action in which IRE1-dependent splicing of Xbp1 leads to
production of XBP1s. This in turn leads to expression of target genes which work in
concert with the other pathways to resolve ER stress. (B) In Xbp1ΔEx2 acinar cells,
XBP1s cannot be synthesized, resulting in disabling of the entire IRE1 branch of the
UPR. This leads to increasing ER stress, which eventually feeds back to the PERK and
ATF6 master regulators and triggers expression of CHOP and the apoptotic portion of
the UPR.
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apoptotic arm of UPR. The progressive activation of both the MAPK and p38 stress
pathways also indicates that acinar cells are under substantial stress due to basal
metabolic demands but that the effect is sub-lethal for an extended period of time. This
observation could indicate that modulation of the UPR may be an effective means of
controlling the viability of stressed cells, including those undergoing oncogenic
transformation. This hypothesis is supported via studies of bortezomib, a
chemotherapeutic drug used to treat multiple myeloma that induces ER stress while
suppressing the UPR (Mimura et al., 2012; Nawrocki et al., 2005a). Future studies are
required to see if induction of ER stress in acinar cells is sufficient to prevent cancerous
transformation. Preliminary data regarding the interaction of ER stress and oncogenesis
in Mist1CreER/+; Xbp1fl/fl mice will be presented in Chapter 4.
This study revealed that XBP1 is essential for the homeostasis and viability of pancreatic
acinar cells via its role in the unfolded protein response. Future studies will investigate
whether specific, downstream effectors of XBP1 are similarly capable of controlling
viability in stressed cells (see Chapter 6). Additional work, detailed in Chapter 5, has
focused on a specific XBP1-target, MIST1, which itself has been shown to be a key
regulator of acinar cell identity during pancreatic disease (Kowalik et al., 2007; Shi et al.,
2009b, 2012; Zhu et al., 2004). Together, this work demonstrates that XBP1 and its
targets may be an effective means of regulating homeostatic mechanisms in secretory
cells.
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CHAPTER 4. PANCREATIC DAMAGE IN Mist1CreER/+; Xbp1ΔEx2 MICE TRIGGERS A
COORDINATED, MULTI-CELL COMPARTMENT REGENERATIVE RESPONSE
4.1 Introduction
Damage in the exocrine pancreas is generally caused by one of two insults; oncogenic
transformation or pancreatitis. Oncogenic transformation refers to the transdifferentiation
of acinar cells into duct-like structures via acinar-ductal metaplasia (ADM). Acinar cells
undergoing ADM can then develop into pre-cancerous lesions called pancreatic
intraepithelial neoplasia (PanINs), eventually progressing into pancreatic ductal
adenocarcinoma (PDA). This transition occurs after initial expression of mutated,
constitutively active KrasG12D oncogene, thus representing an intrinsic stress on the cells
(Hruban et al., 2006). Pancreatitis is an inflammatory disease in which autoactivation of
digestive enzymes (experimentally induced by secretagogue treatment) results in acinar
cell death, pancreatic edema, and the appearance of ductal structures also from acinarductal metaplasia (Klöppel and Maillet, 1993; Strobel et al., 2007). Multiple mouse
models have been generated to investigate both of these exocrine pancreas diseases.
As shown in Figure 4.01a, PanIN development is governed by expression of
constitutively active forms of the KRAS protein, a downstream effector of extracellular
growth factor (Maitra and Hruban, 2008). At least ten mouse model systems have been
made utilizing activated KRAS, primarily differing in whether KRAS is expressed via
constitutive or inducible promoters (Hruban et al., 2006). The most prevalent model
system uses Cre-mediated induction of activated KRASG12D via deletion of a STOP
cassette, generating a Cre-inducible mutant KRAS allele with tissue specificity based on
the choice of Cre used (Figure 4.01b) (Jackson et al., 2001). These systems have been
used extensively to characterize early oncogenic transformation events in mice,
demonstrating alongside human patient samples that pancreatic cancer development is
associated with an intense desmoplastic response resulting from extensive inflammation
(Pandol et al., 2009). The pronounced inflammatory environment seen during PDA
development is a shared trait also observed in mouse models of pancreatitis.
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Figure 4.1
Exocrine pancreas damage leads to acinar-ductal metaplasia and
inflammation
(A) Illustration of PanIN development showing initial conversion of acinar cells to ductlike cells via expression of mutant KRAS, a mutation found in approximately 90% of
human pancreatic cancers. Later steps involve mutations in the p16 gene followed by
mutations in the TP53, Smad4, and Brca2 genes. Figure modified from Maitra and
Hruban, 2008. (B) Schematic showing the Mist1CreER/+; LSL-Kras mouse line with acinar
cell-specific expression of KrasG12D. Activation of Cre removes the STOP cassette and
allows for expression of the mutant KRASG12D protein. (C) Representative image of
caerulein-induced pancreatitis showing intralobular stromal deposition (black arrow) as
well as open lumened, acinar cells undergoing ADM (red arrows). Figure A adapted from
Maitra and Hruban, 2008. Figure C courtesy of Dr. Daniel DiRenzo.
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Multiple mouse models of pancreatitis also exist, differing primarily in how exocrine
damage is inflicted. Model systems based on surgical obstruction of the pancreatic duct
(Watanabe et al., 1995), feeding of alcohol (Su et al., 2006) or L-arginine (Lerch and
Adler, 1994), or administration of the cholesystokinin (CCK) homologue caerulein
(Jungermann et al., 1995) have all been used extensively in the literature with varying
degrees of success. Caerulein injection has become the predominant model system due
to its ease of delivery via intraperitoneal injection. Caerulein administration triggers
supramaximal levels of acinar cell zymogen secretion, resulting in aberrant release of
digestive enzymes across the basal acinar membrane as well as autoactivation of
intracellular granules (Jungermann et al., 1995). This results in proteolytic tissue
digestion, edema, and inflammation that mimics the appearance of human disease
(Figure 4.01c) (Dawra et al., 2007). Interestingly, acinar-ductal metaplasia is also
observed during pancreatitis, linking both oncogenic and inflammatory damage to
maintenance of acinar cell identity, discussed extensively in Chapter 5.
Acinar-ductal metaplasia serves as a prime example of the plasticity of adult pancreatic
cells. The ability of acinar cells to convert into a duct-like progenitor state when damaged
has been demonstrated in response to oncogenic transformation (Zhu et al., 2007),
caerulein-induced pancreatitis (Strobel et al., 2007), and following dissociation of human
tissue explants in culture (Houbracken et al., 2011). Additionally, the use of growth
factors on cultured acinar cells can trigger conversion of the exocrine-lineage, digestive
enzyme-producing acinar cells to endocrine-lineage, insulin-producing β-cells, a
transition that occurs through a duct-like intermediate (Baeyens et al., 2009; Minami et
al., 2005). These transitional events indicate that damaged or stressed acinar cells
become more duct-like via dedifferentiation, presumably entering a damage-refractory
progenitor state and subsequently redifferentiating following resolution of stress. The
specific transcriptional networks and stress signaling pathways active within acinar cells
are therefore particularly important in maintaining the differentiated identity of the cell.
ADM has been studied using numerous model systems. Isolated acinar cells have been
observed to transdifferentiate into duct-like cysts in culture (Means et al., 2005), while
lineage tracing studies in mice with activated KRAS expression have confirmed that
acinar cells contribute to duct-like PanIN structures in vivo (Habbe et al., 2008; Shi et al.,
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2009b). The use of these model systems has identified specific signaling pathways that
are required for ADM, including the mitogen-activated protein kinase (MAPK) pathway, a
key regulatory pathway known to be affected by the activating KrasG12D mutations that
initiate pancreatic cancer (Habbe et al., 2008; Houbracken et al., 2011). ADM can also
be accelerated via loss of key acinar differentiation factors including MIST1, discussed in
Chapter 5 (Shi et al., 2009b, 2012). Signaling studies using caerulein-induced
pancreatitis models have similarly revealed a need for activation of embryonic signaling
pathways during pancreatic regeneration, specifically the Hedgehog and Notch
pathways (Fendrich et al., 2008). A combination of oncogenic and inflammatory damage
can also synergize in regards to ADM and disease progression, with some studies
indicating that a chronic inflammatory environment is essential for oncogenic
progression in mouse models expressing activated KRAS proteins (Guerra et al., 2007,
2011). Interestingly, both cancer progression and pancreatitis have been linked to
activation of the unfolded protein response.
Expression of the key UPR mediator BiP has been associated with poor prognosis and
lack of chemo-sensitivity in multiple secretory organ cancers including prostate
(Daneshmand et al., 2007), hepatocellular (Su et al., 2010), and breast (Lee et al., 2006)
malignancies. Additionally, multiple chemotherapeutics have been utilized to induce ER
stress as a means of inducing cancer cell cycle arrest or apoptosis (Martins et al., 2011;
Nawrocki et al., 2005b; Wang et al., 2010). UPR activation is also observed in several
experimental models of pancreatitis including L-arginine, alcohol, and caerulein-induced
systems (Alahari et al., 2011; Kubisch et al., 2006; Lugea et al., 2011), with full activation
of the unfolded protein response and all of its branches observed within 8 hours of
pancreatitis induction (Kubisch et al., 2006). Specific studies of Xbp1+/- mice have
indicated that loss of a single copy of Xbp1 also impairs acinar cell recovery in alcoholinduced pancreatitis, supporting the idea that the UPR is a necessary component in
maintaining pancreatic homeostasis during damage. Existing models of pancreatic
damage, however, have produced conflicting data regarding cellular maintenance and
regeneration during damage, necessitating the development of new ways of examining
both pancreas recovery and the role that the UPR may be playing.
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Current pancreatic damage models, while useful, have limitations regarding their
applicability to human disease. Secretagogue-induced mouse models mimic the
histological appearance of human disease but this model relies on the use of caerulein,
a chemical that does not produce a response in human acinar cells and thus may not
accurately replicate the molecular signature of recovering human patients (Ji et al.,
2002). Non-inflammatory, endogenous stress models, including acinar-specific
expression of diphtheria toxin receptors, generate striking levels of acinar cell
destruction and regeneration (Criscimanna et al., 2011). The lack of inflammation in
these models, however, does not mimic the environment of a diseased or damaged
pancreas and thus fails to account for complex epithelial-stromal interactions that may
take place during damage. An ideal system for studying pancreatic damage would
generate sufficient inflammation to mimic human disease while also generating damage
via an intrinsic acinar mechanism known to affect humans. We sought to investigate
whether pancreatic damage resulting from ER stress-induced acinar cell loss in the
Mist1CreER/+; Xbp1fl/fl model system could recapitulate known histological and gene
expression patterns associated with pancreatic damage and regeneration.
In this study we analyzed the effects of extensive, progressive damage on the murine
pancreas following the loss of the Xbp1ΔEx2 acinar cell population. We determined that
ER stress-induced acinar cell loss is compensated for by cell cycle reentry by both the
acinar and centroacinar compartments, with subsequent regeneration of exocrine tissue.
Furthermore, we demonstrate that recovering acinar cells are histologically unusual, with
swollen zymogen compartments and increased cell and nuclear dimensions that may
indicate a compensatory response to exocrine destruction. Finally, we show that loss of
Xbp1 results in long-term pancreatic remodeling and damage, but this damage does not
appear to predispose the pancreas to oncogenic transformation.
4.2 Xbp1ΔEx2 pancreata develop a pronounced inflammatory response and activate
embryonic signaling components
As described in Chapter 3, acinar cells in Mist1CreER/+; Xbp1ΔEx2 mice fail to execute a
sufficient unfolded protein response, leading to progressive UPR activation and eventual
ER stress-induced crisis. One of the hallmarks of exocrine pancreatic damage in both
human patients and rodent models is a pronounced mixed inflammatory/desmoplastic
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response involving tissue-resident macrophage activation and systemic B and T cell
infiltration (Kim, 2008; Whitcomb, 2004). Post-damage tissue regeneration is also linked
to expression of normally silenced pancreas-specific progenitor markers including Pdx1,
Hes1 (a Notch signaling component) and Nestin (Jensen et al., 2005; Means et al.,
2005). We sought to determine whether ER stress-induced damage within the acinar
compartment of Xbp1ΔEx2 mice was sufficient to generate an inflammatory response and
activation of embryonic signaling pathways.
Histological examination of pancreatic sections isolated from two-week post-crisis (6
week post-ablation) Mist1CreER/+; Xbp1ΔEx2 mice revealed extensive cell remodeling within
the intra-acinar spaces. This remodeling included formation of tubular complexes
(Figure 4.02a, white arrows), a common feature seen in caerulein pancreatitis models
and caused by either acinar-ductal metaplasia or reorganization of preexisting ductal
cells (Strobel et al., 2007). These tubular complexes were themselves surrounded by
extensive collagen deposits as determined by Sirius Red staining (Figure 4.02b).
Immunohistochemical staining for the T-cell marker CD3 revealed an extensive influx of
T-cells surrounding the tubular complexes (Figure 4.02c, red arrows). Additional
staining for the B-cell marker F4/80 also revealed the presence of B-cells among the
non-epithelial, tubular complex-adjacent cells (Figure 4.02d, red arrows). These data
indicated that a mixed stromal/inflammatory response occurred within the intra-acinar
spaces in post-crisis pancreata.
We next sought to determine whether Mist1CreER/+; Xbp1ΔEx2 pancreata had altered
progenitor marker expression. RNA isolates from Mist1CreER/+; Xbp1ΔEx2 mice taken
weekly from two to six weeks post-Xbp1 ablation were analyzed for expression of the
progenitor marker/genes Nestin, Hes1, and Pdx1. As shown in Figure 4.03a-c, all three
genes exhibited a similar expression pattern, with significantly upregulated expression
following ablation that progressively increased until four weeks post-Xbp1 ablation. This
was then followed by decreasing expression of all three genes to wild-type levels by six
weeks, with the exception of Pdx1 which still had significantly higher expression levels,
albeit at lower levels than the peak at four weeks. This pattern strongly suggested a
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Figure 4.2
Mixed inflammatory response occurs in recovering pancreata of
CreER/+
Mist1
; Xbp1ΔEx2 mice
(A) H&E image of pancreatic section taken from recovering pancreas showing
development of mucinous, duct-like tubular complexes (TCs) (white arrows). (B) Sirius
Red staining of 6 week post-ablation pancreatic section showing extensive collagen
deposition surrounding tubular complexes (black arrows). (C) Histological stain of
stromal infiltrate and tubular complexes (red outlines) for CD3, showing CD3-positive Tcells (red arrows) surrounding the TCs. (D) Histological stain of stromal infiltrate showing
for F4/80 showing F4/80-positive B-cells surrounding the TCs.
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Figure 4.3
Recovering pancreata in Mist1CreER/+; Xbp1ΔEx2 mice have increased
expression of progenitor genes
RNA isolates from Mist1CreER/+; Xbp1fl/fl pancreata taken at weekly intervals following
Xbp1 ablation. Relative transcript levels for progenitor genes (A) Nestin, (B) Hes1, and
(C) Pdx1 are shown. All genes were progressively expressed, peaking at 4 weeks postablation before to near basal levels. (* = p-value < 0.05 relative to control samples,
normalized to 18s expression)
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correlation between the increasing levels of ER stress described in Chapter 3 and the
expression of known, damage-responsive progenitor genes associated with pancreatic
regeneration.
4.3 Pancreata in post-crisis Xbp1ΔEx2 mice have diminished UPR activation and
recover normal exocrine parameters
Despite the pronounced inflammatory and transcriptional responses to ER stress in the
Mist1CreER/+; Xbp1ΔEx2 mice, we were interested in determining if the pancreata retained
long-term damage or whether there might be a post-crisis restoration of the exocrine
compartment. Histological examination of four-week post-Xbp1 ablation pancreatic
isolates undergoing ER stress-induced crisis revealed a nearly complete lack of acinar
zymogen staining in Xbp1ΔEx2 cells relative to wild-type tissue (Figure 4.04b,e). This
pronounced exocrine deficiency, however, did not result in early lethality in these mice,
prompting us to investigate how the pancreas was capable of continued function despite
a diminished exocrine compartment. Specifically, we sought to identify whether the
remaining acinar cells compensated for the loss of the Xbp1ΔEx2 population or whether a
regenerative response was mounted to replace the damaged cells. We first attempted to
establish if post-crisis Mist1CreER/+; Xbp1ΔEx2 mice were histologically normal.
As shown in Figure 4.04c/f, increased eosinic (zymogen) staining is observed in
samples isolated two weeks after ER stress-induced crisis (6 weeks post-ablation). The
observed acinar cells have substantially increased zymogen staining relative to the four
week post-ablation pancreata, although isolated regions of tissue (Figure 4.04c/f, black
arrows) continue to show signs of residual damaged acinar cells as well as open tubular
structures (yellow arrow). We also noted a pronounced increase in the size of the
acinar compartment (discussed in section 4.5). Given the reestablishment of acinar cells
with substantial zymogen staining, we sought to quantify whether the previously
observed increase in UPR activation seen in Xbp1ΔEx2 acinar cells had been resolved.
Monitoring of the IRE1 branch of the UPR was accomplished via RT-qPCR using Xbp1
splice-specific primers. As seen in Figure 4.05a, IRE1 activity (measured by Xbp1
splicing) was significantly reduced following loss of the Xbp1ΔEx2 acinar population,
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Figure 4.4
Damaged pancreata in Xbp1ΔEx2 mice regenerate the acinar cell
compartment
All images are paired at 20X (A-C) and 60X (D-F) magnification. (A,D) Control (no
tamoxifen) pancreatic sections with normal strong eosinic staining (pink) surrounded by
dense ER and polarized nuclei (purple). (B,E) Four week post-ablation pancreata with
near complete loss of zymogenic staining outside the small, zymogenic clusters of cells
(white outlines). (C,F) Recovering, six week post-ablation pancreatic sections with dense
stromal infiltrate (black arrows) and tubular complexes (yellow arrow). The majority of
the acinar compartment has been restored.
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Figure 4.5
Pancreas-wide UPR activity returns to near-basal levels following loss of
the Xbp1ΔEx2 acinar population
(A) IRE1 activity (as determined by RT-qPCR analysis of splicing of the Xbp1 transcript)
escalates up to four weeks post-ablation and then returns to control levels by six weeks.
(B) Protein blot of pancreatic homogenates shows that activation of the PERK (p-eIF2α)
and ATF6 (nATF6) branches also returns to control levels by 6 weeks. (C) Downstream
effector BiP was elevated and then returned to control levels as determined by RTqPCR. (D) Expression of Chop was drastically reduced in recovering pancreata,
although not quite reaching control levels. (* = p-value < 0.05 relative to control samples,
normalized to 18s expression)
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reaching wild-type levels by six weeks post-ablation. This was accompanied by a similar
reduction in UPR activity in the PERK and ATF6 UPR branches as determined by
protein analysis of pEIF2α and nATF6 levels (Figure 4.05b). RT-qPCR analysis was
conducted on the UPR downstream effectors BiP and Chop, both of which were reduced
to control (BiP) or near-control (Chop) levels by six weeks post-ablation (Figure 4.05cd). These results indicated that UPR activation had returned to basal levels following ER
stress crisis in the Xbp1ΔEx2 acinar cells. As a next step, we investigated whether
zymogen production and localization were similarly returned to wild-type levels in the
post-crisis acinar cells.
RT-qPCR analysis of Amylase transcripts revealed a pronounced increase in expression
following the ER stress crisis observed at four weeks post-ablation in Mist1CreER/+;
Xbp1ΔEx2 mice (Figure 4.06a). This was accompanied by increased protein levels for
amylase as well as a reduction in aberrantly activated carboxypeptidase A (Figure
4.06b), indicating reduced zymogen autoactivation and thus damage within the exocrine
compartment. Immunofluorescence for amylase staining on 4-week post-ablation
pancreatic sections revealed tightly concentrated pockets of amylase expression
restricted to the previously described zymogenic, Xbp1fl/fl acinar cell population (Figure
4.06c, white outlines). This was in stark contrast to 6-week post-ablation sections
(Figure 4.06d) in which amylase was more diffused throughout the pancreas. This
confirmed that the reestablished acinar population observed in Figure 4.04 was correctly
expressing and localizing intracellular zymogens. The 6-week exocrine compartment
also showed an increased presence of ductal cells and duct-like structures, previously
described in section 4.2 (Figure 4.06d, red outlines).
Closer analysis of six week post-ablation pancreatic sections indicated that the recovery
process within the pancreas was accompanied by increased fat deposition (Figure
4.07a,b). Fat deposition is a known hallmark of acute pancreatic damage, and in this
model it is a likely consequence of acinar cell destruction following loss of the Xbp1ΔEx2
population (Klöppel et al., 2004). Additionally, the intra-acinar spaces were analyzed for
expression of the ductal marker SOX9. As shown in Figure 4.07b, large numbers of
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Figure 4.6
Acinar parameters including zymogen synthesis, localization, and
activation all return to normal in recovering Xbp1ΔEx2 pancreata
(A) RT-qPCR of amylase transcripts reveals a return to control expression levels during
recovery. (B) Protein blot of amylase (amy) and damage-induced activated
carboxypeptidase-A (CPAActive) indicating that amylase protein increases to control levels
during recovery while CPAActive disappears. (C) Immunofluorescence staining showing
the restriction of strong amylase staining to the zymogenic, Xbp1fl/fl acinar cells (white
outlines) in 4 week post-ablation pancreata. (D) Immunofluorescence staining showing a
return to clustered, distributed amylase in recovering pancreata. Red outlines depict
amylase-negative ductal and stromal cells in the periacinar space. (* = p-value < 0.05
relative to control samples, normalized to 18s expression)
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Figure 4.7
SOX9

Recovering pancreata express high levels of the ductal/progenitor marker

(A) Six week post-ablation pancreatic sections have signs of damage including fat
deposition and formation of duct-like tubular complexes (white outlines). (B) Staining for
the ductal marker SOX9 shows extensive expression in normal ducts (D) and
ductal/tubular complexes (black arrows) but not in the stromal cells (red arrow) or acinar
tissue (Ac). (C) Sox9 transcripts are elevated during peak damage but remain high in
recovering pancreata. (* = p-value < 0.05 relative to control samples, normalized to 18s
expression)
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ductal cells (black arrows) accumulate in recovering pancreata, a separate response
from the previously described mixed inflammatory cells (red arrow). These duct-like
cells are primarily in the form of tubular complexes, also a known facet of pancreatic
damage (Strobel et al., 2007). RT-qPCR similarly revealed increased expression of Sox9
during and continuing after acinar cell crisis (Figure 4.07c). This is likely due to the
persistent ductal cell population observed in these pancreata.
4.4 Exocrine regeneration following loss of Xbp1ΔEx2 acini is accompanied by
proliferation of both the acinar and centroacinar compartments
The restoration of normal acinar parameters in the recovering Mist1CreER/+; Xbp1ΔEx2
exocrine compartment, coupled with the TUNEL-labeled non-zymogenic acinar cells
reported in Chapter 3, strongly suggested that cells lacking XBP1 died and were
replaced with new acinar cells. There was, however, a possibility that the restored acinar
compartment could have been composed of acinar cells that managed to overcome the
lack of XBP1 and resume their normal program. Indeed histological analysis of
pancreatic sections in 6 week post-ablation mice revealed areas with small acini
expressing low levels of zymogen (Figure 4.08a, white outlines). Additionally,
expression analysis of RNA samples utilizing primers specific for the Xbp1ΔEx2 transcript
revealed persistent, low levels of expression (Figure 4.08b), possibly indicating a
subpopulation of Xbp1ΔEx2 cells that survived within the pancreas.
In order to test whether Xbp1ΔEx2 acinar cells were contributing to the restored acinar
compartment, we performed lineage tracing experiments using the Mist1CreER/+; Xbp1ΔEx2
; R26LacZ reporter line. As described in Chapter 3 (Figure 3.02), cells in Mist1CreER/+;
Xbp1ΔEx2 ; R26LacZ mice express the β-galactosidase gene in response to Cre activity.
This expression occurs following a permanent, Cre-mediated DNA splicing event that
marks both Cre-expressing cells and their progeny. As shown in Figure 4.08c, staining
of stressed 4 week post-ablation pancreatic sections for β-galactosidase expression
revealed that the minor zymogenic acinar population was β-gal negative, while the
majority of the non-zymogenic acinar cells were β-gal positive and thus lacked XBP1.
Matched staining performed on 8 week post-ablation pancreata (Figure 4.08d) showed

86

Figure 4.8

Regenerated acinar cells are derived from a non-Xbp1ΔEx2 lineage

(A) Histological stain showing persistent, small acini (white outlines) within recovering (6
week post-ablation) pancreata. (B) RT-qPCR analysis of the Cre-remodeled Xbp1ΔEx2
transcript shows a significant reduction in levels during recovery, although still above
control (no tamoxifen) values. (C) β-galactosidase (β-gal) immunofluorescence analysis
of four week post-ablation pancreatic sections indicates that non-zymogenic cells
expressed active Cre for recombination while the zymogenic acini (white outline) did not.
(D) β-gal analysis of 8 week post-ablation pancreata indicates that restored acinar cells
are not derived from cells that underwent Cre-mediated DNA recombination. (E) β-gal
analysis shows rare isolated acini that were positive for β-gal but with normal zymogen
content and no signs of ER stress. (* = p-value < 0.05 relative to control samples,
normalized to 18s expression)
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that the recovered acinar compartment was almost entirely β-gal negative, indicating that
these acinar cells were not derived from the Xbp1ΔEx2 population. Interestingly, a small
minority of isolated acini remained β-gal positive despite no obvious cell defects (Figure
4.08e). These cells likely represent acinar cells in which the open ROSA26 (reporter)
locus was recombined while both copies of the endogenous Xbp1fl/fl locus was not.
Given the overwhelmingly β-gal negative state of the restored acinar compartment, we
sought to investigate which pancreatic lineage was responsible for the acinar
regeneration response observed in this model.
Initial investigation of recovering pancreata revealed visual evidence of proliferating
acinar cells via the presence of mitotic figures (Figure 4.09a). This was supported by
immunohistochemical staining for the proliferation marker Ki67 which showed a distinct
and significant increase in proliferative cells following ablation of Xbp1 (Figure 4.09b).
Regeneration was further confirmed by coexpression of Reg1, a protein known to be
associated with regenerating pancreatic cells (Okamoto, 1999). These data suggested
that the restoration of normal acinar properties in recovering acinar cells was due to both
proliferative and regenerative mechanisms.
We next sought to investigate the nature of the exocrine restoration via population
analysis of proliferative staining patterns. As shown in Figure 4.10a,b, cells positive for
both Ki67 and the mitosis-associated phospho-histone 3 (pH3) were found within the
zymogenic, Xbp1fl/fl acinar population in 4 week post-ablation pancreata. This is
consistent with previous findings utilizing caerulein-induced pancreatitis that indicated
that preexisting acinar cells give rise to new acinar cells during pancreatic damage
(Strobel et al., 2007). Interestingly, however, proliferative analysis also revealed Ki67
staining within the centroacinar compartment (Figure 4.10c-e), a HES1/SOX9-positive
cell type that has also been implicated in separate studies as a possible source for
regenerating acinar cells (Criscimanna et al., 2011). Unfortunately, it is not possible to
use lineage tracing in these cells because neither the zymogenic acinar nor centroacinar
compartments would express β-gal, since zymogenic cells did not undergo Cremediated recombination and centroacinar cells do not have an active Mist1 promoter to
express the Cre protein. Therefore, the restored acinar compartment could be
regenerated by either the preexisting acinar or centroacinar compartments.
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Figure 4.9
Recovering pancreata display visible signs of proliferation and express
proliferative and regenerative markers
(A) Histological examination of early recovering pancreata (5 weeks post-ablation)
reveals the presence of mitotic figures in the regenerating acinar compartment. (B)
Analysis of immunohistochemical stains for the proliferative marker Ki67 shows a
significant increase in proliferation as cell damage peaks followed by a reduction in
staining during late recovery. (C) RT-qPCR analysis of RNA isolates shows an increase
in the pancreatic recovery-associated factor Reg1 as ER stress accumulates followed by
a reduction during recovery. (* = p-value < 0.05 relative to control samples, Fig. C
normalized to 18s expression)
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4.5 Recovered pancreata retain abnormal long-term histological features but show
no evidence of increased pancreatic malignancies
Fully regenerated acinar cells (12 weeks post-ablation) in Mist1CreER/+; Xbp1ΔEx2 mice
display no evidence of higher than normal ER stress and express wild-type levels of
amylase. From a morphological perspective, however, the process of regeneration was
seen to alter the structure of the restored cells. As shown in Figure 4.11a, the overall
area of localized zymogens per acinus (white outlines) increased in Mist1CreER/+;
Xbp1ΔEx2 mice relative to control animals. This effect is quite striking at high
magnification (Figure 4.11b, right), where immunofluorescence analysis of amylase
revealed a nearly membrane-to-membrane distribution of zymogen granules within a
recovered acinus. This pattern was very different from the focal, apically-localized
zymogen granules observed in control cells. Quantification of cell and nuclear area in
post-ablation cells via analysis of E-cadherin stained pancreatic sections showed a
progressive increase in both attributes (Figure 4.11c). This increase began to lessen by
12 weeks post-ablation, though still remained significantly higher than wild-type animals.
Given the previously reported link between inflammation and increased likelihood of
pancreatic cancer development (Farrow and Evers, 2002), we also sought to investigate
whether ablation of Xbp1 would increase the likelihood of developing pancreatic
malignancies. Mist1CreER/+; Xbp1ΔEx2 mice were allowed to age for 12 months following
ablation. As shown in Figure 4.12a, pancreata in these animals have a largely
unremarkable acinar compartment populated by histologically normal acinar cells.
Extensive fat deposits, first observed at six weeks post-ablation, remained throughout
the pancreas (Figure 4.12b-d), although tubular complexes are largely absent,
indicating a return to steady-state conditions. Examination of the tissue for precancerous
lesions revealed a general lack of PanINs, although several small proliferative ductal
lesions were apparent (Figure 4.12c,d – black boxes). The observed lesions were
presumably derived from the Xbp1fl/fl tissues in response to the inflammatory
environment generated, since we had previously demonstrated that these mice had
nearly complete loss of the Xbp1ΔEx2 acinar population. These lesions expressed high
levels of mucin (light pink staining) but did not show any degree of nuclear stacking, a
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Figure 4.10 Proliferation takes place in multiple cell compartments following ER
stress-induced death of the Xbp1ΔEx2 acinar cells
(A,B) Ki67 and phospho-Histone 3 (pH3) stainings of 4 week pancreatic sections show
expression (black arrows) and proliferation in the Xbp1fl/fl acinar population. (C,D)
Staining shows coexpresion of HES1 and SOX9 in centroacinar cells (black arrows). (E)
SOX9 and Ki67 colocalize (white arrows) in centroacinar cells following damage.
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Figure 4.11 Regenerated acinar cells are larger than control cells and contain more
widely distributed zymogen granules
(A) Comparison of control and 12 week post-ablation pancreata showing a larger
zymogen compartment (white outlines). (B) Amylase stain revealing cell-wide zymogen
localization of amylase vs. tight, apical localization in control pancreata. Outlines denote
cell boundaries among individual acini. (C) Quantification of cell and nuclear size shows
increases relative to control that persist through 12 weeks post-ablation. (* = p-value <
0.05 relative to control samples)
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Figure 4.12 12 month post-ablation pancreata have normal acinar compartments but
persistent signs of damage
(A) 12 month post-ablation acinar cells have normal histological appearance and
zymogen localization. (B) Fat deposition remains throughout the pancreas, although
healthy acinar cells (Ac) exist within the deposits. (C) Histologically unusual areas exist
in 12 month post-ablation pancreata including ductal structures (black boxes). (D) Highmagnification image of a ductal structure (black box) showing mucinous deposition
(purple stain) but no nuclear atypia.
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known histological feature of developing PanINs (Figure 4.01a). The lack of typical
precancerous lesions is not unexpected, as previous reports have shown that
even the presence of the potent the KrasG12D oncogene is unable to rapidly generate
pancreatic tumors without the addition of either other oncogenes or inflammation via
induced pancreatitis (Guerra et al., 2007; Hruban et al., 2006). We thus sought to
investigate whether addition of a Cre-inducible KrasG12D transgene (LSL-Kras) into the
Mist1CreER/+; Xbp1fl/fl line would lead to increased development of PanIN lesions
immediately following ER stress-induced acinar cell loss.
Mist1CreER/+; Xbp1fl/fl; LSL-KrasG12D (XKC) mice were generated through standard
breeding techniques. These mice underwent acinar-specific Xbp1 ablation with
simultaneous expression of the KrasG12D oncogene (Figure 4.01b). Activation of the
LSL-KrasG12D transgene in otherwise normal mice (Mist1CreER/+; LSL-KrasG12D, or KC
mice) leads to formation of small, focal PanIN lesions with occasional advanced,
mucinous neoplasms and desmoplasia by six weeks post-Cre administration (Figure
4.13 a,b, yellow outlines). We therefore administered tamoxifen to KC and XKC mice
and sacrificed the animals at six weeks post-ablation/activation to determine whether
these animals exhibited increased susceptibility to PanIN formation.
As shown in Figure 4.13c, XKC mice have extensive stromal infiltration of their
periacinar spaces by six weeks post-tamoxifen. This is consistent with standard
Mist1CreER/+; Xbp1ΔEx2 mice that are recovering from loss of the Xbp1ΔEx2 acinar
population, indicating that a similar apoptotic fate was encountered by the Xbp1ΔEx2;
LSL-Kras acinar cells as their counterparts lacking Kras expression. We then used
standard histological stains on isolated pancreatic extracts in order to identify and
quantify the types and numbers of lesions found in both Mist1CreER/+; Xbp1ΔEx2; LSL-Kras
mice and control animals lacking the Xbp1fl/fl allele. As shown in Figure 4.13d, mice in
which Xbp1 had been ablated had significantly fewer small lesions as well as half as
many advanced lesions. These data show that ablation of Xbp1 results in significantly
fewer small lesions per section as well as half as many advanced lesions indicating
either a refraction to KRASG12D-induced lesion formation of or a loss of KRAStransformed cells.
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Figure 4.13
mice

Ablation of Xbp1 reduces occurrence of ADM and early PanINs in XKC

(A) H&E stain of a focal, KRAS-derived lesion (yellow outline). (B) H&E stain of an
advanced lesion (yellow outline) with extensive stromal infiltrate (red arrows). (C)
Comparison of the acinar compartments of 6 week post-tamoxifen Mist1CreER/+; LSLKrasG12D (KC) mice and Mist1CreER/+; Xbp1fl/fl; LSL-KrasG12D (XKC) mice reveals extensive
stromal infiltrate and tubular complex formation (white arrows) in XKC mice. (D)
Histogram showing numbers of focal and advanced lesions in XKC vs. KC mice per
tissue section. There is a nearly 16-fold reduction in focal lesions along with a 2-fold
reduction in advanced lesions in XKC mice.
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4.7 Discussion
Studies of pancreatitis damage often focus on rapid, organ-level responses or long term
development of malignancies. Specifically, the use of rodent models to study damage as
it relates to oncogenesis often utilizes expression of activated mutant forms of KRAS, an
intrinsic stressor that drives transformation (Hruban et al., 2006). These studies allow an
exquisite level of genetic and chemical cell manipulation for studying acinar responses,
but fail to account for the effects of chronic damage or inflammation on cancer
progression. In contrast, research involving pancreatitis typically uses administration of
the secretagogue caerulein to trigger supramaximal levels of aberrant zymogen
secretion (Jungermann et al., 1995). This damage event mimics the appearance of
severe acute pancreatitis in human patients including the appearance of inflammatory
infiltration of the periacinar spaces, loss of exocrine tissue, and edema (Niederau et al.,
1985). Supramaximal zymogen secretion, however, is not a recognized cause of
pancreatitis in human patients, most of whom exhibit acinar cell loss and inflammation
following pancreatic duct obstruction by gallstones (Jha et al., 2009). Additionally,
induction via large doses of caerulein produces inconsistent disease states with mild to
severe inflammation and a large degree of variability in time until recovery (Su et al.,
2006). Other pancreatitis model systems have similar issues with variable inflammatory
induction and variable timing until recovery, making none of the existing systems ideal
for investigating acinar and organ regeneration in response to severe instrinsic stresses
including ER stress. In this study we characterized recovering pancreata in Mist1CreER/+;
Xbp1ΔEx2 mice (Figure 4.14) following extensive ER stress-induced acinar cell death in
order to establish that a near complete exocrine recovery is accompanied by expansion
of the acinar and centroacinar compartments.
The extensive acinar cell death observed in Mist1CreER/+; Xbp1ΔEx2 mice (Figure 3.10)
triggered formation of ductal tubular complexes, collagen and stromal matrix deposition,
and infiltrating immune cells (Figure 4.02). The stromal and immune components of this
response are a key finding as recent studies have indicated that stromal-epithelial
interactions may play a substantial role in progression of cancer (Hwang et al., 2008).
Furthermore, the activation of embryonic signaling pathways (Figure 4.03) mimics
both in vitro (Means et al., 2005) and in vivo (Fendrich et al., 2008) work demonstrating
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Figure 4.14

Timeline of damage and regeneration in Mist1CreER/+; Xbp1ΔEx2 pancreata

(A) Schematic summarizing the effects of ablation of Xbp1 on ER stress, damage, and
reporter gene expression before and after crisis. (B) Schematic summarizing the
regeneration and recovery phenotypes observed following Xbp1 ablation.
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that the recovery mechanisms following ER stress-induced exocrine damage are
consistent with other forms of injury. Additionally, the timing of recovery from the ER
stress-induced apoptotic crisis may increase the utility of the Mist1CreER/+; Xbp1ΔEx2 model
for studying pancreatic regeneration, as an extended, two-week window would allow for
increased observation of molecular events that occur fleetingly during recovery.
As previously described, caerulein-induced pancreatitis is highly variable in terms of its
severity and timing of recovery (Su et al., 2006). In contrast, mice undergoing ER stressinduced acinar cell death in the Mist1CreER/+; Xbp1ΔEx2 model exhibit an extended and
consistent period of damage and recovery. Acinar tissue succumbs to apoptosis on or
about the fourth week following ablation (Figure 4.04), with the majority of recovery
occurring during a two week period four to six weeks after Xbp1 ablation. This recovery
completely ameliorates the ER stress condition (Figure 4.05) while restoring normal
exocrine parameters (Figure 4.06) and exhibiting stromal and ductal cell remodeling in
the periacinar spaces (Figure 4.07). Additionally, acinar cell zymogen compartments
remain dilated for at least 12 weeks following ablation (Figure 4.11), but resolve to
normal size by 12 months (Figure 4.12). Compensatory mechanisms may be
necessitating this altered acinar morphology during the recovery period, but the
regenerative process eventually allows cells to resume their normal structure and
function. These events all take place over a span of weeks or months and allow for a
thorough analysis of cellular and organ responses. This is a distinct advantage over the
highly variable and rapid regeneration observed in response to caerulein which fully
restores the organ 9-12 days following cessation of treatment (Adler et al., 1979).
While the exact source of regenerated acinar cells in Mist1CreER/+; Xbp1ΔEx2 pancreata
cannot be determined due to limitations in lineage tracing in the system, proliferation
analysis indicates that both the acinar and centroacinar compartments reenter the cell
cycle (Figure 4.10). This finding could lead to a reexamination of how these two cell
types may play a role in regeneration. Indeed, analysis of pancreata 12 months after
Xbp1 ablation indicated persistent damage in the form of fat deposition and ductal lesion
formation (Figure 4.12), a unique long-term affect not typically seen in caerulein-induced
models of acute pancreatitis. As a result, the Mist1CreER/+; Xbp1ΔEx2 system could be ideal
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for developing intervention strategies, including treatments for pancreatitis, as the longterm effects are persistent and unique compared to those seen in other model systems.
Finally, we examined whether damage inflicted via ER stress-induced acinar cell
destruction could exacerbate KrasG12D-driven transformation. Our initial hypothesis was
that the pro-inflammatory environment generated by loss of the Xbp1ΔEx2 population
would increase the occurrence of ductal lesion formation. However, as shown in Figure
4.13d, we actually observed a drastic reduction in focal and advanced lesions. Upon
further consideration, this is likely due to the high levels of stress that were placed on the
Xbp1ΔEx2; KrasG12D-expressing acinar cells, who likely succumbed to apoptosis prior to
any substantial oncogenic development. Interestingly, while this hypothesis explains the
overall lack of small PanIN lesions in the pancreas, the presence of several advanced
growths could imply that the inflammatory environment generated by Xbp1ΔEx2-driven
apoptosis created a permissive environment for development of lesions from acinar cells
that only recombined the LSL-Kras gene without ablation of Xbp1. Alternatively, the
advanced lesions could represent acinar cells whose transformation had occurred before
the onset of Xbp1 ablation-mediated ER stress, implying that current work investigating
ER stress as a means of therapy may need to focus on specific stages of cancer
progression. Both hypotheses can be tested in future work utilizing independent
induction systems for the Xbp1flox allele and expression of KRASG12D.
This study demonstrates that the Mist1CreER/+; Xbp1fl/fl system is a viable system for
generating intrinsic, ER stress-derived damage in the exocrine pancreas. Furthermore,
recovery from this damage is prolonged, recapitulating several known characteristics of
pancreatic regeneration including stromal deposition, immune cell infiltration, and
proliferation of pre-existing cells. This regeneration is consistent in terms of timing, with
animals reaching peak pancreatic damage four weeks after Xbp1 ablation and
subsequent full recovery taking place over a period of at least eight weeks. These
characteristics make the Mist1CreER/+; Xbp1fl/fl system ideal for studies of acinar cell
renewal and pancreatic remodeling during damage and recovery.
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CHAPTER 5. MIST1 FUNCTIONS AS A TRANSCRIPTIONAL SCALING FACTOR IN
THE XBP1-MEDIATED BRANCH OF THE UNFOLDED PROTEIN RESPONSE
5.1 Introduction
As discussed previously and later in Chapter 6, multiple forms of stress can lead to
acinar-ductal metaplasia in the mature pancreas. This ability of acinar cells, once
considered a terminally differentiated cell population, to alter their identity to deal with
stress reveals the remarkable plasticity governed by transcriptional networks in adult
pancreatic tissues. One of the key transcription factors linked to maintenance of the
acinar differentiation program is the acinar cell-specific transcription factor MIST1.
MIST1 is a basic helix-loop-helix (bHLH) transcription factor found exclusively in
secretory tissues including secretory B cells, zymogenic chief cells, and pancreatic
acinar cells (PACs) (Capoccia et al., 2011; Pin et al., 2000). In the pancreas, MIST1 is
restricted to healthy acinar cells (Figure 5.01a) and is known to be downregulated as an
early feature seen in human ADM lesions (Figure 5.01b). While MIST1 is not essential
for pancreatic development, its presence is refractory to ADM lesion formation, as
Mist1KO mice develop spontaneous ductal lesions as they age (Pin et al., 2001). This
suggests that MIST1 plays a role in maintaining acinar cell identity via regulation of its
transcriptional targets.
MIST1 has also been shown to be essential for a number of normal acinar cell properties
including cell communication, coordinated secretion, and refraction to oncogenic and
pancreatitis-induced acinar cell damage (Direnzo et al., 2012; Kowalik et al., 2007; Shi et
al., 2012). Importantly, these phenotypes are all reversed upon exogenous expression of
a Cre-inducible MIST1 transgene in adult pancreata, indicating that MIST1 actively
maintains adult PACs rather than merely facilitating their proper development (Direnzo et
al., 2012). The nature of how MIST1 activates its targets is still under active
investigation.
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Figure 5.1
MIST1 is a basic helix-loop-helix transcription factor expressed in
pancreatic acinar cells
(A) Immunohistochemical (IHC) stain for MIST1 shows expression in acinar tissue but
not in islets or blood vessels. (B) IHC stain on a human tissue specimen reveals a lack
of MIST1 expression in ADM lesions. (C) Consensus sequences for a general E-box as
well as the preferred MIST1 binding sequences. (D) Diagram of MIST1 truncations and
relative transcriptional activity, revealing that the bHLH region is sufficient to activate
MIST1 target gene expression.
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MIST1 is a classic bHLH transcription factor, binding to DNA target sequences termed
E-boxes (enhancer boxes) and, more specifically the TA and GC variants (Figure 5.01c)
(Direnzo et al., 2012). However, MIST1 has been shown to lack a recognized
transcriptional activation domain (Tran et al., 2007). In fact, MIST1 can still activate or
repress its transcriptional targets even when truncated down to only its DNA binding
bHLH domain (Figure 5.01d) (Tran et al., 2007). This activity is under current
investigation in the Konieczny lab in an attempt to identify whether MIST1 serves as the
DNA targeting component of a bHLH protein:protein complex with a transcriptional
activator or repressor. Recent work by others, however, has postulated that MIST1 is
part of a relatively new class of transcriptional regulators termed “scaling factors” (Mills
and Taghert, 2012).
The concept of a scaling factor purports that cells utilize unique transcription factors to
more effectively specialize in specific tasks following initial differentiation during
development (Mills and Taghert, 2012). These factors would function to scale up certain
features including expansion of an extensive secretory compartment or a regulated,
polarize cellular architecture in secretory cells. Importantly, these genes would not be
required for the initial establishment of many cell features, but adult cells would require
their constitutive expression in order to maintain a fully functional repertoire of unique,
cell-specific capabilities. MIST1 is a prime candidate for classification as a scaling factor,
as it is not essential for development of the acinar cell secretory machinery or for initial
specification, but mature acinar cells lacking MIST1 have impaired secretion and a
predisposition to transdifferentiate (Direnzo et al., 2012; Pin et al., 2001). Interestingly,
MIST1 is also found exclusively in serous secretory cells, indicating that its scaling
capabilities may be responsible for increasing the secretory capacity of specialized cells
(Pin et al., 2000). This characterization of MIST1’s role in acinar cells is remarkably
similar to the description of many features of the unfolded protein response, which is
itself a specialized transcriptional network designed to facilitate high protein throughput
in secretory cells.
The UPR is a reactive transcriptional response in which misfolded proteins trigger
activation of three distinct ER-embedded sensors; (PKR)-like ER kinase (PERK),
activating transcription factor 6 (ATF6), or inositol requiring enzyme 1 (IRE1) (See
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Figure 1.05 for summary) (Walter and Ron, 2011). IRE1 activates its targets via a
unique endoribonuclease domain that cleaves a 26 nucleotide fragment from the mRNA
of the Xbp1 gene, which causes a frameshift in the translated XBP1 protein (Ron and
Walter, 2007). This protein, termed XBP1s, then proceeds to the nucleus where it
activates its transcriptional targets. We previously have shown that XBP1s is essential
for proper functioning of the UPR in PACs (Hess et al., 2011).
From a transcriptional standpoint, XBP1 shares extensive overlap in targets with nATF6,
the downstream effector of the ATF6 branch of the UPR (Yamamoto et al., 2004). In
fact, both are capable of binding a specific DNA sequence termed the ER stress element
(ERSE), a variable consensus sequence with a five base pair CCACG core but generally
described as CCAAT-N9-CCACG (Acosta-Alvear et al., 2007). Interestingly, XBP1 is
capable of binding the CCACG core directly while nATF6 requires the co-binding of NF-γ
at the upstream CCAAT site before binding. XBP1 also has a unique binding site with a
four-nucleotide ACGT core and a general sequence of CGACGTG(G/A). The relative
abundance of the short CCACG and ACGT sequences in the genome, coupled with the
highly variable nature of the consensus binding sequences, has made bioinformatics
identification of XBP1 direct targets difficult.
MIST1 has been previously linked to expression of XBP1 in a developmental context, as
zymogenic chief cells (ZC) in the stomach of Xbp1ΔEx2 mice fail to express MIST1 when
differentiating (Huh et al., 2010). Surprisingly, these cells did not show signs of ER
stress despite the lack of XBP1 and MIST1, implying that the effects and targets of
XBP1 may be specific to certain cellular contexts. ZCs and other stomach cells are
constantly regenerating, as opposed to the adult pancreas which, in an unstressed
condition, has a turnover rate of less that 1% (Oates and Morgan, 1982). As previously
shown in Figure 3.01 and in contrast to ZCs, acinar cells in Xbp1KO mice express MIST1
, again indicating that the developmental role of XBP1 as a regulator of MIST1 may not
be the same for all cell types.
Generally speaking, XBP1 targets tend to facilitate protein folding including components
expressed throughout the ER and secretory pathway (Sriburi et al., 2007). ER stress,
however, is relatively unique in that it occurs infrequently outside of development or in
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unusual environmental conditions such as hypoxia (Tsang et al., 2010). The exception to
this general rule is in secretory cells, whose primary function is to generate large
volumes of proteins that must properly traffic through the ER and Golgi. Highly secretory
cells, such as pancreatic acinar cells (PACs), have constitutive activation of the UPR
due to the demand placed on their synthetic machinery (Iwawaki et al., 2004). As a
result, one can envision a scenario in which the UPR in secretory cells could regulate
expression of scaling factors that proceed to independently facilitate secretory cell
homeostasis. Such factors could either regulate the expression of unique target genes
outside the canonical UPR pathways, or could aid in increased expression of existing
target genes. We sought to investigate whether ER stress in PACs triggers expression of
the scaling factor MIST1 and its downstream targets
In this study, we utilized in vitro studies with cell lines to characterize the expression of
Mist1 following chemically-induced ER stress. We show a similar expression phenotype
in acinar cells from mice lacking XBP1 or MIST1 in a 3D culture system. We also
demonstrate that expression of XBP1 following ER stress leads to upregulation of Mist1
via direct interaction with its promoter. Furthermore we show via bioinformatic analysis
that a subset of likely MIST1 target genes are induced during periods of ER stress and
share a similar expression pattern to Mist1. We thus conclude that Mist1 is a direct
target of XBP1 and that it functions to control target genes as a component of the
unfolded protein response.
5.2 Induction of ER stress leads to activation of MIST1
ER stress frequently results when increased demand for protein synthesis surpasses the
limit of what the basal cellular machinery is capable of producing. Such a condition was
likely in the Xbp1ΔEx2 pancreata during crisis (4 weeks post-Xbp1 ablation), as the
minority Xbp1fl/fl acinar cells were forced to synthesize sufficient quantities of zymogens
to maintain the health of the animal. In order to test this, we stained pancreatic sections
from Xbp1ΔEx2 mice during crisis (4 weeks post-Xbp1 ablation) for phosphorylated
eukaryotic initiation factor 2 (pEIF2α), the primary target in the PERK UPR branch. As
shown in Figure 5.02b, both zymogenic (red outlines) and non-zymogenic (yellow
outlines) were positive for pEIF2α while associated blood vessels (BV) and stromal cells
(blue outlines) were negative. This confirmed that the zymogenic, XBP1-expressing
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Figure 5.2
Xbp1fl/fl acinar cells undergo ER stress and express higher than normal
levels of MIST1 during pancreatic crisis
(A) IHC stain for phospho-EIF2α (pEIF2α) shows little to no staining in wild-type
pancreata. (B) IHC stain for pEIF2α in 4 week post-Xbp1 ablation pancreata reveals
extensive staining (red arrows) in zymogenic (red outlines) and non-zymogenic (yellow
outline) cells. No staining (black arrows) is present in blood vessels (BV) or associated
stromal tissue (blue outline). (C) RT-qPCR for Mist1 shows increased expression
following Xbp1 ablation up until apoptotic crisis, then decreasing to wild-type levels by 6
weeks. (D) Immunofluorescence image showing high levels of MIST1 staining largely
restricted to the zymogenic acinar population (white outlines). (* = p-value ≤ 0.05 relative
to control samples, normalized to 18s expression)
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acinar population also underwent ER stress, but did not express CHOP or initiate an
apoptotic cascade, likely due to an intact UPR.
We next sought to determine whether Mist1 expression was affected by ER stress
induction. Mist1 transcript levels were quantified using pancreatic RNA isolated from
Xbp1ΔEx2 mice following Xbp1 ablation. As shown in Figure 5.02c, MIST1 expression
increased over control pancreata by 3.5 fold, peaking during apoptotic crisis before
returning to normal. This was surprising as Mist1 is constitutively expressed in normal
acinar cells and is not generally associated with dying cells. We proceeded to stain
pancreatic sections taken at 4 weeks post-Xbp1 ablation (Figure 5.02d) and saw high
expression of MIST1 (white arrows) that was restricted to the zymogenic acinar
population, with only minimal MIST1 staining in the non-zymogenic, Xbp1ΔEx2 cells. This
indicated that the 3.5-fold increase in Mist1 expression levels was due to the <10% of
acinar cells that had retained XBP1 expression. This prompted us to investigate whether
MIST1 expression was a common feature of cells undergoing ER stress.
In order to investigate whether MIST1 expression was a common hallmark of cells
undergoing ER stress we turned to in vitro cell lines. Cell lines have a distinct advantage
versus mice as they can be induced to enter ER stress via treatment with a number of
chemicals, including thapsigargin (a sarco/endoplasmic reticulum calcium ATPase
inhibitor that slows protein transport in and out of the ER), tunicamycin (an inhibitor of nlinked glycosylation that prevents ER sorting of peptides), and DTT (a reduction agent
that cross-links protein disulfide bonds). Each of these induces transient ER stress and a
subsequent UPR within treated cells, allowing analysis of downstream signaling
pathways and molecular events.
We first screened a number of non-transformed and transformed cell lines for normal
UPR initiation, since the tumors that were used to derive transformed lines are usually
subjected to and survive hypoxia and UPR-mediated apoptosis, possibly indicating an
aberrant cellular response to stress (Ma and Hendershot, 2004). As shown in Figure
5.03a-b, analysis of non-transformed mouse embryonic fibroblasts (MEFs) and mouse
266-6 cells (SV40 large T antigen immortalized, non-transformed pancreatic acinar cells)
showed significant Xbp1 splicing following ER stress induction via thapsigargin that
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remained high at 36 hours post treatment. In contrast, HEK293 (human embryonic
kidney), MDA231 (human mammary gland adenocarcinoma), and PANC1 (human
pancreatic cancer) cell lines all lacked significant Xbp1 splicing following treatment
despite strong induction of BiP expression, confirming that these cells also exhibited
increased ER stress (Figure 5.03c-e). Thus, we concluded that non-transformed cell
lines would be the most effective cells for studying UPR targets.
We next sought to determine whether we could replicate the induction of Mist1
expression following ER stress that we observed in Xbp1fl/fl acinar cells in cultured cells
with a normal UPR response. This involved treating cell lines with thapsigargin and
harvesting RNA, protein, and fixed cells for closer analysis. Despite increased Mist1
transcript levels following thapsigargin treatment in MEFs (Figure 5.04a), no MIST1
protein could be detected by protein blot or immunohistochemical staining (Figure
5.04b). Interestingly, a MEF line derived from reporter mice in which β-galactosidase
was knocked into the Mist1 locus revealed that the Mist1 locus was transcriptionally
active during ER stress, but only in a minority of cells. This led us to conclude that Mist1
expression in MEFs may be alternatively regulated, either in a cell cycle-dependent
fashion or possibly via post-translational silencing of MIST1.
266-6 cells are known to express acinar cell digestive enzyme transcripts and respond to
some secretagogues, making them among the most “acinar-like” cell lines available.
Protein analysis performed in the Konieczny lab by Patrick Schweickert confirmed
MIST1 expression in wild-type cells, making them relatively unique among pancreatic
cell lines that are usually derived from ductal cancers in which MIST1 is silenced.
Characterization of the 266-6 cell line following ER stress induction revealed increased
Mist1 transcripts and MIST1 protein, with strong expression maintained up to 36 hours
post-thapsigargin treatment (Figure 5.04c-d). Immunohistochemical staining of fixed
266-6 cells also showed a strong induction of MIST1 protein after ER stress onset
(Figure 5.04e-f). These data confirmed our hypothesis that Mist1 is indeed expressed
following ER stress.
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Figure 5.3
thapsigargin

266-6 cells and mouse embryonic fibroblasts splice Xbp1 in response to

RT-qPCR using primers for spliced Xbp1 and BiP transcripts following thapsigargin
treatment in: (A) Mouse embryonic fibroblasts, high expression of both transcripts. (B)
266-6 cells, high expression of both transcripts. (C) HEK293, little expression of Xbp1s
despite BiP induction. (D) MDA231, high levels of BiP induction without associated
Xbp1s expression. (E) Panc1, high levels of BiP with no Xbp1s. (* = p-value ≤ 0.05
relative to control samples, normalized to 18s expression)
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Figure 5.4

266-6 cells express MIST1 in response to ER stress

(A,B) RT-qPCR and protein blot on thapsigargin-treated WT MEFs reveals increased
Mist1 transcripts but no detectable MIST1 protein. (C,D) RT-qPCR/western blot in
thapsigargin-treated 266-6 cells shows increased Mist1 transcripts and protein. (E,F)
IHC stain for MIST1 reveals few positively-stained cells (white arrows) in basal-state
266-6 cells and extensive staining following ER stress induction via thapsigargin. (* = pvalue ≤ 0.05 relative to control samples, normalized to 18s expression)
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5.3 Mist1 is specifically targeted by XBP1 under conditions of ER stress
Following confirmation of increased Mist1 expression during ER stress, we next sought
to investigate whether XBP1 activity could be correlated with Mist1 expression or its
activities. Since MIST1 is known to control acinar identity and differentiation, we utilized
a collagen-based 3D acinar cell culture system to study whether ablation of Xbp1 would
cause any changes in Mist1 levels or acinar differentiation status. We harvested
Xbp1ΔEx2 acinar cells 48 hours post-ablation and embedded them in a 3D collagen
matrix. As shown in Figure 5.05a, Xbp1ΔEx2 acinar cells are initially deficient in Mist1 and
become moreso by 48 hrs post-embedding (96 hours post-Xbp1 ablation). We also
gauged acinar differentiation status by quantifying the degree to which the embedded
acinar clusters converted to duct-like cysts upon treatment with TGFα, an extracellular
growth factor receptor agonist that mimics activated KRAS signaling (Figure 5.05b).
Xbp1ΔEx2 acinar cells showed an increased tendency to undergo ductal cyst
transdifferentiation when treated with TGFα, a similar phenotype seen in embedded
Mist1KO acinar cells (Shi et al., 2012). Interestingly, Xbp1ΔEx2 acinar cells also showed a
marked tendency to spontaneously convert in the absence of TGFα (Figure 5.05c),
implying an intrinsic differentiation defect that may be related to a lack of Mist1 induction.
We next sought to experimentally determine whether Mist1 was expressed in response
to UPR and Xbp1 activation. To accomplish this we acquired Xbp1KO MEFs, a generous
gift from Dr. Ann-Hwee Lee at Harvard University. These cells were derived from Xbp1KO
embryos, avoiding the problem of post-natal lethality known to occur in Xbp1KO neonates
and allowing analysis in a mouse cell completely devoid of XBP1 protein. Similar to the
Xbp1ΔEx2 allele, these mice have a missing second exon, resulting in a truncated,
nonfunctional protein but still undergoing IRE1-mediated RNA splicing, allowing splicespecific primers to be used to measure ER stress induction (Lee et al., 2003). We
repeated our initial characterization studies of MEFs, this time utilizing WT and Xbp1KO
lines to assay whether Mist1 transcript levels were induced following ER stress in the
absence of XBP1. Intriguingly, Xbp1KO MEFs failed to upregulate Mist1 gene expression
upon ER stress induction, indicating that XBP1 was responsible for Mist1 expression
(Figure 5.06a). We further confirmed that MIST1 expression was not a result of
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Figure 5.5
Loss of Xbp1 in vitro results in increases in induced and spontaneous
ductal cyst formation
(A) RT-qPCR data on isolated acinar clusters in our collagen-based 3D culture system
showing a precipitous drop in Mist1 expression in Xbp1ΔEx2 acinar cells relative to
isolated wild-type acini. (B) Counts of ductal cyst formation in wild-type vs. Xbp1ΔEx2
acinar cells shows significantly increased cyst generation in Xbp1ΔEx2 acinar cells
following TGFα treatment. (C) Ductal cysts spontaneously form at a significantly higher
rate in Xbp1ΔEx2 acinar cells. (* = p-value ≤ 0.05 relative to control samples, Fig. A
normalized to 18s expression)
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activation by other UPR branches by transfecting MEFs with an Xbp1s-encoding plasmid
that caused increased Mist1 transcript levels similar to those seen in response to
thapsigargin (Figure 5.06b). These data indicated that XBP1 activity was directly
responsible for increased Mist1 expression during ER stress.
We next sought to determine whether the Mist1 gene was a direct transcriptional target
of XBP1. This initially involved a sequence analysis of both the human (huMist1) and
mouse (muMist1) promoters, which encode similar proteins but are structurally distinct
due to the presence of an untranslated first exon in the mouse sequence (Figure 5.07a).
We scanned the 1000 base pairs preceding the transcriptional start site of msMist1 and
the corresponding region of huMist1 through to the end of the gene and identified no ER
stress element (ERSE) consensus sequences, eliminating the possibility of a joint
ATF6/XBP1 induction of MIST1. Analysis of the same sequence in the msMist1 gene for
the XBP1-specific unfolded protein response element (UPRE) (Figure 5.07b) revealed
two candidate sites within the mouse gene, termed site A and site B, both matching 7/8
nucleotides of the consensus UPRE sequence. Intriguingly, these sites are either
partially (site A) or fully (site B) conserved in the huMist1 promoter, with the partially
conserved huMist1 site A (termed A’) actually matching 8/8 nucleotides of the consensus
UPRE.
In order to determine whether XBP1 could bind to and activate these regions of the
Mist1 promoter, we utilized luciferase containing fragments of the msMist1 promoter
through intron 1 sequences. These plasmids were cotransfected into 266-6 cells along
with an expression plasmid encoding XBP1. As shown in Figure 5.07c, the promoter
fragment containing both candidate sites was capable of producing a 7-fold increase in
luciferase expression relative to control, indicating XBP1s could directly bind that region
of the Mist1 promoter. Intriguingly, when we tested mutated reporter plasmids in which
either Site A (mutA) or Site B (mutB) had been mutated to remove the UPRE (GACGTG
-> ACTAGT), it was the partially conserved site A that had reduced luciferase activity
while mutation of site B had no significant impact on luciferase expression. We thus
concluded that site A was directly bound by XBP1 while site B was not.
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Figure 5.6

XBP1 is directly responsible for inducing Mist1 expression

(A) RT-qPCR on spliced Xbp1 transcripts in Xbp1KO MEFs indicates ER stress induction
following thapsigargin treatment but with no increase in Mist1 expression levels. (B) RTqPCR analysis of vector (control) or Xbp1s transfected MEFs shows a significant
increase in Mist1 transcripts in cells expressing XBP1s. (* = p-value ≤ 0.05 relative to
control samples, normalized to 18s expression)
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Figure 5.7
constructs

XBP1 activates reporter gene expression in Mist1-promoter region

(A) Schematic of the mouse and human Mist1 genes (msMist1 and huMist1,
respectively). HuMist1 contains only one exon that consists of mostly the entire coding
sequence (CDS), although a 87% sequence match exists between msMist1 exon 1 and
an upstream huMist1 region (green box). (B) Sequence analysis of huMist1 and
corresponding region of msMist1 showing the location of two conserved putative XBP1s
binding sites (A/A’, B). (C) Luciferase expression data following XBP1/Mist1pr-Luc
constructs in 266-6 cells, showing increased expression in the construct containing both
UPREs. Increased expression is lost by mutating site A but unaffected by mutating site
B. (* = p-value ≤ 0.05 relative to pGL3p luciferase value after Xbp1 transfection)
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As a final verification that XBP1-mediated activation of MIST1 was an important
component of MIST1’s activity, we expanded our sequence analysis to an additional
eight species to determine whether either of the two candidate UPRE sites were
conserved. As shown in Table 5.01, site A (found in exon 1) is conserved in human,
mouse, and rat while site B (found in intron 1) is 100% conserved across five species.
Interestingly, four of the remaining five species also have putative XBP1 binding sites
matching the UPRE consensus sequence, indicating that XBP1 binding to the Mist1
promoter plays an important role across higher eukaryotes.
5.4 Proposed MIST1 targets are induced during ER stress
We found no published data analyzing pancreatic acinar cells in the context of ER
stress. Rather than conducting costly microarray or RNA-seq genome-wide expression
studies, we chose to bioinformatically search for possible MIST1-regulated genes by
correlating available published microarray data on XBP1 and the Konieczny lab’s own
data regarding unstressed pancreata. A detailed description of this analysis can be
found in Chapter 2, and selection criteria are summarized in Figure 5.08. Briefly, we
generated a list of 184 possible MIST1 effectors based on published microarray data
utilizing fibroblasts transfected with XBP1 as well as general UPR-associated genes
gleaned from literature searches and commercially available UPR PCR arrays. We then
refined this list using data generated previously by the Konieczny lab by selecting only
genes with significant ChIP-Seq enrichment scores, expression changes following
induction of a Mist1 transgene in a Mist1KO acinar cells, and the presence of either TA or
GC E-boxes in the promoter and first two exons and introns of each candidate gene.
Finally, we cross-checked our remaining candidate effectors against available
microarray data from Ire1KO liver samples treated with tunicamycin as a final selection
criteria, selecting for genes with significantly altered expression levels in WT vs. Ire1KO
samples. This analysis resulted in a short list of 15 high-scoring candidates satisfying all
criteria, with a further 6 genes with strong scores in most areas but that failed to satisfy
one criteria. These genes are listed in Table 5.02.
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Table 5.1

Evolutionary conservation of UPRE sites in the Mist1 gene

Sequence analysis indicates a 100% conservation of the putative UPRE binding site in
intron 1 across five species. Four additional species have variants on UPRE sites in
similar locations, with only one species lacking any identified XBP1 binding site.
Intron 1 (Site 2)

Exon 1 (Site 1)

Species

Sequence

UPRE Match

Sequence

UPRE Match

Human

CCACGTGG

7/8

CGACGTGT

8/8

Mouse

CCACGTGG

7/8

CTACGTGT

7/8

Rat

CCACGTGG

7/8

CGACGTGT

8/8

Chimp

CCACGTGG

7/8

N/A

N/A

Wolf

CCACGTGG

7/8

N/A

N/A

Killer Whale

CGACGTGT

8/8

N/A

N/A

Tasmanian Devil

AGACGTGA

6/8

N/A

N/A

Drosophila

GGACGTGG

7/8

N/A

N/A

Zebrafish

CAACGTGC

6/8

N/A

N/A

Chicken

N/A

N/A

N/A

N/A
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Figure 5.8

Summary diagram of candidate gene selection criteria

Selection criteria for putative MIST1-dependent UPR target genes. Each circle
represents an additional criteria, with the number of genes possessing that criteria and
all previous ones shown in parentheses. Only 15 of the original 184 genes met all five
selection criteria.
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Following the selection of likely MIST1 targets, we next sought to determine if any of the
purported effectors were upregulated following ER stress induction. Given the previously
discussed cell context specificity of XBP1’s targets, we determined that an investigation
of MIST1’s role in the UPR necessitated a viable system for triggering ER stress
specifically in pancreatic acinar cells at higher levels than normally present under basal
conditions. However, the available Xbp1fl/fl mouse model generated extensive and
cumulative ER stress in acinar cells, but removed XBP1, our hypothesized MIST1
activator. Published reports on targeted deletions of other UPR master regulators in
mice did not show extensive ER stress as a consequence of their deletion (Reimold et
al., 2000; Urano et al., 2000; Yamamoto et al., 2007; Zhang et al., 2002). Our own
efforts at inducing ER stress induction in vivo via intraperitoneal injection of both
thapsigargin and tunicamycin showed that such agents either resulted in animals that
became rapidly nonresponsive and ill or a cellular response that was insufficient to
initiate a UPR. We thus determined that 266-6 cells would be our best system for
monitoring how MIST1 functions in the UPR.
We conducted a time course on 266-6 cells treated with thapsigargin to induce ER
stress. These cells were harvested every 12 hours for RNA in order to study expression
changes of candidate genes. Interestingly, analysis of transcript levels over repeated
thapsigargin challenges indicated that Xbp1s expression following thapsigargin
challenge in 266-6 cells rapidly climbs and diminishes, while Mist1 expression increases
and remains elevated for 36 hours after induction (Figure 5.09a). Because of the
sustained Mist1 expression levels, we hypothesized that MIST1 targets would follow a
similar expression pattern, with an initial increase following thapsigargin treatment and
subsequent prolonged elevation. We proceeded to design primers for each candidate
target gene to test the expression pattern of each following ER stress in 266-6 cells.
As shown in Figure 5.09c, 14 of the 21 candidate MIST1 target genes behave similarly
to Mist1, with an initial spike in expression at 12 hours post-ER stress induction followed
by sustained expression over the following 24 hours. This expression pattern is
consistent with our hypothesis regarding MIST1 targets being expressed in a similar
fashion as the Mist1 gene. Five remaining candidates (Figure 5.09b) all have a spike
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Table 5.2

Summary of candidate effectors of MIST1 within the UPR pathway

Catalog of 15 highest scoring and 6 highly-scored putative MIST1 targets. Each gene is
shown with its relative ChIP enrichment score, E-box content at enrichment sites, fold
change in Mist1WT vs. Mist1KO pancreata, fold change with significance in published
Ire1KO + tunicamycin liver sample microarray (So et al., 2012), and associated function.
Commas are used to separate ChIP enrichment and E-box locations when multiple
enrichment sites were identified.
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Figure 5.9
Candidate MIST1 targets display predicted expression patterns upon ER
stress induction
RT-qPCR data from 266-6 cells treated with thapsigargin. (A) Combined Xbp1s and
Mist1 expression data from multiple experiments showing rapid increase and decrease
in Xbp1s levels and comparatively long, persistent elevation of Mist1 expression. (B)
Five of the 19 putative MIST1 targets share a common expression pattern, with high
expression at 12 hours post-ER stress induction followed by approximately 50%
expression at 24 hours that remains by 36 hours. (C) Remaining putative MIST1 targets
all share a similar expression profile to Mist1, with initial elevation and continued, nearly
constant levels at later time points. (* = p-value ≤ 0.05 relative to control samples,
normalized to 18s expression)
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in expression at 12 hours followed by a decline to approximately half that level at 24 and
36 hours, suggesting that they may be targets for direct XBP1 and MIST1 binding, but
not necessarily MIST1 alone.
5.5 A subset of putative MIST1 targets are expressed in a MIST1-dependent
fashion following ER stress
Following our expression analysis, we sought to directly determine whether knock-down
of Mist1 via expression of a Mist1-targeting shRNA would significantly alter expression
levels of the putative target genes. We generated both shCtrl (non-targeting control
shRNA) and shMist1 (targeting the Mist1 CDS) viral constructs and infected 266-6 cells
to generate stable lines. We then proceeded to challenge these cells with thapsigargin
and harvested RNA at 12 hours post-ER stress induction to measure expression levels.
As shown in Figure 5.10, there was no significant difference in Xbp1 activation between
the two groups, although both were significantly induced vs. DMSO-treated controls
(data not shown). Interestingly, nine of the previously identified candidate Mist1-effector
genes had significantly reduced expression following ER stress induction (Figure
5.10b). This is consistent with a model in which MIST1 is serving as the primary
regulator of these ER stress-responsive genes in pancreatic acinar cells.
5.6 Discussion
Molecular mechanisms behind complex cell phenomena are increasingly being utilized
to design modern therapeutics. As more and more knowledge regarding how cells utilize
signaling pathways and feedback mechanisms to regulate their survival accumulates, so
too do the opportunities to target these control circuits more precisely in order to
manipulate aberrant cell behaviors. The unfolded protein response is an emerging target
of interest in cancer treatment, as it utilizes unique pathways to regulate gene
expression and cell survival independent of the more frequently targeted growth
signaling and developmental gene networks (Koong et al., 2006). Ideally, novel
therapeutics would modulate expression of downstream components of a pathway,
making scaling factors such as MIST1 ideal targets as they are not essential for cell
survival or pathway initiation but do facilitate homeostasis and overall cellular health. In
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Figure 5.10 Expression of a subset of Mist1 candidate target genes is significantly
decreased in shMist1 266-6 cells following thapsigargin treatment
Expression analysis of transcripts from shCtrl and shMist1 266-6 stable cell lines treated
with thapsigargin (12 hours post-induction) reveals nine putative MIST1 gene targets
with significantly reduced expression. Splicing of Xbp1, a measure of ER stress levels,
was not affected by Mist1 knockdown. Expression values are scaled to shCtrl values for
illustrative purposes. (* = p-value ≤ 0.05, ** = p-value ≤ 0.01 relative to control samples,
normalized to 18s expression)
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this work we set out to establish if and how MIST1 plays a role in the XBP1-mediated
branch of the unfolded protein response.
Our analysis established that Mist1 is directly upregulated by pancreatic acinar cells
undergoing ER stress (Figure 5.02). Indeed, stressed acinar cells increased total Mist1
expression to over 3.5 fold higher than basal levels, a particularly surprising finding as
this expression took place with less than 10% of the total acinar cell population
contributing to the result. This data indicates that the actual enrichment of MIST1 protein
in the zymogenic population may be far higher than shown in transcript analysis, further
supporting the idea that Mist1 expression is important in regulating acinar cell health
during periods of heightened stress.
We next proceeded to establish that the 266-6 immortalized acinar cell line has
increased MIST1 expression in response to ER stress that mimics our in vivo mouse
findings (Figure 5.03c-d). We also showed that ablation of Xbp1 in cells embedded in a
collagen-based 3D culture system resulted in a general reduction in Mist1 levels and a
drastically increased rate of acinar cell transdifferentiation that mimics the phenotype of
MIST1KO acinar cells (Figure 5.05) (Shi et al., 2012). Furthermore, we established that
Mist1 expression is directly correlated with expression and binding of XBP1 to the Mist1
promoter (Figure 5.07), indicating that MIST1 is involved in the UPR via direct
interaction with one of its primary initiating transcription factors. This provides a link
between previous research showing that Mist1 is developmentally regulated by XBP1
(Huh et al., 2010) and our own work showing a connection between Mist1 expression
and ER stress. Interestingly, we also showed a strong evolutionary conservation
between possible XBP1-binding sites in the human and mouse Mist1 genes, indicating
that the regulation of Mist1 by XBP1 may be an important feature of Mist1-expressing
secretory cells across species.
We lastly sought to identify candidate MIST1 targets that were modulated in response to
ER stress. Using a number of bioinformatic data sets we were able to identify a suite of
21 likely MIST1 targets, with eleven of candidates associated with various protein
transport mechanisms into and out of the ER. This is consistent with recent reports of
MIST1 regulating the Atp2c2 gene, a sarcoplasmic reticulum calcium ATPase known to
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be associated with the secretory pathway and involved in shuttling proteins across the
ER membrane (Garside et al., 2010). In fact, our analysis also independently identified
HTRA2, a protein involved in ER-associated degradation that has also been
demonstrated to be a direct target gene of MIST1 (Direnzo et al., 2012). Htra2 also
shares a similar expression pattern to 13 of the 21 candidate genes upon thapsigargin
treatment (Figure 5.08c). These data support the validity of our approach, and they also
add further support to the idea that one of the primary functions of MIST1 is to facilitate
secretory networks via activation and expression of downstream genes in response to
stress conditions. Indeed, the previously described constant UPR and XBP1 activity
present in the pancreas may be the reason why MIST1 is found constitutively expressed
in exocrine tissue (Iwawaki et al., 2004).
Finally, we validated that nine of our candidate genes have altered expression following
thapsigargin treatment of 266-6 cells and shRNA-mediated knockdown of Mist1. This
prompted us to conclude that Mist1, and not Xbp1, was directly responsible for
expression of this subset of candidate genes, as differences between Xbp1 levels in the
two cell lines were insignificant. Further testing is planned on this suite of genes
including anti-MIST1 ChIP experiments to verify direct binding of MIST1 to each
candidate gene’s respective promoter. Additionally, whole-genome approaches including
ChiP-Seq and RNA-Seq may be utilized to further investigate MIST1 targets in the UPR.
Based on our data, we propose that MIST1 functions as a scaling factor for the unfolded
protein response via activation by XBP1. This role as a facilitating influence rather than
as a critical UPR regulator is also in agreement with published literature showing altered
ER stress responses in MIST1KO mice, which likely survive despite aberrant UPR
functioning due to the supportive nature of MIST1’s target genes. This work serves as a
jumping-off point for possible therapeutic design targeting the UPR and its downstream
networks. While direct disabling of key molecules, such as XBP1, has been shown by us
and others be deleterious to cell survival, targeted modulation of MIST1 or its gene
targets could impair UPR function sufficiently to allow increased cell sensitivity to
chemotherapeutics. We believe that the MIST1 transcriptional network may present an
accessible and effective means of controlling secretory cell survival as a means to treat
human disease.
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CHAPTER 6. HIGH-LEVEL KRASG12D EXPRESSION IN DEVELOPING PANCREATIC
ACINAR CELLS LEADS TO ACINAR-DUCTAL METAPLASIA THAT IS MITIGATED
BY MIST1
6.1 Introduction
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies, with a
five-year survival rate of less than 6% (Siegel et al., 2013). The high fatality rate of PDA
is primarily attributed to a lack of early diagnostic markers and a clear understanding of
early transformation events. The median survival time following diagnosis plummets
from a high of 24 months in patients with small, isolated pancreatic tumors to less than
10 months in patients with local lymph node invasion and less than 5 months in patients
with detectable metastases (Hidalgo, 2010). As a result, extensive research in humans
and mouse models has focused on classifying and investigating how PDA develops and
progresses.
Molecular analysis of pancreatic tumors shows mutations in the RAS proto-oncogene in
greater than 90% of PDA tumor specimens (Hidalgo, 2010). The RAS protein is a
molecular switch that couples activation of membrane-embedded receptor tyrosine
kinases (RTKs) to cytoplasmic and nuclear effectors (Figure 6.01a) (Spaargaren et al.,
1995). RAS binds to activated RTKs via adapter proteins, including growth factor
receptor-bound protein 2 (GRB2) and Son of Sevenless (SOS), that couple the signal
generated by activation and phosphorylation of ligand bound receptors to RAS activation
(McCormick, 1993; Spaargaren et al., 1995). The activation of RAS is governed by GTP
binding facilitated by guanine nucleotide exchange factors (GEFs) while RAS
deactivation is accomplished via hydrolysis of the bound GTP, a process that is
dependent on GTPase activating proteins (GAPs) (Figure 6.01b) (Cox and Der, 2003).
RAS mutations that prevent GTP hydrolysis (including the previously described
KRASG12D mutation) are among the most prevalent in pancreatic and other cancers,
since RAS activity drives downstream pathways that positively affect cell growth and

125

Figure 6.1

Diagram of normal and mutant RAS-based signal transduction

(A) Receptor tyrosine kinase signaling in which ligand binding promotes dimerization of
receptors which then auto/transphosphorylate themselves. Adapter proteins bind to
phosphorylated receptor sites, tethering the RAS molecule and causing it to become
active and initiate signal cascades promoting growth and proliferation. (B) Diagram of
normal RAS activity in which activated GTP-bound RAS hydrolyzes the bound GTP with
the assistance of GTPase activating proteins (GAPs). Reactivation of the molecule
involves exchange of GDP for a new GTP molecule and is facilitated by guanine
nucleotide exchange factors (GEFs). (C) RASG12D has a mutant 12th amino acid (GD)
that prevents RAS inactivation by GAPs and thus is constitutively active.
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proliferation events (Figure 6.01c) (Hingorani and Tuveson, 2003). Interestingly, PDA
progression is believed to require additional genetic insults including deregulation of cell
death pathways via mutations in the p16Ink4A and p53 proteins (Maitra and Hruban,
2008). The disease, however, may still be RAS dependent, as recent work has shown
that inactivation of RAS in a mouse model of RAS-driven pancreatic cancer can cause
tumor regression (Collins et al., 2012).
Advanced PDA is characterized by extensive stromal infiltration of the pancreas that is
often seen alongside epithelial structures resembling enlarged and abnormal ductal
structures termed pancreatic intraepithelial neoplasias (PanINs) (Hruban et al., 2006). A
proposed model for progression from small PanINs into advanced disease utilized
findings that the stromal deposition observed in patients is often focused on specific
pancreatic lobes, termed lobulocentric atrophy (Brune et al., 2006).
The observed fibrous stroma deposition seen in early PDA samples is restricted to lobes
also containing PanINs (Brune et al., 2006). Further analysis of post-mortem pancreatic
samples taken from elderly patients with no evidence of pancreatic disease also found
foci of fibrosis associated with PanIN structures (Detlefsen et al., 2005). These data led
to a proposed model in which PanIN development obstructs normal ducts, preventing
normal zymogen secretion and triggering autoactivation of digestive enzymes leading to
localized tissue damage (Hruban et al., 2008). Localized damage then triggers
inflammation and regeneration via prolonged mitogenic signaling, suppressing normal
cellular mechanisms for preserving DNA integrity and suppressing proliferation. This
allows the expansion of the existing PanIN lesion and development of more extensive
fibrosis, initiating a feedback loop in which the initial lesion promotes an inflammatory
environment that gives rise to other lesions. These findings, coupled with the ductal
expression phenotype and ductal histological appearance prompted many researchers
to conclude that PDA was derived from ductal cells that acquire an activating KRAS
mutation (Figure 6.02a) (Hruban et al., 2008).
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Figure 6.2

Acinar cells directly contribute to PanIN lesions

(A) Proposed model for PanIN development in which duct cells give rise to PanIN
lesions(Hruban et al., 2008). (B) Schematic of genetic loci in Mist1CreER/+; LSL-Kras;
R26LacZ reporter mice coupling acinar-specific KRASG12D expression to β-galactosidase.
(C) PanIN lesions in Mist1CreER/+; LSL-Kras; R26LacZ reporter mice are positive for β-gal
expression, indicating an that these PanINs are initially derived from acinar cells. Image
adapted from Shi et al., 2009b.
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Questions regarding the ductal origin of PDA arose when mouse models in which
oncogenic KRAS was expressed from the duct-specific cytokeratin 19 (K19) promoter
failed to produce PanINs or PDA (Brembeck et al., 2003). Other researchers utilized
lineage tracing models with Cre-mediated acinar-specific activated KRAS expression
coupled to expression of the β-galactosidase gene (Figure 6.02b) (Habbe et al., 2008;
Shi et al., 2009b). This construct labels all cells expressing KRAS as well as their
progeny, allowing tracing of acinar cells that undergo Cre-mediated recombination
regardless of any transdifferentiation events tied to oncogenic transformation. The
appearance of β-gal positive PanIN structures following KRASG12D expression allowed
investigators to conclude that PanIN lesions were being derived from acinar cells via a
process known as acinar-ductal metaplasia (ADM) (Figure 6.02c) (Habbe et al., 2008;
De La O et al., 2008). Updated models of PanIN progression that include data from
mouse studies now include acinar cells as possible sources of PanIN lesions, although
the exact transcriptional networks that are required for ADM have not been fully
elucidated.
Acinar-ductal metaplasia is frequently seen associated with PanIN lesions in human and
mouse models (Brune et al., 2006; Zhu et al., 2007). ADM is accompanied by reduced
digestive enzyme synthesis, altered acinar morphology resulting in cells resembling duct
cells, and expression of duct-restricted proteins including mucin and transcription factor
Sox9 (Figure 6.03) (Kopp et al., 2012). ADM conversion also involves downregulation of
the acinar cell-specific transcription factor MIST1 (Rooman and Real, 2011), although
the exact role MIST1 plays in maintaining acinar cell identity is still under investigation.
Loss of MIST1 in transgenic mice is associated with cell disorganization, polarity loss,
loss of intracellular gap junctions/communication, and increased acinar lumen size
(Figure 6.04) (Direnzo et al., 2012; Jia et al., 2008; Pin et al., 2000; Rukstalis et al.,
2003; Zhu et al., 2004). These mice, however, show no significant decrease in lifespan.
Interestingly, Mist1 knockouts have increased ADM and PanIN formation in KRASG12D
expressing mice (Shi et al., 2009b). However, even in KRAS-expressing, MIST1KO mice,
PanIN formation is sparse and temporally dispersed with only a small subset of acinar
cells undergoing ADM at any given time. This has made studies of KRAS-derived ADM
and its role in PDA development difficult.
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Figure 6.3
Acinar-ductal metaplasia involves alterations to acinar cell morphology
and protein expression
Early PN1 neonatal pancreata have little endoplasmic reticulum staining but still
abundantly express amylase, the highest-produced zymogen in the pancreas. Mist1Kras/+
(discussed later) PN1 mouse pancreata with extensive ADM have multiple openlumened acini (B, left) and drastically reduced amylase production (B, right).
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Figure 6.4
MIST1 regulates cell polarity, gap junction formation, and lumen size in
pancreatic acinar cells
(Left panels) Wildtype adult pancreata with characteristic acinar morphology including
apical-basal polarity (H&E image), expression of CONNEXIN32 (Cx32), and tight acinar
lumens marked by ZONA OCCLUDENS 1 (Zo-1). (Middle panels) Mist1KO pancreata
lack apical-basal polarity and Cx32 expression and have enlarged lumens. (Right
panels) Mist1KO pancreata expressing a Mist1myc transgene have restored polarity, Cx32
expression, and lumen size.
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Correlative studies utilizing human patient samples found that ADM can be observed in
both stand-alone and PanIN-associated states (Shi et al., 2009a). When isolated for
genetic analysis via laser capture microdissection, stand-alone ADMs were found to be
KRASWT while ADM-containing RAS-mutations were exclusively found associated with
PanINs. This data suggests that ADM is not exclusively derived from KRAS mutants in
pancreatic cancer patients, necessitating a further investigation of ADM to determine
how and if RAS governs the ADM process. This has proven to be very difficult in human
patients and existing mouse models, since mutant RAS expression triggers only limited
transformation events despite high penetrance in many mouse systems (Guerra et al.,
2003). More recent work has shown that this refractory response to KRASG12D
expression is due to the need for KRAS activation via initiation of extrinsic mitogenic
signaling (Huang et al., 2013). Indeed, multiple studies have confirmed that oncogenic
RAS mutations within the pancreas do not necessarily lead to development of PDA or
metastatic disease (Lu et al., 2002; Parsons and Meng, 2009; Yan et al., 2005). These
findings indicate that cellular context must be accounted for in developing systems for
studying ADM.
Mouse model work studying pancreatic cancer development has shown that even single
occasions of acute pancreatitis following expression of mutant KRAS can drastically
accelerate PDA progression (Carrière et al., 2009). Pancreatitis leads to development of
extensive ADM, however, it also induces extreme damage throughout the pancreas and
may complicate studies of the KRAS-specific component of ADM development.
Therefore, it seems that the ideal model for studying ADM should utilize a suitable
cellular context to allow KRAS-induced ADM formation without chemical or damageinduced exacerbation. We thus sought to investigate whether high-level expression of
oncogenic RAS in developing mouse pancreata could be used to study acinar-ductal
metaplasia.
In this study, we utilized a mouse model in which activated KRASG12D is expressed from
the acinar cell-specific Mist1 promoter during embryonic development and in the adult
exocrine pancreas. Herein we demonstrate that high-level, acinar cell-specific
expression of activated RAS during embryogenesis generates extensive ADM ductal
structures both during and following development. Furthermore, we show that these
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ductal structures bear the hallmarks of ADM structures including decreased zymogen
synthesis and increased proliferative capacity. Finally, we show that the severity of ADM
formation is mitigated by the MIST1 protein, indicating that MIST1 likely plays a role in
maintaining the acinar cell phenotype during KRAS-induced ADM formation.
6.2 Generation of Mist1Kras/+ mice
The Mist1Kras/+ line was generated via collaboration between the Konieczny and the
Tuveson research group at the University of Pennsylvania. This line expresses
oncogenic KRASG12D from the Mist1 promoter, previously described in this report as
restricted to acinar cells in the pancreas. The mouse line was generated via standard
“knock in” techniques utilizing generation of chimeric mice following homologous
recombination of the Kras4BG12D cDNA into embryonic stem cells (Figure 6.05a)
(Tuveson et al., 2006). Median survival time for Mist1Kras/+ mice was decreased by
approximately 55% (Figure 6.05b). Notably, Mist1Kras/LacZ mice (not included on the plot)
appear externally normal at birth but are severely undersized and die by three days postbirth, revealing the importance of MIST1 to normal acinar cell function.
In order to investigate the effects of KRASG12D expression driven by the Mist1 promoter,
we bred Mist1Kras/+ mice to Mist1LacZ/+ animals (Figure 6.05c). This crossing scheme
generated control Mist1+/+ and Mist1LacZ/+ animals as well as Mist1Kras/+ and Mist1Kras/LacZ
experimental mice. This design allowed us to investigate the effects of KRASG12D
expression both in the presence and absence of MIST1. Of note, Mist1Kras/+ females are
incapable of nursing their young due to expression of KRASG12D in the lactating
mammary gland. As a result, only male Mist1Kras/+ mice were used as breeders, however
female mice were used in embryo studies.
6.3 Mist1Kras/LacZ mice develop extensive ADM that can be rescued by expression of
a MIST1myc transgene
Previous work in mouse models had demonstrated that embryonic expression of high
levels of RAS can lead to development of hyperplasia (Perez-Mancera and Tuveson,
2006). In order to investigate whether Mist1Kras/+ mice develop ADM during development,
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Figure 6.5
Crosses for generating the Mist1Kras/+ line and relevant controls for
embryonic studies
(A) Targeting strategy for generation of the Mist1Kras/+ mouse line. (B) Kaplan-Meier plot
showing median survival time of 10.8 months for Mist1Kras/+ mice vs. 24.2 months for
Mist1+/+ mice. (C) Mist1Kras/+ mice were mated to Mist1LacZ/+ mice to generate both control
(Mist1+/+) animals as well as mice bearing the KrasG12D allele either with or without Mist1
(Mist1Kras/+ and Mist1Kras/LacZ respectively). Figures A and B adapted from Tuveson et al.,
2006.

134
we first harvested pancreata from post-natal day 1 (PN1) embryos from the previously
described mouse cross. Histological examination of sections from fixed pancreata
showed that Mist1+/+ acini have normal apical-basal polarity with basally-localized nuclei
(Figure 6.06a), but they lack strong staining of the ER, presumably due to decreased
need for digestive hydrolases during development and while still nursing. Additionally,
acini in these animals had closed lumens, indicating no basal levels of damage or
developmentally- associated acinar-ductal metaplasia (Figure 6.06a, blue arrows). In
contrast, Mist1Kras/+ PN1 pancreata had a pronounced increase in the occurrence of
ADM-like, open-lumened acini (Figure 6.06b, red outlines and arrows), although
normal acini with closed lumens were also present (Figure 6.06b, blue outline and
arrow). Mist1Kras/LacZ mice had no normal acini. Instead, pancreata in Mist1Kras/LacZ mice
contained a mix of ADM-like open-lumened acini (Figure 6.06c, red outlines and
arrows) and larger duct-like complexes (Figure 6.06c, D.C.).
The striking difference between Mist1Kras/+ and Mist1Kras/LacZ was confirmed to be due to a
deficiency in MIST1 following an experiment performed by Dr. Yan Sun in the Konieczny
lab (Shi et al., 2009b) in which Mist1Kras/LacZ mice were mated to mice expressing a
Mist1myc transgene from the acinar cell-specific elastase promoter (Elpr-Mist1myc). As
shown in Figure 6.07b,c, expression of MIST1myc rescues the Mist1Kras/LacZ phenotype,
eliminating the appearance of large ductal complexes and returning the pancreas to a
Mist1Kras/+ appearance. We next sought to determine whether we could observe the
earliest stages of ADM development via analysis of embryonic pancreata from Mist1Kras/+
and Mist1Kras/LacZ animals.
6.4 Mist1Kras/+ pancreata develop increasing numbers of proliferative ductal
structures during embryogenesis
Embryos were obtained via timed pregnancies at three specific ages; E13.5, E 16.5, and
E18.5. MIST1 expression (and thus KRASG12D expression) was first detected at day
E13.5 and was only present in cells coexpressing amylase (Figure 6.08b, c). However,
no phenotypic difference could be observed between Mist1+/+, Mist1Kras/+, and
Mist1Kras/LacZ animals at E13.5 as distinct, properly organized acini were not yet
distinguishable.
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Figure 6.6

Mist1Kras/+ and Mist1Kras/LacZ animals have disrupted pancreata at birth

(A) Mist1+/+ neonatal pancreata at post-natal day 1 (PN1) have acini (blue dotted lines)
with normal, basal-localized nuclei and closed apical lumens (blue arrows). (B) Mist1Kras/+
PN1 pancreata have both normal acini (blue outline, arrow) and abnormal acini (red
outlines) with open lumens (red arrow) resembling acinar-ductal metaplasia. (C)
Mist1Kras/LacZ PN1 pancreata have predominantly abnormal acini with open lumens (red
outlines, arrows) as well as large duct-like complexes (D.C.).
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Figure 6.7
ADM formation in Mist1Kras/LacZ mice can be rescued via expression of a
Mist1myc transgene
(A) Protein blots on neonatal (PN1) pancreatic isolates for β-galactosidase (β-gal),
MIST1, and MYC. Mist1Kras/LacZ mice lack expression of MIST1 while Mist1Kras/LacZ/ElprMist1myc mice regain expression of MIST1. (B) Mist1Kras/LacZ PN1 pancreata have large
ductal complexes. (C) Mist1Kras/LacZ/Elpr-Mist1myc PN1 pancreata do not have predominant
ductal complexes and resemble Mist1Kras/+ pancreata. Images courtesy from Shi et al.,
2009b.

137

Figure 6.8

E13.5 pancreata express MIST1 in cells coexpressing AMYLASE

(A) Low-magnification of E13.5 embryo. Red box indicates location of the developing
pancreas. (B) H&E and anti-MIST1 IHC images of pancreatic sections from E13.5
embryo. MIST1 is expressed in the terminal buds of the developing pancreas (black
arrows). (C) High magnification image of a pancreatic terminal bud showing
coexpression of MIST1 and AMYLASE, both markers exclusive to acinar cells.
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ADM/open-lumened acini were first observed at E16.5 in all three genotypes (Figure
6.09b). However, the majority of Mist1+/+ acini exhibited normal polarity and closed
lumens with a scant minority of open-lumened structures (Figure 6.09b, left panel
insets). In contrast, acini from Mist1Kras/+ and Mist1Kras/LacZ pancreata were largely of the
open lumen variety (figure 6.09b, center and right panels). This difference in the
KRASG12D-expressing mice was drastically increased by E18.5 (Figure 6.09a). Mist1Kras/+
pancreata, however, had a marked increase in both open-lumened acini and ductal
complexes (Figure 6.09a, middle). Interestingly, Mist1Kras/LacZ pancreata were even
more severe, with the pancreas consisting almost entirely of ductal complexes with few
surviving normal acini (Figure 6.09a, right).
In order to confirm that the ADM/open-lumened acini had decreased acinar properties
we quantified amylase expression via serial section fluorescence imaging on isolated
pancreata. As shown in Figure 6.10a,b, the diffuse amylase content throughout the
exocrine compartment in Mist1+/+ pancreata was vastly diminished in Mist1Kras/+ and
Mist1Kras/LacZ animals, with the majority of zymogen content present in the lumens of the
large ductal complexes (to be discussed later). Quantification of relative amylase
intensity of non-lumenal areas via pixel analysis showed a significant reduction in
amylase content in both KRASG12D-expressing groups relative to control, with no
significant difference between either of the KRAS groups.
Finally, we sought to determine whether the ADM/open-lumened acini were more highly
proliferative, a common observation in ADM and PanIN lesions in human patients. We
stained embryonic sections for the proliferation marker Ki67 and quantified the numbers
of positive nuclei per field as a percentage of total nuclei. As shown in Figure 6.11b,
Mist1Kras/+ and Mist1Kras/LacZ pancreata have a significantly higher proliferative index
during embryonic development relative to Mist1+/+. Both also remain elevated at birth,
although only the Mist1Kras/LacZ pancreata reached the significance threshold of ≥95%.
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Figure 6.9
ADM and ductal lesion formation precede birth in Mist1Kras/+ and
Mist1Kras/LacZ animals
(A) Low magnification images of whole pancreata isolated from E18.5 mice. Mist1+/+
pancreata appear normal, while Mist1Kras/+ pancreata have extensive open lumen acinar
structures and Mist1Kras/LacZ mice have almost entirely large ductal complexes. (B)
Pancreatic sections from E16.5 animals reveal that Mist1+/+ acinar cells have
predominantly closed lumens (inset, white box) with occasional open lumened acini
(inset, red box). Mist1Kras/+ acinar cells are predominantly open lumened (inset, red box),
while Mist1Kras/LacZ acinar cells are entirely open lumened.
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Figure 6.10 Zymogen production is reduced in Mist1Kras/+ and Mist1Kras/LacZ pancreata
throughout development
(A, B) Confocal microscopy of PN1 and E18.5 pancreata reveal diffuse amylase staining
in Mist1+/+ acinar cells (Ac) with little amylase content outside of duct-like complex
lumens (white arrows) in Mist1Kras/+ and Mist1Kras/LacZ animals. (C) Quantification of
relative intensity of amylase staining in acinar areas shows significantly reduced
expression in both Mist1Kras/+ and Mist1Kras/LacZ animals by E18.5. (* = significantly
different with p-value <0.01 relative to Mist1+/+)
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Figure 6.11 Mist1Kras/LacZ pancreata have significantly increased proliferative capacity
throughout development
(A) Immunofluorescence staining for the proliferation marker Ki67 in PN1 pancreatic
sections. (B) Counts of Ki67-positive nuclei per 10X field in E16.5, E18.5, and PN1
pancreatic sections as a percentage of total nuclei. Mist1Kras/LacZ pancreata have
significantly increased proliferative capacity relative to Mist1+/+ throughout development
while Mist1Kras/+ pancreata are significantly increased until birth when they remain
elevated. (* = significantly different with p-value < 0.05 relative to Mist1+/+)
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6.5 Ductal complex size is correlated with expression of MIST1
Since MIST1 appeared to have a substantial effect on phenotype severity between
Mist1Kras/+ and Mist1Kras/LacZ mice, we sought to determine if the previously stated link
between ADM formation and downregulation of MIST1 could be observed in our
embryonic mice. We first stained E16.5 Mist1Kras/+ pancreatic sections for MIST1, as they
previously had been seen to have large numbers of ADM/open-lumened acini.
Surprisingly, the open-lumened acinar structures in E16.5 pancreata were all MIST1
positive (Figure 6.12a, black outlines and arrows). We proceeded to stain E18.5
Mist1Kras/+ pancreatic sections and found extensive MIST1 expression in the ADM
structures (Figure 6.12b, black stars). Interestingly, upon closer examination we
determined that while small ADMs were MIST1 positive, larger ductal complexes were
almost uniformly MIST1 negative (Figure 6.12c). This expression pattern was consistent
in ductal complexes that were larger than their acinar cell counterparts, however smaller
open-lumened acini consistently expressed MIST1.
In order to determine if the downregulation of MIST1 in ductal complexes was
associated with any secretory phenotypes, we stained E18.5 pancreatic sections for the
zymogens amylase and carboxypeptidase A. As shown in Figure 6.13a-c, the lumens of
the ductal cysts in Mist1Kras/+ and Mist1Kras/LacZ pancreata were positive for both amylase
and CPA but negative for a non-zymogen control (α-MIST1, unretrieved). This is unique
as normal ducts in Mist1+/+ pancreata have no zymogen staining. This may be a
byproduct of the ductal complexes being forced to expel the remaining zymogen
granules before completing the conversion from acinar to duct-like cells, although further
analysis is required.
6.6 Adult Mist1Kras/+ acinar cells are predisposed to ductal complex and cyst
formation
In order to determine whether the observed ADM and ductal cysts seen in embryonic
sections from Mist1Kras/+ mice would give rise to ductal lesions in adult mice, we
performed ex vivo and in vivo analyses of mature Mist1Kras/+ pancreata. We first utilized
the collagen-based 3D culture system described in detail in Chapter 4. Briefly, we
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Figure 6.12 Ductal complexes in Mist1Kras/+ mice have a correlation between
expression of Mist1 and reduced size
(A) Immunohistochemical (IHC) stain for MIST1 in Mist1Kras/+ mice at E16.5 shows openlumened acini (black outlines) with MIST1-positive nuclei (black arrows). MIST1-negative
islet nuclei (red arrows) shown for reference. (B) IHC for MIST1 in Mist1Kras/+ E18.5
pancreata shows the presence of both ADM (black stars) and large ductal complexes
(red stars). (C) High magnification image of black boxed area from image B showing
ADM lesions with MIST1-positive nuclei (black outlines, arrows) while ductal complexes
have predominantly MIST1-low or MIST1-negative nuclei (red outlines, arrows).
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Figure 6.13 Ductal structures aberrantly secrete zymogens into their lumens in
Mist1Kras/+ and Mist1Kras/LacZ pancreata
(A) High-magnification confocal immunofluorescence image of representative ductal
lumen in E18.5 Mist1Kras/+ pancreata. Amylase is largely absent from the cells but is
present in the ductal lumen. White outlines represent boundaries of the ductal structures.
(B) Low-magnification stain for carboxypeptidase A (CPA), another zymogen, also
shows strong staining in the ductal lumens. White outlines represent boundaries of the
ductal structures. (C) Non-zymogenic antibody control (α-MIST1, unretrieved) does not
stain ductal lumens. White outlines represent boundaries of the ductal structures.
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isolated acinar cells from 3 month-old Mist1Kras/+ mice via collagenase digestion and
subsequent size exclusion filtering before embedding the resulting clusters in a collagen
matrix. As shown in Figure 6.14, Mist1Kras/+ acinar clusters begin forming ductal cysts
(Figure 6.14, red boxes) within 24 hours of embedding. These clusters subsequently
grew and merged, becoming a large cluster of duct-like cysts with no remaining acinar
clusters by day 5 in culture. Interestingly, this conversion to ductal cysts was
accompanied by a pronounced degradation of the collagen matrix, seen in Figure 6.14
as a pronounced transparency in the collagen by day 5. Mist1+/+ acinar clusters
remained quiescent over the duration of the experiment with a minimum of ductal cyst
conversion.
In order to see whether the pronounced tendency of Mist1Kras/+ acinar clusters to convert
to ductal cysts would lead to in vivo disease, we isolated pancreata from 3-9 month old
Mist1Kras/+ animals. These animals all had palpable masses in the pancreas area of the
gut, although the size of the masses was highly variable. Pancreata were isolated and
sectioned, and representative images are shown in Figure 6.15. Pancreata from
Mist1Kras/+ mice were deficient in acinar tissue (Figure 6.15, right panel - labeled Ac),
with most of the pancreatic bulk being composed of small ductal complexes (Figure 6.15
- black stars) and larger, encapsulated mucinous structures. Following analysis of the
sections conducted with the assistance of Dr. Michael Logan, a certified pathologist, we
concluded that the large encapsulated complexes most closely resembled mucinous
cystic neoplasms (MCNs), a less common oncogenic lesion that progresses slowly and
does not generally give rise to pancreatic ductal adenocarcinoma.
6.7 Discussion
PDA remains a highly lethal human cancer due primarily to insufficient methods of early
diagnosis and understanding of early disease. Mouse models utilizing inducible
expression of oncogenic KRAS variants can give rise to ADM and PanIN precursor
lesions, but typically do so in a wide spatial and temporal window, making analysis of
early events in ADM formation difficult to observe. We sought to determine whether the
Mist1Kras/+ mouse model expressing high levels of acinar-cell specific oncogenic
KRASG12D throughout embryogenesis could serve as a means to investigate early
acinar-ductal metaplasia.
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Figure 6.14

Mist1Kras/+ acinar cells rapidly develop into duct-like cysts in 3D culture

(Top panel) Mist1+/+ acinar clusters grown in a collagen 3D-culture model remain largely
quiescent over five days. (Lower panel) Mist1Kras/+ acinar clusters begin forming duct-like
cysts (red boxes) in culture within 24 hours of collagen embedding. These clusters grow
and combine over subsequent days and also appear to migrate as the collagen disk
degrades.
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Figure 6.15

Mist1Kras/+ mice develop extensive mucinous neoplasms but not PanINs

(A) Low-magnification image of pancreatic section from a 6 month old Mist1Kras/+ mouse.
The vast majority of acinar tissue has been replaced by ductal complexes (black stars)
and other ductal tissues of mixed pathology. (B) High-magnification image of boxed area
from 6.13a shows small pockets of acinar tissue (Ac) as well as well-encapsulated ductal
structures (black outlines). Analysis by a certified pathologist identified these structures
as MCNs, not PanINs.
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As demonstrated in Figure 6.05b, Mist1Kras/+ mice have a drastically shortened lifespan
compared to Mist1+/+ littermates. This decreased lifespan was hypothesized to be due to
advanced pancreatic cancer, although hepatocellular carcinomas resulting from either
metastasis or transient MIST1 (and thus KRASG12D) expression in hepatic stem cells
were also observed (Tuveson et al., 2006). Importantly, Mist1Kras/+ mice develop large
ADM and ductal cyst populations at least as early as E18.5 (Figure 6.09), indicating that
use of the model to observe ADM development would necessitate embryonic tissue
isolation.
ADM and ductal cyst development in both Mist1Kras/+ and Mist1Kras/LacZ animals was
accompanied by a significant decrease in amylase expression (Figure 6.10) and a
significant increase in proliferative capacity (Figure 6.11). Interestingly, the decrease in
amylase expression was observed alongside an aberrant depositing of zymogens into
the ductal lumens of the large complexes (Figure 6.13). This was surprising as ductal
lesions in vivo are frequently disconnected from established ductal networks. This could
indicate that early conversion to ductal cysts is accompanied by aberrant secretion of
digestive enzymes into the periacinar space, providing an alternative reason as to why
ductal cyst formation is closely associated with fibrous stromal deposition (Brune et al.,
2006; Detlefsen et al., 2005).
Reduced MIST1 expression is a hallmark of early ADM and PanIN development, as well
as a general response to damage in acinar cells (Rooman and Real, 2011). Here, we
showed that the absence of MIST1 drastically enhances the effects of embryonic
expression of KRASG12D (Figures 6.07, 6.09). Indeed, recent work by the Konieczny
group utilizing acinar cells isolated from LSL-KrasG12D transgenic mouse showed that
forced overexpression of MIST1 in 3D cultured acinar cells attenuated ductal cyst
formation (Shi et al., 2012). This further establishes that MIST1 serves as a critical
regulator of acinar cell transdifferentiation, either via direct interaction with KRAS
downstream signaling pathways or through enforcement of acinar cell differentiation
programs.
Isolation of acinar clusters from adult Mist1Kras/+ mice indicated a predisposition for these
cells to spontaneously convert to duct-like cysts in culture (Figure 6.14). This finding is
likely due to the high level of RAS expression driven by the MIST1 promoter prompting a
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more rapid damage response following dissociation of the acinar clusters. This is in
agreement with recent work indicating that normal levels of oncogenic RAS are
insufficient to generate substantial lesion development but that high levels of RAS
expression can lead to a pancreatitis-like phenotype and development of cystic
carcinomas and metastatic PDA (Ji et al., 2009). This work is also consistent with our
finding of cystic neoplasm development in adult Mist1Kras/+ mice.
Future directions involving the Mist1Kras/+ line are complicated due to the numerous
pitfalls of high-level RAS expression in MIST1-expressing tissues. The previously
described inability of Mist1Kras/+ females to nurse pups either necessitates the use of
foster mothers for rearing or reduces the available breeding pool to only males.
Additionally, the occurrence of pancreatic malformations as early as PN1 (Figure 6.06)
leads to often severe pancreatic disease by breeding age onset. Anecdotal observations
indicate a reduced drive in Mist1Kras/+ males, making breeding of sufficient numbers of
mice difficult. Nevertheless, the Mist1Kras/+ line does develop extensive ADM throughout
the pancreas, making it ideal for future studies of molecular mechanisms of ADM
conversion using whole pancreatic isolates. Additionally, the correlation of ductal cyst
size with lack of MIST1 expression in E18.5 Mist1Kras/+ pancreata would allow for
molecular analysis of the role of MIST1 in the two structures via laser capture
microdissection of embryonic pancreas sections. Finally, the development of non-PDA
advanced cancer in Mist1Kras/+ mice could be used to investigate the causes and
molecular characteristics of mucinous cystic neoplasms, a form of pancreatic cancer that
receives infrequent attention due to its less common occurrence.
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CHAPTER 7. SUMMARY AND FUTURE DIRECTIONS
Pancreatic ductal adenocarcinoma (PDA) is the most prevalent form of pancreatic
cancer, a malignancy that has become the 4th leading cause of national cancer-related
deaths despite being primarily considered a disease of the elderly (Siegel et al., 2013).
The astonishingly high mortality rate is due to poor understanding of the mechanisms of
development, progression, and spread of the disease. While behavioral and genetic
insults are suspected to be a link between pancreatic cancer and inflammatory
pancreatitis, few studies have attempted to explore the novel cellular response and
transcriptional networks that may link the two diseases and provide novel treatment
options (Farrow and Evers, 2002). This has resulted in a lack of knowledge regarding
possible overlap between the damage responsive pathways of the pancreas and
alternative approaches to preventing malignant progression.
Pancreatic cancer and inflammatory pancreatitis both present substantial hurdles for
researchers and physicians attempting to improve disease understanding and
management. Scientists researching possible causes and treatments of PDA are
hampered by a plethora of mouse models that often fail to recapitulate the full spectrum
of disease conditions (Hruban et al., 2006). Additionally, controversy regarding the
applicability of data based on mouse model systems to human patients has also delayed
possible treatment developments (Rooman and Real, 2011). Physicians face a difficult
problem as well, as patients suffering from either PDA or chronic pancreatitis are
increasingly turning to surgical resection as the only available treatment for either
condition (Ho et al., 2005). Despite technical improvements that have reduced the
exceptionally high mortality rate that once saw over half of patients die from postoperative complications, surgical intervention still carries a morbidity rate as high as 60%
(Ho et al., 2005). These data point to a glaring need for increased knowledge of cancer
development, damage responses, and regenerative mechanisms in the pancreas in
order to provide efficacious, non-surgical treatment options in human disease.
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Recent work in designing targeted cancer therapeutics that are based on a molecular
understanding of the disease have yielded astonishingly effective pharmaceutical
treatments, including drugs such as trastuzumab (an antibody to the Her2 receptor
overexpressed in breast cancer) and imantiinib (an inhibitor to the aberrant Bcr-Abl
tyrosine kinase expressed in certain forms of chronic myelogenous leukemia). Other
approaches, however, have proven less successful, including the long history of
attempted inhibition of the Ras signaling pathway. Ras mutations are among the most
frequent occurrences in human cancers, but represent a difficult-to-drug pathway due to
the incredibly high occurrence of off-target effects and the importance of Ras signaling to
normal cell processes (Chappell et al., 2011). The struggles with Ras have led to new
approaches to chemotherapeutics, particularly a refocusing on small, downstream
signaling pathway and pathway components that may allow sensitization of cancer cells
to broad spectrum chemotherapy options. The unfolded protein response (UPR) is an
emerging pathway of interest for design of new drugs to weaken transformed cancer
cells (Wang et al., 2010).
Transforming cells must initially acquire mutations or genetic insults that promote their
aberrant growth and proliferation. Once acquired, however, cells must then meet the
challenge of increased need for nutrients and oxygen, requiring extensive use of protein
folding in the ER (Ma and Hendershot, 2004). The UPR can initiate adaptive or apoptotic
signaling cascades in transformed cells, making it an ideal target for pharmacological
intervention (Li et al., 2011). Indeed, recent drugs taking advantage of ER stress
induction, coupled with UPR inhibition (Mimura et al., 2012) or novel small molecules
that specifically activate the apoptotic arm of the UPR (Flaherty et al., 2010), have
shown promise in treating various malignancies. These approaches necessitate
advances in understanding how the UPR maintains cell homeostasis as well as the
downstream targets that may be viable options as drugable targets.
Several recent investigations have turned to mouse models in order to investigate the
inner workings of the UPR. While yeast studies have long established that the
IRE1/XBP1 branch of the UPR is the most prevalent and conserved of the three master
regulatory arms (Kimmig et al., 2012), higher eukaryotes have evolved a more complex
interacting response utilizing downstream signaling from the ATF6 and PERK embedded

152
ER sensors (Chakrabarti et al., 2011). This finding prompted numerous groups to
generate developmental knock-out mouse lines of each of the respective UPR master
regulators, producing a wide range of effects from no observable phenotypic differences
at birth (ATF6) to embryonic or neonatal lethality (IRE1) (Reimold et al., 2000; Urano et
al., 2000; Yamamoto et al., 2007; Zhang et al., 2002). The lethality associated with either
IRE1 or XBP1 germline knockouts made investigations of this particular UPR branch
difficult, a problem that was addressed via generation of a Cre-inducible knockout line by
Drs. Ann-Hwee Lee and Laurie Glimcher at Harvard University (Hetz et al., 2008). This
line, termed the Xbp1fl/fl mouse line, has been used by multiple groups to investigate
XBP1’s role in both the UPR and development.
Early investigations of XBP1 revealed that its expression was required for normal liver
development and survival of developing mouse embryos (Reimold et al., 2000). When
XBP1 expression was rescued in the liver, a key observation was made that secretory
machinery in a number of exocrine tissues was disrupted, demonstrating that XBP1 was
required for generating normal protein synthetic organelles (Lee et al., 2005). This
prompted the Mills group at Washington University to use the Xbp1fl/fl mouse line to
generate an inducible adult knock-out line lacking XBP1 expression in the constantly
renewing zymogenic chief (ZC) cells of the stomach (Huh et al., 2010). This research
revealed a deficiency in newly generated ZCs following Xbp1 ablation that was attributed
to failure of these cells to express MIST1, a bHLH transcription factor associated with
maintenance of secretory function in serous secretory cells throughout the body (Huh et
al., 2010). Interestingly, no observable changes in levels of ER stress were observed
despite a lack of XBP1, the primary effector of IRE1 in the UPR. This prompted us to ask
whether XBP1 was essential for UPR functioning and, if so, whether Mist1 was itself a
downstream target of XBP1 playing a previously uncharacterized role in the unfolded
protein response.
In order to better study XBP1 in the context of a highly secretory cell type, our research
utilized pancreatic acinar cells (PACs) that produce more protein than any other cell type
in the human body (Case, 1978). PACs have low-level, constitutive expression of
XBP1s, indicating a basal level of ER stress (Iwawaki et al., 2004). PACs also
constitutively express MIST1, previously shown to be essential for acinar cell

153
organization and identity (Direnzo et al., 2012; Pin et al., 2001; Shi et al., 2012). We thus
sought to generate a PAC-specific, Cre-inducible line in which we could ablate Xbp1 in
adult pancreata. These mice (Mist1CreER/+;Xbp1fl/fl) were then utilized to conduct timed
observations of the effects of Xbp1 ablation on PACs.
Our data revealed that PACs are entirely dependent on the IRE1/XBP1 branch of the
UPR, with strong activation of the other two UPR master regulators failing to ameliorate
basal levels of ER stress. This resulted in an apparent cumulative effect, with PACs
developing increasing signs of zymogen deficit, damage, and ER structural changes
consistent with ER stress, ultimately culminating in expression of CHOP, a key mediator
of the apoptotic component of the UPR, and cell death. This gradual stress accumulation
shows promise for XBP1-mediated therapeutic development, as acinar cells can tolerate
Xbp1 ablation for an extended period of time. While our own studies attempting to
combine Xbp1 ablation with activated KRAS expression were hampered by the
simultaneous ablation/activation necessitated by our Cre-mediated model system, future
investigations utilizing shRNA or small molecule inhibitors of XBP1 in the context of
transformed cells may reveal a novel solution to sensitizing these growing, highly
proliferative masses to chemotherapeutics in a way that spares normal acinar cells. This
could represent an ideal system for preventing expansion of tumors in a way that spares
the organ-devastating effects of pancreatic resection.
Existing models of damage often produce sub-optimal results, requiring either extensive
chemical treatment or genetic “second hits” in order to generate physiologically relevant
levels of exocrine damage and regeneration (Lerch and Adler, 1994). Additionally, these
model systems often produce conflicting results regarding the cell of origin for
regenerated exocrine cells, with some studies implicating pre-existing acinar cells
(Strobel et al., 2007) and others suggesting that the centroacinar/ductal compartment
(Criscimanna et al., 2011) serves as a source of new cells. Inflammatory cells also likely
play a role in exacerbating pancreatic damage, as recent studies have shown a
substantial role for stromal cells in contributing to damage (Guerra et al., 2011). We thus
sought to determine whether ER stress-induced loss of a large portion of the exocrine
compartment could represent a clinically relevant system for studying pancreatic
regeneration.
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Our studies have shown that acinar cell regeneration following Cre-mediated Xbp1
ablation and subsequent loss of acinar cells is accompanied by cell cycle reentry and
proliferation of both the acinar and centroacinar compartments. This proliferation results
in a substantial recovery of the acinar lineage from a minority of acinar cells that failed to
delete both Xbp1 alleles. Importantly, this system leads to large-scale acinar destruction
accompanied by a mixed inflammatory response that is reminiscent of human patient
samples. We thus believe that this model represents a preferred alternative to standard
damage systems, combining the inflammatory environment seen in weaker, chemicallyinduced models with the intrinsic, massive acinar cell loss observed in transgenic
models that fail to generate inflammation. Further follow-up studies may also take
advantage of the generous window of opportunity for studying regenerative signaling
events, as the prolonged recovery time (several weeks) is a distinct advantage over the
rapid regeneration observed following chemical treatments. Indeed, the use of ER stress
as a means of inducing extensive damage may more accuratly represent a chronic
damage state than existing methods requiring frequent hourly treatments inducing
supramaximal levels of aberrant zymogen secretion.
While both the demonstration of XBP1 as an element of acinar cell homeostasis and the
establishment of a novel model of pancreatic damage and regeneration are important
aspects of our work, we believe the most promising use of our data lies in the
establishment of MIST1 as a new component of the unfolded protein response. This is
because tumor cells often overcome regulatory mechanisms mediated by intrinsic stress
pathways as a necessary component of tumor initiation and promotion (Li et al., 2011).
Indeed, recent work has shown that restoration/induction of the UPR in cancer cells can
restore the ability of certain chemotherapeutics to kill previously resistant cell types
(Martins et al., 2011). Thus, increased knowledge regarding downstream targets of
major UPR components may aid in the discovery of new compounds to facilitate current
treatments for pancreatic and other secretory malignancies.
We have shown that Mist1 expression is correlated both in vivo and in vitro with ER
stress, indicating a physiological response suggesting a role in the UPR. We furthermore
demonstrated that this activation was directly due to Xbp1 expression, and XBP1 was
capable of binding to elements of the Mist1 promoter in order to activate transcription.
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Finally, we revealed that a number of putative MIST1 gene targets, determined via
bioinformatic analysis of genome-wide expression data, are expressed in a pattern
suggesting a correlation with MIST1 protein, indicating that these targets may be the
means by which MIST1 exerts an influence on the unfolded protein response. These
data may allow the targeting of specific MIST1 effectors, or MIST1 itself, as a means of
compromising normal UPR function in transformed cells. This, in turn, could provide an
approach to switching cellular ER stress responses from the adaptive to the apoptotic
phases of the UPR. Such a treatment could be combined with other cytotoxic and
chemotherapeutic treatment options in order to provide an extra “push” to cells that may
be responsive to standard drug and radiation therapy, but only submaximally initiating
damage/apoptotic cascades.
In summary, our work has generated a more complete understanding of how the UPR,
and specifically XBP1, play a role in maintaining and sustaining the homeostatic balance
in highly secretory pancreatic acinar cells. We show that XBP1 is an indispensable part
of the mammalian UPR in cells with high demand for secreted products, and that the ER
stress imparted by loss of Xbp1 can be used as a means to study pancreatic disease in
vivo. We furthermore show that XBP1 may exert influence on cell processes both within
and outside the canonical UPR via its direct interaction with MIST1. We believe that
exploring the molecular events mediated by the XBP1/MIST1 interaction should be an
important goal of future work focused on understanding and manipulating exocrine cell
fate in pancreatic disease.
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APPENDICES
Appendix A: ChIP Enrichment Scores and E-box Analysis for all MIST1 Candidate
Effectors

Identification

ChIP-Seq
Enrichment
Locations
Fold
Promoter
2.3

E-boxes
GC
TA
1
0

Gene
abbr.
Alg12

asparagine-linked glycosylation 12

Alg2

asparagine-linked glycosylation 2

Promoter

3.0

2

2

Amfr

Autocrine motility factor receptor

Intron 4

7.0

1

1

Arcn1

archain 1

Intron 1

5.0

0

1

Arfgap3

In 1, Ex 2

5.8, 3.8

1, 2

0

Atf4

ADP-ribosylation factor GTPase
activating protein 3
Activating transcription factor 4

Upstream

3.0

2

0

Atf6

Activating transcription factor 6

Intron 1

5.0

0

2

Atp2a2

Intron 1

8.0

1

0

Atxn3

ATPase, Ca++ transporting, cardiac
muscle, slow twitch 2
Ataxin 3

2.0

1

1

Bet1

blocked early in transport 1

Upstream (900)
Promoter

2.8

1

0

Cct7

Chaperonin containing Tcp1, subunit
7 (eta)
CCAAT/enhancer binding protein
(C/EBP), beta
coatomer protein complex, subunit
zeta 1
CAMP responsive element binding
protein 3-like 3
cAMP responsive element binding
protein 3-like 1
Der1-like domain family, member 1

Promoter

9.0

1

0

Exon 1

3.7

2

0

Intron 1

23.0

0

1

Intron 3

4.0

1

0

Promoter

10.0

2

0

Promoter

2.0

1

0

DnaJ (Hsp40) homolog, subfamily B,
member 9
DnaJ (Hsp40) homolog, subfamily B,
member 11
DnaJ (Hsp40) homolog, subfamily C,
member 1
DnaJ (Hsp40) homolog, subfamily C,
member 10

Exon 1/TSS

4.0

1

0

-2.5K

3.0

0

1

Prom, In 1

7.8, 8.0

0, 2

1, 0

Promoter (2),
In 1

15.0

2, 0,
0

0, 0,
2

Cebpb
Copz1
Creb3I3
Creb3l1
Derl1
Dnajb11
Dnajb9
Dnajc1
Dnajc10

Name

174
Dnajc3

Ero1L

DnaJ (Hsp40) homolog, subfamily C,
member 3
DnaJ (Hsp40) homolog, subfamily C,
member 4
ER degradation enhancer,
mannosidase alpha-like 1
ER degradation enhancer,
mannosidase alpha-like 3
eukaryotic translation initiation factor
2A
Eukaryotic translation initiation factor
2 alpha kinase 3
Endoplasmic reticulum (ER) to
nucleus signalling 1
ERO1-like (S. cerevisiae)

Ero1Lb

ERO1-like beta (S. cerevisiae)

Erp44

Endoplasmic reticulum protein 44

Intron 1

2.5

0

2

Fbxo6

F-box protein 6

Intron 1

8.0

0

0

Fkbp10

FK506 binding protein 10

Upstream -1K

2.1

1

0

Fkbp11

FK506 binding protein 11

Exon 1/TSS

2.4

1

0

Fkbp14

FK506 binding protein 14

Promoter

7.0

2

0

Gcc1

golgi coiled coil 1

Promoter

7.0

0

1

Golga3

golgi autoantigen, golgin subfamily a,
3
golgi autoantigen, golgin subfamily a,
4
golgi autoantigen, golgin subfamily b,
macrogolgin 1
golgi phosphoprotein 3

Intron 1

6.0

1

0

Intron 1

4.0

1

0

Upstream -4K

9.0

1

0

Intron 2

10.0

0

2

Intron 1

7.0

0

1

Promoter

3.0

2

2

Dnajc4
Edem1
Edem3
Eif2a
Eif2ak3
Ern1

Golga4
Golgb1
Golph3
Gopc

Intron 1

3.5

0

2

Exon 1

2.7

1

0

Intron 1 (2)

17, 4.5

0, 1

1, 1

Prom, In 1

7, 4.5

1, 1

0, 1

Intron 1

3.5

0

0

Intron 2

2.7

0

0

Intron 1 (2)

5.7, 21

1, 1

0

Promoter, In
1, In 2
Promoter

6, 6, 10

0,0,1

1,0,0

NO CTRL

0

0

Gorasp2

golgi associated PDZ and coiled-coil
motif containing
golgi reassembly stacking protein 2

H13

histocompatibility 13

Intron 1

2.3

4

0

H47

Histocompatibility 47

Ex 1, In 2

2, 10

2, 1

0, 0

Herpud1

Homocysteine-inducible,
endoplasmic reticulum stressinducible, ubiquitin-like domain
member 1
heme oxygenase (decycling) 1

Intron 1

2.3

0

0

Exon 1/TSS

3.3

2

1

Intron 4

4.0

1

0

Upstream -1k

8.0

1

1

Promoter

4.0

0

0

Intron 1

5.0

2

0

Intron 2

2.1

4

0

Hmox1
Hsp90b1
Hspa13
Hspa2
Hsph1
Htra2

heat shock protein 90 alpha
(cytosolic), class B member 1
Heat shock protein 2
heat shock protein 70 family,
member 13
Heat shock 105kDa/110kDa protein
1
HtrA serine peptidase 2
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Htra4

HtrA serine peptidase 4

Intron 8

2.7

0

0

Hyou1

hypoxia up-regulated 1

7.0

1

0

Kdelr2

KDEL (Lys-Asp-Glu-Leu)
endoplasmic reticulum protein
retention receptor 2
lectin, mannose-binding, 1

Exon 1/Intron
1
Upstream -2K

23.0

1

0

Exon 1

9.0

0

0

Lman1
Manf

Exon 1

3.7

1

1

Mapk10

Mesencephalic astrocyte-derived
neurotrophic factor
Mitogen-activated protein kinase 10

Intron 1

10.0

0

0

Mapk9

Mitogen-activated protein kinase 9

Intron 1

10.0

2

0

Mbtps1

Exon 1/TSS

11.0

1

0

Upstream (3K)
Intron 1

6.0

1

0

4.0

0

1

Promoter

5.5

0

0

Exon 4

10.0

1

0

Intron 1

12.5

0

1

Nucb1

Membrane-bound transcription factor
peptidase, site 1
Membrane-bound transcription factor
peptidase, site 2
multiple coagulation factor deficiency
2
mannoside
acetylglucosaminyltransferase 2
mannosyl-oligosaccharide
glucosidase
Nuclear protein localization 4
homolog (S. cerevisiae)
Nucleobindin 1

Intron 1

4.7

1

0

Ormdl3

ORM1-like 3 (S. cerevisiae)

10, 5

1, 1

0

Os9

Amplified in osteosarcoma

Upstream (3K), Ex 1
Prom, In 3

10, 4

1, 0

0, 2

PDI/Pdia3

Promoter

14.0

2

0

Ex 1, In 1 X 2

13, 4, 8

Pfdn2

Protein disulfide isomerase
associated 3
protein disulfide isomerase
associated 4
Prefoldin 2

Exon 1/TSS

3.0

1, 0,
1
0

0, 1,
0
0

Pfdn5

Prefoldin 5

Intron 2

3.0

0

0

Piga

phosphatidylinositol glycan anchor
biosynthesis, class A
peptidylprolyl isomerase B

Intron 4

8.0

1

0

Intron 1

3.5

2

0

Intron 1

7.7

2

0

Exon 1/TSS

2.3

1

0

Rnf139

Protein phosphatase 1, regulatory
(inhibitor) subunit 15b
RAB33B, member of RAS oncogene
family
Ring finger protein 139

Ex 1, In 1

5, 3.7

0, 1

0, 0

Rnf5

Ring finger protein 5

Intron 1

2.5

0

1

Rpn1

Ribophorin I

Intron 1 (2)

3, 3

1, 0

0, 0

Rrbp1

ribosome binding protein 1

Intron 1

7.0

1

0

Sdf2l1

stromal cell-derived factor 2-like 1

7, 7

1, 1

0, 0

Sec11a

SEC11 homolog A (S. cerevisiae)

Exon 1/TSS,
In 1
Upstream -1K

5.0

1

0

Sec11c

SEC11 homolog C (S. cerevisiae)

Intron 1

4.5

1

1

Mbtps2
Mcfd2
Mgat2
Mogs
Nploc4

Pdia4

Ppib
Ppp1r15b
Rab33b
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Sec31a

Sec31 homolog A (S. cerevisiae)

Intron 1

4.0

0

0

Sec61a1

Sec61 alpha 1 subunit (S. cerevisiae)

Intron 1

3.0

0

0

Sec61b

Sec61 beta subunit

Intron 2

3.8

2

1

Sec61g

SEC61, gamma subunit

-1K, In 1

6, 4

1, 0

0, 0

Sec62

SEC62 homolog (S. cerevisiae)

Intron 1

3.0

1

0

Sec63

SEC63-like (S. cerevisiae)

Intron 1 (2)

5, 4.3

1, 2

1, 0

Sel1I

Sel-1 suppressor of lin-12-like (C.
elegans)
selenoprotein M

Upstream (1.5K), In 1
Exon 1/TSS

8, 5.5

0, 1

0, 0

3.0

0

0

Intron 2

2.7

1

0

Intron 1

12.0

1

1

Intron 1

6.0

1

0

-1K, In 1, In 2

9, 12, 16

0, 1,
1
0

Selm
Serp1
Sil1
Spcs2
Spcs3

signal peptidase complex subunit 3
homolog (S. cerevisiae)
Endoplasmic reticulum chaperone
SIL1 homolog (S. cerevisiae)
signal peptidase complex subunit 2
homolog (S. cerevisiae)
signal recognition particle 68

Intron 1

3.5

Upstream (3K)
Intron 2

10.0

1

0

Srp19

Sterol regulatory element binding
transcription factor 1
Sterol regulatory element binding
factor 2
signal recognition particle 19

1, 0,
2
0

3.7

1

0

Srp54a

signal recognition particle 54A

Exon 1/TSS

11.0

1

0

srp68

signal recognition particle receptor

Intron 1

6.0

2

1

Srpr

signal sequence receptor, gamma

Intron 1

4.8

1

0

Srprb

signal recognition particle receptor, B
subunit
signal sequence receptor, alpha

Intron 1

7.0

0

0

Srebf1
Srebf2

Ssr1

1

0

Intron 1

3.5

0

2

Stx18

translocating chain-associating
membrane protein 1
syntaxin 18

Intron 1 X 3

6, 2.3, 4.8

Surf4

surfeit gene 4

Exon 1/TSS

3.7

1, 2,
1
1

0, 0,
0
0

Syvn1

Synovial apoptosis inhibitor 1,
synoviolin
Torsin family 1, member A (torsin A)

Upstream (3K)

8.0

0

1

Intron 1 X 4

Txndc11

Stress-associated endoplasmic
reticulum protein 1
thioredoxin domain containing 11

4.3, 2.5,
2.8, 4.3
4, 5

2, 1,
0, 0
0, 0

0, 0,
1, 1
0, 0

Txndc5

thioredoxin domain containing 5

Intron 1

1

0

Ube2g2

Ubiquitin-conjugating enzyme E2G 2

Intron 1

2.7

0

0

Ubxn4

UBX domain protein 4

Exon 1

2.0

0

0

Uggt1

Exon 1/TSS,
In 1
Intron 1

2, 2.3

1, 0

0, 0

Uso1

UDP-glucose glycoprotein
glucosyltransferase 1
USO1 vesicle docking factor

3.7

2

0

Usp14

Ubiquitin specific peptidase 14

Promoter

3.0

1

0

Ssr3

Tor1a
Tram1

Promoter

Intron 1 (2)

177
Vamp2

Vcp

vesicle-associated membrane protein
2
vesicle-associated membrane protein
4
vesicle-associated membrane protein
7
Valosin containing protein

Xbp1

X-box binding protein 1

Promoter, In
1, In 2
Promoter

Yipf5

Yip1 domain family, member 5

Exon 1/TSS

Vamp4
Vamp7

Upstream (1K), In 1
Promoter

2.5, 5.0

4, 0

0, 0

6.0

0

0

5, 2.8, 4.7
3.5

1, 1,
1
1

0, 1,
0
0

6.0

0

0

NO DATA
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Appendix B: MIST1 Candidate Effectors With No ChIP Enrichment

Identification
Gene
abbr.
Atf5
Atf6b
Bax
Bet1l
Bfar
Blzf1
Calr
Canx
Cct4
CHOP/D
dit3
Cog3
Cog6
Copb1
Copb2
Cope
Copg
Creb3
Dad1
Ddost
Derl2
Dnajb2

Name
Activating transcription factor 5
Activating transcription factor 6
beta
Bcl2-associated X protein
blocked early in transport 1-like
bifunctional apoptosis regulator
basic leucine zipper nuclear
factor 1
Calreticulin
Calnexin
Chaperonin containing Tcp1,
subunit 4 (delta)
component of oligomeric golgi
complex 3
component of oligomeric golgi
complex 6
coatomer protein complex,
subunit beta 1
coatomer protein complex,
subunit beta 2 (beta prime)
coatomer protein complex,
subunit epsilon
coatomer protein complex,
subunit gamma 1
CAMP responsive element
binding protein 3
DNA-damage inducible transcript
3
defender against cell death 1
dolichyl-diphosphooligosaccharide-protein
glycotransferase
Der1-like domain family, member
2
DnaJ (Hsp40) homolog,
subfamily B, member 2

ChIP-Seq
Enrichment
Locations
Fold
N/A
N/A
N/A
N/A

E-boxes
GC
TA
N/A N/A
N/A N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A
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Dolpp1
Ern2
Erp29
Fkbp1b
Fkbp2
Fkbp7
Ganab
Ganc
Ggcx
Golph3l
Gosr2
Hspa1L
Hspa4
Hspa4L
Hspa5
Hspb9
Insig1
Insig2
Kdelr3
Lepre1
Lman2
Mapk8
Pdia6
Ppia
Prkcsh
Rab3a
Rabac1
Rcn3
Rpn2
Scap
Sec22b
Sec23a

dolichyl pyrophosphate
phosphatase 1
Endoplasmic reticulum (ER) to
nucleus signalling 2
endoplasmic reticulum protein 29
FK506 binding protein 1b
FK506 binding protein 2
FK506 binding protein 7
Alpha glucosidase 2 alpha neutral
subunit
Glucosidase, alpha; neutral C
gamma-glutamyl carboxylase
golgi phosphoprotein 3-like
golgi SNAP receptor complex
member 2
Heat shock protein 1-like
Heat shock protein 4
Heat shock protein 4 like
Heat shock protein 5
Heat shock protein, alphacrystallin-related, B9
Insulin induced gene 1
Insulin induced gene 2
KDEL (Lys-Asp-Glu-Leu)
endoplasmic reticulum protein
retention receptor 3
leprecan 1
lectin, mannose-binding 2
Mitogen-activated protein kinase
8
protein disulfide isomerase
associated 6
Peptidylprolyl isomerase A
Protein kinase C substrate 80K-H
RAB3A, member RAS oncogene
family
Rab acceptor 1 (prenylated)
reticulocalbin 3, EF-hand calcium
binding domain
ribophorin II
SREBF chaperone
SEC22 vesicle trafficking protein
homolog B (S. cerevisiae)
SEC23A (S. cerevisiae)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A

N/A

N/A

N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A
N/A
N/A

N/A

N/A

N/A

N/A
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Sec23b
Sec24d
Srp9
Ssr2
Ssr4
Stx5a
Tcp1
Ube2j2
Ufd1I
Uggt2
Wfs1
Yif1a

SEC23B (S. cerevisiae)
Sec24 related gene family,
member D
signal recognition particle 9
signal sequence receptor, beta
signal sequence receptor, delta
syntaxin 5A
T-complex protein 1
Ubiquitin-conjugating enzyme E2,
J2 homolog (yeast)
Ubiquitin fusion degradation 1 like
UDP-glucose glycoprotein
glucosyltransferase 2
Wolfram syndrome 1 homolog
Yip1 interacting factor homolog A
(S. cerevisiae)

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A

N/A
N/A
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Appendix C: Relative Fold Change in MIST1WT, MIST1KO, and MIST1KO;LSLMIST1MYC for MIST1 Candidate Effectors With ChIP Enrichment and Significant
Expression Differences in MIST1WT vs. MIST1KO

Identification

Array Data

asparagine-linked
glycosylation 12
archain 1

1

1.20

1.01

P-value
(WT vs.
KO)
0.0260

1

-1.21

-1.16

0.0400

Partial

ADP-ribosylation factor
GTPase activating protein 3
ATPase, Ca++ transporting,
cardiac muscle, slow twitch 2
coatomer protein complex,
subunit zeta 1
cAMP responsive element
binding protein 3-like 1
DnaJ (Hsp40) homolog,
subfamily B, member 9
DnaJ (Hsp40) homolog,
subfamily B, member 11
DnaJ (Hsp40) homolog,
subfamily C, member 1
DnaJ (Hsp40) homolog,
subfamily C, member 3
DnaJ (Hsp40) homolog,
subfamily C, member 4
ER degradation enhancer,
mannosidase alpha-like 3
eukaryotic translation initiation
factor 2A
ERO1-like beta (S. cerevisiae)

1

-2.23

-1.35

0.0001

Partial

1

-1.34

-1.04

0.0460

Full

1

-3.19

-1.07

0.0000

Full

1

1.32

1.11

0.0070

Partial

1

1.26

1.22

0.0560

None

1

1.19

1.14

0.0880

None

1

-1.82

-1.12

0.0001

Partial

1

-1.216

1.077

0.0370

Partial

1

1.334

1.05

0.0005

Partial

1

-1.75

-1.11

0.0003

Partial

1

-1.16

-1.2

0.0670

None

1

-1.27

-1.33

0.0130

None

1

-1.24

-1.18

0.0040

None

Fbxo6

Endoplasmic reticulum protein
44
F-box protein 6

1

-1.22

1.07

0.0600

Partial

H13

histocompatibility 13

1

-1.28

1.01

0.0490

Full

H47

Histocompatibility 47

1

-1.16

-1.11

0.0880

Partial

Htra2

HtrA serine peptidase 2

1

-2.78

-1.48

0.0000

Partial

Mapk9

Mitogen-activated protein
kinase 9

1

-1.24

1.01

0.0197

Full

Gene abbr.
Alg12
Arcn1
Arfgap3
Atp2a2
Copz1
Creb3l1
Dnajb11
Dnajb9
Dnajc1
Dnajc3
Dnajc4
Edem3
Eif2a
Ero1Lb
Erp44

Name

Expression fold change
WT

KO

Rescue

Rescue
Full
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Mcfd2

multiple coagulation factor
deficiency 2
mannosyl-oligosaccharide
glucosidase
Amplified in osteosarcoma

1

-1.20

-1.04

0.0650

Full

1

-1.56

-1.20

0.0056

Partial

1

-1.77

-1.24

0.0001

Partial

1

1.24

1.2

0.0890

None

1

1.40

1.36

0.0630

None

Pfdn2

Protein disulfide isomerase
associated 3
protein disulfide isomerase
associated 4
Prefoldin 2

1

1.17

1.08

0.0320

Partial

Pfdn5

Prefoldin 5

1

1.17

1

0.0010

Full

Piga

phosphatidylinositol glycan
anchor biosynthesis, class A
peptidylprolyl isomerase B

1

2.56

1.34

0.0003

Partial

1

1.13

1.04

0.0061

Full

1

-1.22

1

0.0530

Full

Rnf139

Protein phosphatase 1,
regulatory (inhibitor) subunit
15b
Ring finger protein 139

1

-1.264

-1.11

0.0410

Partial

Rrbp1

ribosome binding protein 1

1

1.21

1.18

0.0040

None

Sec11a

1

1.21

1.08

0.0240

Partial

1

-2.62

-1.74

0.0000

Partial

1

-1.20

-1.05

0.0630

Partial

Sec61b

SEC11 homolog A (S.
cerevisiae)
SEC11 homolog C (S.
cerevisiae)
Sec31 homolog A (S.
cerevisiae)
Sec61 beta subunit

1

-1.33

-1.16

0.0148

Partial

Sec61g

SEC61, gamma subunit

1

1.18

1.12

0.0990

Partial

Sec62

SEC62 homolog (S.
cerevisiae)
selenoprotein M

1

1.15

1.16

0.0560

None

1

-1.17

-1.20

0.0810

None

signal peptidase complex
subunit 3 homolog (S.
cerevisiae)
signal peptidase complex
subunit 2 homolog (S.
cerevisiae)
signal recognition particle 68

1

-1.567

-1.19

0.0001

Partial

1

-1.16

-1.03

0.0450

None

1

-1.61

-1.29

0.0004

Partial

1

-1.45

-1.13

0.0019

Partial

1

-1.35

-1.14

0.0010

Partial

1

-1.16

-1.04

0.0305

Full

Stx18

signal recognition particle
receptor
signal sequence receptor,
gamma
translocating chain-associating
membrane protein 1
syntaxin 18

1

-1.19

-1.10

0.0630

Partial

Surf4

surfeit gene 4

1

1.20

-1.02

0.0730

Full

Syvn1

Synovial apoptosis inhibitor 1,
synoviolin

1

-1.386

-1.17

0.0850

Partial

Mogs
Os9
PDI/Pdia3
Pdia4

Ppib
Ppp1r15b

Sec11c
Sec31a

Selm
Serp1
Spcs2
Spcs3
srp68
Srpr
Ssr3
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Tram1

1

-1.80

-1.19

0.0000

Partial

1

-1.2

-1.02

0.0750

Full

Ubxn4

Stress-associated
endoplasmic reticulum protein
1
Ubiquitin-conjugating enzyme
E2G 2
UBX domain protein 4

1

-1.301

-1.032

0.0450

Full

Uso1

USO1 vesicle docking factor

1

-1.18

-1.11

0.0710

Partial

Xbp1

X-box binding protein 1

1

1.16

1.21

0.0640

None

Yipf5

Yip1 domain family, member 5

1

-1.27

-1.27

0.0606

None

Ube2g2
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Appendix D: Relative Fold Change In MIST1WT, MIST1KO, and MIST1KO;LSLMIST1MYC For MIST1 Candidate Effectors With ChIP Enrichment But no Significant
Expression Changes Between MIST1WT vs. MIST1KO

Identification
Gene
abbr.

Alg2
Amfr
Atf4
Atf6
Atxn3
Bet1
Cct7
Cebpb
Creb3I3
Derl1
Dnajc10
Edem1
Eif2ak3
Ern1
Ero1L
Fkbp10
Fkbp11
Fkbp14
Gcc1
Golga3
Golga4

Name

asparagine-linked glycosylation
2
Autocrine motility factor receptor
Activating transcription factor 4
Activating transcription factor 6
Ataxin 3
blocked early in transport 1
Chaperonin containing Tcp1,
subunit 7 (eta)
CCAAT/enhancer binding
protein (C/EBP), beta
CAMP responsive element
binding protein 3-like 3
Der1-like domain family,
member 1
DnaJ (Hsp40) homolog,
subfamily C, member 10
ER degradation enhancer,
mannosidase alpha-like 1
Eukaryotic translation initiation
factor 2 alpha kinase 3
Endoplasmic reticulum (ER) to
nucleus signalling 1
ERO1-like (S. cerevisiae)
FK506 binding protein 10
FK506 binding protein 11
FK506 binding protein 14
golgi coiled coil 1
golgi autoantigen, golgin
subfamily a, 3
golgi autoantigen, golgin
subfamily a, 4

Array Data
Expression fold change
WT
KO
Rescue

P-value
(WT vs.
KO)

1

-1.22

-1.09

>0.1

1
1
1
1
1
1

1.1
-1.12
-1.01
1.12
1.04
-1.05

-1.07
-1.23
1.08
-1.09
-1.09
0.93

>0.1
>0.1
>0.1
>0.1
>0.1
>0.1

1

1.06

-1.1

>0.1

1

-1.02

1.02

>0.1

1

1.09

-1.09

>0.1

1

1.11

-1.67

>0.1

1

-1.12

-1.05

>0.1

1

1.05

-1.11

>0.1

1

-1.02

1.05

>0.1

1
1
1
1
1
1

-1.14
1.24
1.05
1.08
-1.14
1.14

1.21
1.19
-1.07
1.26
-1.16
-1.03

>0.1
>0.1
>0.1
>0.1
>0.1
>0.1

1

-1.16

1.01

>0.1
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Golgb1
Golph3
Gopc
Gorasp2
Herpud1

Hmox1
Hsp90b1
Hspa13
Hspa2
Hsph1
Htra4
Hyou1
Kdelr2
Lman1
Manf
Mapk10
Mbtps1
Mbtps2
Mgat2
Nploc4
Nucb1
Ormdl3
Rab33b
Rnf5
Rpn1
Sdf2l1

golgi autoantigen, golgin
subfamily b, macrogolgin 1
golgi phosphoprotein 3
golgi associated PDZ and
coiled-coil motif containing
golgi reassembly stacking
protein 2
Homocysteine-inducible,
endoplasmic reticulum stressinducible, ubiquitin-like domain
member 1
heme oxygenase (decycling) 1
heat shock protein 90 alpha
(cytosolic), class B member 1
Heat shock protein 2
heat shock protein 70 family,
member 13
Heat shock 105kDa/110kDa
protein 1
HtrA serine peptidase 4
hypoxia up-regulated 1
KDEL (Lys-Asp-Glu-Leu)
endoplasmic reticulum protein
retention receptor 2
lectin, mannose-binding, 1
Mesencephalic astrocytederived neurotrophic factor
Mitogen-activated protein kinase
10
Membrane-bound transcription
factor peptidase, site 1
Membrane-bound transcription
factor peptidase, site 2
mannoside
acetylglucosaminyltransferase 2
Nuclear protein localization 4
homolog (S. cerevisiae)
Nucleobindin 1
ORM1-like 3 (S. cerevisiae)
RAB33B, member of RAS
oncogene family
Ring finger protein 5
Ribophorin I
stromal cell-derived factor 2-like
1

1

1.19

1.14

>0.1

1
1

-1.13
1.16

-1.02
-1.13

>0.1
>0.1

1

1.05

-1.13

>0.1

1

1.08

-1.15

>0.1

1
1

1.15
1.16

1.09
1.23

>0.1
>0.1

1
1

-1.20
-1.02

-1.39
-1.04

.0.1
>0.1

1

-1.03

1.003

>0.1

1
-1.04
1
1.16
NO DATA

1.14
1.12

>0.1
>0.1

1
1

-1.20
1.07

1.00
-1.02

>0.1
>0.1

1

1.05

1.33

>0.1

1

1.09

1.13

>0.1

1

1

1.03

>0.1

1

1.06

-1.33

>0.1

1

-1.11

-1.03

>0.1

1
1
1

1.075
1.04
1.13

-1.07
1.17
-1.04

>0.1
>0.1
>0.1

1
1
1

-1.11
1.08
1.01

-1.24
1.115
-1.02

>0.1
>0.1
>0.1
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Sec61a1
Sec63
Sel1I
Sil1
Srebf1
Srebf2
Srp19
Srp54a
Srprb
Ssr1
Tor1a
Txndc11
Txndc5
Uggt1
Usp14
Vamp2
Vamp4
Vamp7
Vcp

Sec61 alpha 1 subunit (S.
cerevisiae)
SEC63-like (S. cerevisiae)
Sel-1 suppressor of lin-12-like
(C. elegans)
Endoplasmic reticulum
chaperone SIL1 homolog (S.
cerevisiae)
Sterol regulatory element
binding transcription factor 1
Sterol regulatory element
binding factor 2
signal recognition particle 19
signal recognition particle 54A
signal recognition particle
receptor, B subunit
signal sequence receptor, alpha
Torsin family 1, member A
(torsin A)
thioredoxin domain containing
11
thioredoxin domain containing 5
UDP-glucose glycoprotein
glucosyltransferase 1
Ubiquitin specific peptidase 14
vesicle-associated membrane
protein 2
vesicle-associated membrane
protein 4
vesicle-associated membrane
protein 7
Valosin containing protein

1

-1.07

1.07

>0.1

1
1

-1.12
-1.12

1.06
-1.13

>0.1
>0.1

1

1.12

1.13

>0.1

1

-1.2

1.08

>0.1

1

1

1.14

>0.1

1
NO
DATA
1

1.00

-1.23

>0.1

-1.25

-1.12

>0.1

1
1

1.01
1.12

1.01
1.07

>0.1
>0.1

1

-1.03

-1.34

>0.1

1
1

1.15
-1.01

1.14
1.13

>0.1
>0.1

1
1

1.16
-1.02

1.03
-1.01

>0.1
>0.1

1

-1.07

-1.03

>0.1

1

1.01

-1.35

>0.1

1

1.08

-1.04

>0.1
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